| Mineral supplement | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Multivitamin with Minerals Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Mineral supplement |
| Thiamine Mononitrate | IP | 10 mg | ||
| Riboflavin | IP | 3.0 mg | ||
| Pyridoxin Hydrochloride | IP | 15 mcg | ||
| Vitamin B12 | IP | 100mg | ||
| Niacinamide | IP | 50 mg | ||
| Calcium Pantothenate | IP | 1.5 mg | ||
| Folic Acid | USP | 100 mcg | ||
| Biotin | IP | 150 mg | ||
| Ascorbic Acid (as Coated ) | q.s. | |||
| Excipients | ||||
| Approved colored used in Hard Gelatin Capsule shell | ||||
| Multivitamin and Multimineral capsules. | Each Hard Gelatin Capsule contains: | IP | 5000 IU | Mineral supplement |
| Vitamin A concentrate ( powder form) | IP | 5 mg | ||
| Vitamin B1 | IP | 5 mg | ||
| Vitamin B2 | IP | 2 mg | ||
| Vitamin B6 | IP | 25 mcg | ||
| Methylcobalamin | IP | 75 mg | ||
| Vitamin c (coated) | IP | 400 IU | ||
| Vitamin D3 | IP | 15 mg | ||
| Vitamin E acetate | IP | 50 mg | ||
| Nicotinamide | IP | 5 mg | ||
| Calcium D-Pantothenate | IP | 1 mg | ||
| Folic Acid | BP | 0.5 mg | ||
| Copper sulphate | ||||
| Equ. to Copper | USP | 2 mg | ||
| Potassium( as Potassium Sulphate) | USP | 0.5 mg | ||
| Manganese sulphate Monohydrate | IP | |||
| Magnesium sulphate | 3 mg | |||
| Equ. to Magnesium | IP | 75 mg | ||
| Calcium dibasic phosphate equ. to Calcium | IP | 25 mg | ||
| Zinc Sulphate monohydrate | IP | 0.1 mg | ||
| Potassium iodide equ. to Iodine. | q.s. | |||
| Excipients | ||||
| Approved colored used in Hard Gelatin Capsule shell | ||||
| Antibaterial | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Prebiotic and Probiotic Capsules | Each Hard Gelatin Capsule contains: | 0.48 billion | Antibaterial | |
| Lactobacillus acidophillus | 0.48 billion | |||
| Lactobacillus rhamnosus | 0.48 billion | |||
| Bifidobacterium Longum | 0.48 billion | |||
| Bifidobacterium Bifidum | 0.1 billion | |||
| Saccharomyces noulardii | 0.48 billion | |||
| Streptococcus thermophilus | 300 mg | |||
| Fructo oligo saccharide | q.s. | |||
| Excipients | ||||
| Approved colored used in Hard Gelatin Capsule shell | ||||
| Ciprofloxacin, Metronidazole, Terbinafine HCl & Clobetasol Propionate Cream | Composition : | IP | 1.0% w/w | Antibaterial |
| Ciprofloxacin Hydrochloride | IP | 1.0% w/w | ||
| Eq. to. Ciprofloxacin | IP | 1.0% w/w | ||
| Metronidazole benzoate | IP | 0.05% w/w | ||
| Eq. to. Metronidazole | ||||
| Terbinafine Hydrochloride | ||||
| Clobetasol Propionate | IP | 0.16% w/w | ||
| Preservative | IP | 0.033% w/w | ||
| Methyl Paraben | q.s. | |||
| Propyl Paraben | ||||
| Cream Base | ||||
| Clobetasol Propionate, Gentamicin, Miconazole Nitrate &Chlorcresol Cream | Composition: | IP | 0.05% | Antibaterial |
| Clobetasol Propionate | IP | 0.10% | ||
| Gentamicin | ||||
| (As Gentamicin Sulphate) | IP | 2.00% | ||
| Miconazole Nitrate | IP | 0.10% | ||
| Chlorcresol | q.s. | |||
| Cream Base | ||||
| Clotrimazole, Beclomethasone & Neomycin cream | Composition : | IP | 1 % w/w | Antibaterial |
| Clotrimazole | IP | 0.025 %w/w | ||
| Beclomethasone | ||||
| Dipropionate | IP | |||
| Neomycin Sulphate | 0.5 %w/w | |||
| Eq. to Neomycin | ||||
| Chlorocresol | IP | 0.1%w/w | ||
| ( as preservative) | q.s. | |||
| Cream base | ||||
| Silver Sulfadiazine with chlorhexidine Cream | Composition : | IP | 1.0%w/w | Antibaterial |
| Silver Sulfadiazine | IP | 5.0% w/w | ||
| Chlorhexidine Gluconate solution Equivalent to Chlorhexidine Gluconate | q.s | |||
| Cream Base | ||||
| Fradiomycin Cream | Composition : | JP | 5.0 mg | Antibaterial |
| Fradiomycin sulphate | IP | 0.01%w/w | ||
| Chlorocresol | ||||
| (as preservative) | q.s. | |||
| In cream base | ||||
| Mupirocin Cream USP | Composition :- | IP | 2.0%w/w | Antibaterial |
| Mupirocin | q.s. | |||
| Cream Base | ||||
| Sodium fusidate ointment BP | Each gram contains : | IP | 20 mg | Antibacterial |
| Sodium fusidate | q.s. | |||
| Ointment Base | ||||
| Clotrimazole, Menthol,Ichthammol, Boric AcidandzincoxideCream | Composition : | Antibaterial | ||
| Clotrimazole IP0.5%w/w | ||||
| Menthol IP1.0%w/w | ||||
| Ichthammol USP0.2%w/w | ||||
| BoricAcid IP 1.0%w/w | ||||
| ZincOxide IP 5.0%w/w | ||||
| Preservatives: | ||||
| Phenoxyethanol IP0.2%w/w | ||||
| Benzylalcohol IP1.0%w/w | ||||
| CreamBase q.s | ||||
| Pre probiotic Capsule | Each hard gelatin capsule contains: | 30Millions | Antibacterial | |
| Sterptococcus Faecalis T-110 | 2 Millions | |||
| Clostridium Butyeicum T0-A | 1 Millions | |||
| Bacillus mesentericus T0-A | 50Millions | |||
| Lactobacillus Sporogens | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Streptococcus Faecails, Clostridium Butyricum, Bacillus Mesentericus and Lactic Acid Bacillus Capsules | Each Hard Gelatin Capsule Contains: | 30 million | Antibacterial | |
| Streptococcus Faecails | 2 million | |||
| Clostridium Butyricum | 1 million | |||
| Bacillus Mesentericus | 50 million | |||
| Lactic Acid Bacillus | q.s. | |||
| (Lactobacillus Sporogenes) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Pre & Probiotic Capsules | Each hard gelatin capsule contains:- | 30Million | Antibacterial | |
| Streptococcus Faecalis | 2Million | |||
| Clostridium Butyricum | 1Million | |||
| Bacillus Mesentericus | 50Million | |||
| Lactic Acid Bacillus | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Tetracycline HCl capsules IP | Each hard gelatin capsule contains:- | IP | 500mg | Antibacterial |
| Tetracycline Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Clindamycin Hydrochloride Capsule IP | Each hard gelatin capsule contain: | IP | 150 mg | Antibacterial |
| Clindamycin Hydrochloride | ||||
| Equivalent to Clindamycin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule | ||||
| Oxytetracycline HCl capsules IP | Each hard gelatin capsule contains: | IP | 500mg | Antibacterial |
| Oxytetracycline Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Micanazole Nitrate and Flucinolone Acetonide cream | Composition: | IP | 2.0%w/w | Antibacterial |
| Micanazole Nitrate | IP | 0.01% w/w | ||
| Flucinolone Acetonide | q.s. | |||
| In a Cream base | ||||
| Mupirocin ointment IP | Composition :- | IP | 2.0%w/w | Antibacterial |
| Mupirocin | q.s. | |||
| Ointment Base | ||||
| Clotrimazole & Beclomethasone Dipropionate Cream | Composition : | IP | 1.0%w/w | Antibacterial |
| Clotrimazole | IP | 0.025%w/w | ||
| Beclomethasone Dipropionate | ||||
| Preservatives: | IP | 1.0%w/w | ||
| Benzyl Alcohol | IP | 0.15%w/w | ||
| Methyl Paraben | q.s | |||
| Cream base | ||||
| Fusidic Acid Cream IP | Composition:- | IP | 2.00%w/w | Antibacterial |
| Fusidic Acid | q.s. | |||
| Cream Base | ||||
| Sodium fusidate ointment BP | Each gram contains : | IP | 20 mg | Antibacterial |
| Sodium fusidate | q.s. | |||
| Ointment Base | ||||
| Nanocrystalline Silver Gel | Composition: | 0.002%w/w | Antibacterial | |
| Nanocrystalline Silver | q.s. | |||
| Gel Base | ||||
| Nadifloxacin Gel | Composition: | IP | 1.00% | Antibacterial |
| Nadifloxacin | q.s. | |||
| Cream base | ||||
| Clarithromycin Tablets IP 500 mg | Each Film Coated Tablet Contains:- | IP | 500 mg | Antibacterial |
| Clarithromycin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Clotrimazole Vaginal Tablets IP 100 mg | Each Uncoated Vaginal Tablet Contains:- | IP | 100 mg | Antibacterial |
| Clotrimazole | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Clotrimazole Vaginal Tablets IP 200 mg | Each Uncoated Vaginal Tablet Contains:- | IP | 200 mg | Antibacterial |
| Clotrimazole | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Clotrimazole Vaginal Tablets IP 500 mg | Each Uncoated Vaginal Tablet Contains:- | IP | 500 mg | Antibacterial |
| Clotrimazole | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Sertaconazole Nitrate Vaginal Tablets 500 mg | Each Uncoated vaginal Tablet Contains:- | BP | 500 mg | Antibacterial |
| Sertaconazole Nitrate | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Azithromycin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Azithromycin Dihydrate IP | ||||
| Eq. to Azithromycin ——- 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Norfloxacin Tablets IP. | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Norfloxacin IP ——————-400mg | ||||
| Excipients————————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Norfloxacin Tablets IP. | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Norfloxacin IP 200mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Norfloxacin Tablets IP. | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Norfloxacin IP 800mg | ||||
| Excipients—————–q.s. | ||||
| Colour-Approved colour used. | ||||
| Levofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Levofloxacin Hemihydrate IP | ||||
| Eq. to Levofloxacin ——–750 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Levofloxacin Hemihydrate IP | ||||
| Eq. to Levofloxacin ——–250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ciprofloxacin Hydrochloride IP | ||||
| Eq. to Ciprofloxacin ———500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Azithromycin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Azithromycin Dihydrate IP | ||||
| Eq. to Azithromycin (Anhydrous)—250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ciprofloxacin and Tinidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ciprofloxacin Hydrochloride IP | ||||
| Eq. to Ciprofloxacin ———500 mg | ||||
| Tinidazole IP ————— 600 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ofloxacin and Ornidazole Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ofloxacin IP —————-200 mg | ||||
| Ornidazole IP ————— 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ciprofloxacin Hydrochloride IP | ||||
| Eq. to Ciprofloxacin ———250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ciprofloxacin Hydrochloride IP | ||||
| Eq. to Ciprofloxacin ———750 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ofloxacin IP ————– 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ofloxacin IP ————– 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ofloxacin IP ————– 300 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ofloxacin and Tinidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ofloxacin IP ————– 200 mg | ||||
| Tinidazole —————- 600 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Erythromycin Stearate Tablets IP | Each film Coated Tablet Contains: | Antibacterial | ||
| Erythromycin Stearate IP | ||||
| Eq. to Erythromycin —————– 125 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Azithromycin and Lactic Acid Bacillus Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Azithromycin Dihydrate IP | ||||
| Eq. to Azithromycin ——- 250 mg | ||||
| Lactic Acid Bacillus ————60 million Spores | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Azithromycin and Lactic Acid Bacillus Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Azithromycin Dihydrate IP | ||||
| Eq. to Azithromycin ——- 500 mg | ||||
| Lactic Acid Bacillus ————60 million Spores | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Clarithromycin Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Clarithromycin IP ————— 250 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Norfloxacin &Tinidazole Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Norfloxacin IP ————— 400 mg | ||||
| Tinidazole IP ————– 600 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Roxithromycin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Roxithromycin IP ————— 150 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Erythromycin Stearate Tablets IP | Each film Coated Tablet Contains: | Antibacterial | ||
| Erythromycin Stearate IP | ||||
| Eq. to Erythromycin —————– 250 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Ciprofloxacin and Tinidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Ciprofloxacin Hydrochloride IP | ||||
| Eq. to Ciprofloxacin ——— 250 mg | ||||
| Tinidazole IP ————— 300 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ofloxacin TabletsIP | EachFilmCoatedTabletContains:- | Antibacterial | ||
| Ofloxacin—— 200mg | ||||
| Excipients————q.s. | ||||
| Colour-Approvedcolour used. | ||||
| Doxycycline HCl With Lactic Acid Bacillus Capsule | Each Hard gelatin capsule Contains: | Antibacterial | ||
| Doxycycline Hydrochloride…………………IP100mg | ||||
| Lactic Acid Bacillus ………………………………..100 Million | ||||
| Excipients …………………………………….IP Spores | ||||
| Approved colour used in empty hard gelatin capsule shell…….q.s | ||||
| Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet | Each Enteric Coated Tablet | Antibacterial | ||
| Contains:- USP 20mg | ||||
| Doxylamine Succinate……………………IP 20 mg | ||||
| Pyridoxine Hydrochloride……………….IP 5 mg | ||||
| Folic Acid………………………………………….q.S | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Riboflavin, Folic Acid, Niacinamide with lactic acid bacillus Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Riboflavin IP …………………… 10 mg | ||||
| Folic Acid IP ……………………..1.5 mg | ||||
| Niacinamide IP ………………… 50 mg | ||||
| lactic acid bacillus 60 million Spores | ||||
| Excipients……………………………..q.s. | ||||
| Metronidazole, Sucralfate & Lignocaine Hcl ointment. | Composition: | IP | 1.0%w/w | Antibacterial |
| Metronidazole | IP | 4.0% w/w | ||
| Lignocaine Hydrochloride | IP | 7.0% w/w | ||
| Sucralfate | q.s. | |||
| Cream base | ||||
| Vitamin E & Aloevera cream | Composition: | I.P. | 0.50% w/w | Antibacterial |
| Vitamin E Acetate | ||||
| Moisturizing cream base with Aloevera | q.s. | |||
| Clarithromycin Gel 1.0%w/w | Composition: | I.P. | 1.0%w/w | Antibacterial |
| Clarithromycin | I.P. | 1.0% w/w | ||
| Phenoxyethanol | q.s. | |||
| (As preservative) | ||||
| Gel Base | ||||
| Rifaximin Tablets BP | Each Film Coated Tablet Contains:- | B.P. | 400 mg | Antibacterial |
| Rifaximin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Rifaximin Tablets BP | Each Film Coated Tablet Contains:- | B.P. | 550 mg | Antibacterial |
| Rifaximin | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Levofloxacin and Ornidazole Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Levofloxacin Hemihydrate IP | ||||
| Eq. to Levofloxacin ————–250 mg | ||||
| Ornidazole IP ————— 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Moxifloxacin Tablets 400 mg | Each Uncoated Tablet Contains: | IP | 400 mg | Antibacterial |
| Moxifloxacin Hydrochloride | q.s | |||
| Eq. to Moxifloxacin | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Metronidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Metronidazole IP—————250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
| Levofloxacin Hemihydrate IP | ||||
| Eq. to Levofloxacin ——–500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ornidazole Tablets IP | Each Uncoated Tablet Contains:- | Antibacterial | ||
| Ornidazole IP———–500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tetracycline HCl capsules IP | Each hard gelatin capsule contains: | IP | 250mg | Antibacterial |
| Tetracycline Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Oxytetracycline HCl capsules IP | Each hard gelatin capsule contains: | IP | 250mg | Antibacterial |
| Oxytetracycline Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Minocycline HCl capsules | Each hard gelatin capsule contains: | USP | 100mg | Antibacterial |
| Minocycline Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Antifungal | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Itraconazole capsule BP 100mg | Each hard gelatin capsule contains: | BP | 100 mg | Antifungal |
| Itraconazole Pellets | q.s. | |||
| Eq to Itraconazole | ||||
| Excipients | ||||
| Colour: Approved Colours Used. in Empty Shell & Pellet | ||||
| Itraconazole capsule BP200mg | Each hard gelatin capsule contains: | BP | 200 mg | Antifungal |
| Itraconazole Pellets | q.s. | |||
| Eq to Itraconazole | ||||
| Excipients | ||||
| Colour: Approved Colours Used. in Empty Shell & Pellet | ||||
| Fungal Diastase & Lactic acid Bacillus Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Antifungal |
| Fungal Diastase | 150×106Spores | |||
| Lactic acid bacillus | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 50.0 mg | Antifungal |
| Fluconazole | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 150.0 mg | Antifungal |
| Fluconazole | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 200.0 mg | Antifungal |
| Fluconazole | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Ketoconazole Cream | Composition: | IP | 2.0% w/w | Antifungal |
| Ketoconazole | ||||
| Preservation | IP | 0.1% w/w | ||
| Methyl Paraben | IP | 0.05% w/w | ||
| Phenoxyenthol | q.s. | |||
| Cream Base | ||||
| Ketoconazole Cream | Composition: | IP | 2.0% w/w | Antifungal |
| Ketoconazole | ||||
| Preservation | IP | 0.1% w/w | ||
| Methyl Paraben | IP | 0.05% w/w | ||
| Phenoxyethanol | q.s. | |||
| Cream Base | ||||
| Itraconazole, Ofloxacin, Ornidazole & Clobetasol propionate Cream | Composition: | IP | 1.0% w/w | Antifungal |
| Itraconazole | IP | 0.75 % w/w | ||
| Ofloxacin | IP | 2 0 w/w | ||
| Ornidazole | IP | 0.05%w/w | ||
| Clobetasol Propionate | ||||
| Preservation | IP | 16% | ||
| Methyl Paraben | IP | 0.03% | ||
| Propyl Paraben | q.s. | |||
| Cream base | ||||
| Clobetasol Propionate , Miconazole Nitrate, Neomycin Sulphate Cream | Composition : | IP | 0.05%w/w | Antifungal |
| Clobetasol Propionate | IP | 2%w/w | ||
| Miconazole Nitrate | IP | |||
| Neomycin Sulphate | 0.1%w/w | |||
| Equ. to Neomycin Base | IP | 0.1%w/w | ||
| Chlorocresol | ||||
| (as preservative) | q.s. | |||
| Cream base | ||||
| Itraconazole & Terbinafine Cream 1% w/w | Composition | BP | 1 % w/w | Antifungal |
| Itraconazole | IP | 1 % w/w | ||
| Terbinafine hydrochloride | ||||
| Preservative: | IP | 0.16% w/w | ||
| Methyl Paraben | IP | 0.05% w/w | ||
| Propyl Paraben | q.s. | |||
| Cream base | ||||
| Miconazole Nitrate Gel | Composition : | IP | 2.0 %w/w | Antifungal |
| Miconazole Nitrate | q.s | |||
| Gel Base | ||||
| Clotrimazole Cream IP | Composition : | IP | 2.0 %w/w | Antifungal |
| Clotrimazole | IP | 0.10% w/w | ||
| Chlorocresol | ||||
| ( as preservative) | q.s | |||
| Cream Base | ||||
| Miconazole Nitrate, Nadifloxacin & Mometasone Furoate & Cream | Composition:- | IP | 2% w/w | Antifungal |
| Miconazole Nitrate | USP | 1% w/w | ||
| Nadifloxacin | IP | 0.1%w/w | ||
| Mometasone Furoate | q.s. | |||
| Cream Base | ||||
| Terbinafine Hydrochloride Cream IP | Composition:- | IP | 1% w/w | Antifungal |
| Terbinafine Hydrochloride | q.s. | |||
| Cream Base | ||||
| Ketoconazole with Beclomethasone Dipropionate Cream | Composition : | IP | 2.0% w/w | Antifungal |
| Ketoconazole | IP | 0025% w/w | ||
| Beclomethasone dipropionate | ||||
| Preservatives: | IP | 0.15% w/w | ||
| Methyl Paraben | IP | 0.05% w/w | ||
| Propyl Paraben | q.s. | |||
| Cream Base | ||||
| Voriconazole Tablet IP 50 mg | Each Film coated Tablet Contains:- | IP | 50 mg | Antifungal |
| Voriconazole | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Voriconazole Tablet IP 200 mg | Each Film coated Tablet Contains:- | IP | 200 mg | Antifungal |
| Voriconazole | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Trimethoprim And Sulphamethoxazole Tablets IP. (Co-trimoxazole Tablets I.P.) | Each Uncoated Tablet Contains:- | Antifungal | ||
| Trimethoprim IP———————40mg | ||||
| Sulphamethoxazole IP————-200mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Trimethoprim And Sulphamethoxazole Tablets IP. (Co-trimoxazole Tablets I.P.) | Each Uncoated Tablet Contains:- | Antifungal | ||
| Trimethoprim IP———————80mg | ||||
| Sulphamethoxazole IP————-400mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Metronidazole Tablets IP | Each Film Coated Tablet Contains:- | Antifungal | ||
| Metronidazole IP————— 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metronidazole Tablets IP | Each Film Coated Tablet Contains:- | Antifungal | ||
| Metronidazole IP—————200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
| Fluconazole IP———–50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
| Fluconazole IP———–100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
| Fluconazole IP———–150 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
| Fluconazole IP———–200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ketoconazole Tablet IP | Each Uncoated tablet contains : | Antifungal | ||
| Ketoconazole IP—————200.0 mg | ||||
| Excipients ————————-q.s. | ||||
| Colour :- Approved colour used. | ||||
| Terbinafine Tablets I.P. | Each Uncoated Tablet Contains:- | Antifungal | ||
| Terbinafine Hydrochloride IP | ||||
| Eq.to Terbinafine 500 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Fluconazole & Tinidazole Tablets | Each Film Coated Tablet Contains:- | Antifungal | ||
| Fluconazole IP —————75 mg | ||||
| Tinidazole IP —————- 1000 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ketoconazole,Clobetasol Propionate &Neomycin SulphateCream | Composition: | Antifungal | ||
| Ketoconazole IP1.0%w/w | ||||
| ClobetasolPropionate IP0.025%w/w | ||||
| Neomycin Sulphate IP 5000IU | ||||
| CreamBase q.s | ||||
| Itraconazole Gel 1 %w/w | Composition: | Antifungal | ||
| Itraconazole B.P1.0%w/w | ||||
| Preservatives: | ||||
| MethylParaben IP0.1%w/w | ||||
| PropylParaben IP0.05%w/w | ||||
| CreamBase q.s | ||||
| Itraconazole capsule | Each hard gelatin capsule Contains: | USP | 200 mg | Antifungal |
| Itraconazole | q.s. | |||
| Approved colored used in empty capsule shells. | ||||
| Excipients | ||||
| Metronidazole Benzoate and Chlorhexidine Gluconate Gel | Composition: | IP | 1.0%w/w | Antifungal |
| Metronidazole Benzoate | 0.5 %w/w | |||
| Eq to Metronidazole | IP | qs | ||
| Chlorhexidine Gluconate Solution | ||||
| (as preservative) | ||||
| Gel Base | ||||
| Itraconazole capsule | Each hard gelatin capsule Contains: | USP | 100 mg | Antifungal |
| Itraconazole | q.s. | |||
| Approved colored used in empty capsule shells. | ||||
| Excipients | ||||
| Ketoconazole with ZPTO Sampoo | Composition: | IP | 2.0%w/w | Antifungal |
| Ketoconazole | 1.0%w/w | |||
| Zinc pyrithone (ZPTO) | qs | |||
| Sampoo base | ||||
| Eberconazole cream1.0%w/w | Composition: | IP | 1.0% w/w | Antifungal |
| Eberconazole Nitrate | IP | |||
| Eq. to Eberconazole | 0.1% w/w | |||
| preservative | 0.025% w/w | |||
| Methyl paraben | qs | |||
| Propyl paraben | ||||
| Cream base | ||||
| Clindamycin Phosphate Gel | Composition: | IP | 1.0% w/w | Antifungal |
| Clindamycin Phosphate | 0.1%w/w | |||
| Eq. to Clindamycin | IP | 0.05%w/w | ||
| Sodium methyl paraben | IP | q.s. | ||
| Sodium Propyl paraben | ||||
| Allanton base | ||||
| Metronidazole, & sucralfate cream. | Composition: | IP | 1.0% w/w | Antifungal |
| Metronidazole | IP | 7.0 % w/w | ||
| Sucralfate | q.s. | |||
| Cream Base | ||||
| Ofloxacin and Ornidazole Tablets I.P. | Each Film Coated Tablet Contains:- | I.P. | 200 mg | Antifungal |
| Ofloxacin | I.P. | 500 mg | ||
| Ornidazole | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Itraconazole capsule BP 100mg | Each hard gelatin capsule contains: | BP | 100 mg | Antifungal |
| Itraconazole | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty Shell & Pellets | ||||
| Ornidazole Tablets I.P. 500 mg | Each Film Coated Tablet | I.P. | 500 mg | Antifungal |
| Contains :- | q.s. | |||
| Ornidazole | ||||
| Excipients | ||||
| Colour-Approved colour used | ||||
| Calamine Lotion IP | Calamine | I.P. | 15.0% w/v | Antifungal |
| Zinc oxide | I.P. | 5.0% w/v | ||
| Bentonite | I.P. | 3.0%w/v | ||
| Sodium citrate | I.P. | 0.5% w/v | ||
| Liquefied phenol, | I.P. | 0.5% w/v | ||
| Glycerin | I.P. | 5.0% w/v | ||
| Purified water | q.s. | |||
| Clotrimazole Topical Solution USP. | Composition: | I.P. | 1.0 %w/v | Antifungal |
| Clotrimazole | q.s. | |||
| Non aqueous Base | ||||
| Metronidazole and Benzocaine Gel | Composition: | IP | 0.01%w/w | Antifungal |
| Metronidazole | IP | 0.2 %w/w | ||
| Benzocaine | q.s. | |||
| Gel Base | ||||
| Micanazole Nitrate and FlucinoloneAcetanide cream | Composition: | IP | 2.0%w/w | Antifingal |
| Micanazole Nitrate | IP | 0.01% w/w | ||
| FlucinoloneAcetanide | q.s. | |||
| In a Cream base | ||||
| Ciprofloxacin Hcl, Fluocinolone acetonde, Chlorocresol & Clotrimazole & Clotrimazole & Clotrimazole Cream | Composition: | IP | 0.5% w/w | Antibaterial , Antifugal |
| Ciprofloxacin Hydrochloride | IP | 0.01%w/w | ||
| Eq. to. Ciprofloxacin | IP | 1.0% w/w | ||
| Fluocinolone acetonide | IP | 0.1% w/w | ||
| Clotrimazole | q.s | |||
| Chlorocresol ( as preservative) | ||||
| Cream Base | ||||
| Antibiotics, Antiviral & Antifungal | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Doxycycline HCl With Lactic Acid Bacillus Capsule | Each Hard gelatin capsule Contains: | IP | 100 mg | Antibiotics, Antiviral & Antifungal |
| Doxycycline Hydrochloride | IP | 5 Billion Spores | ||
| Lactic Acid Bacillus | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Chloramphenicol Capsule IP 500 mg | Each Hard Gelatin Capsule Contains: Chloramphenicol | IP | 500 mg | Antibiotics, Antiviral & Antifungal |
| Excipients | q.s. | |||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Racecadotril Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 100 mg | Antibiotics, Antiviral & Antifungal |
| Racecadotril | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Chloramphenicol Capsule IP 500 mg | Each Hard Gelatin Capsule Contains: | IP | 500 mg | Antibiotics, Antiviral & Antifungal |
| Chloramphenicol | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Oseltamivir Capsules IP | Each hard gelatin capsule contains: | IP | 30.0 mg | Antibiotics, Antiviral & Antifungal |
| Oseltamivir Phosphate | q.s. | |||
| eq. to Oseltamivir | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Oseltamivir Capsules IP | Each hard gelatin capsule contains: | IP | 45.0 mg | Antibiotics, Antiviral & Antifungal |
| Oseltamivir Phosphate | q.s. | |||
| equ. to Oseltamivir | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Oseltamivir Capsules IP | Each hard gelatin capsule contains: | IP | 75.0 mg | Antibiotics, Antiviral & Antifungal |
| Oseltamivir Phosphate | q.s. | |||
| equ. to Oseltamivir | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Linezolid Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial & Antiviral | ||
| Linezolid IP—————600 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Doxycycline capsules IP | Each hard gelatin capsule contains: | IP | 50mg | Antibiotics, Antiviral |
| Doxycycline Hydrochloride | q.s. | |||
| eq. to Doxycycline | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Doxycycline capsules IP | Each hard gelatin capsule contains: | IP | 100mg | Antibiotics, Antiviral |
| Doxycycline Hydrochloride | q.s. | |||
| eq. to Doxycycline | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Doxycycline capsules IP | Each hard gelatin capsule contains: | IP | 200mg | Antibiotics, Antiviral |
| Doxycycline Hydrochloride | q.s. | |||
| eq. to Doxycycline | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Doxycycline and Ambroxol capsule | Each hard gelatin capsule contains: | IP | 100mg | Antibiotics & Antiviral |
| Doxycycline Hydrochloride | 7.5mg | |||
| eq. to Doxycycline | IP | q.s. | ||
| Ambroxol Hydrochloride | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Acyclovir & Hydrocortisone Cream | Compositions | IP | 5% w/w | Antibiotics & Antiviral |
| Acyclovir | IP | 1 % w/w | ||
| Hydrocortisone acetate | q.s. | |||
| In a cream base | ||||
| Antifungal, Antiseptic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Povidone Iodine & Metronidazole Ointment | Composition: | IP | 5.0 % w/w | Antifungal, Antiseptic |
| Povidone Iodine | IP | 1 % w/w | ||
| Metronidazole | q.s. | |||
| Ointment base | ||||
| Povidone Iodine & Metronidazole Ointment | Composition: | IP | 10.0 % w/w | Antifungal, Antiseptic |
| Povidone Iodine | IP | 1 % w/w | ||
| Metronidazole | q.s. | |||
| Ointment base | ||||
| Povidone Iodine, Metronidazole &Dexapanthanol | Composition: | IP | 5.0 % w/w | Antiseptic, Antifungal |
| Ointment | Povidone Iodine | IP | 1 % w/w | |
| Metronidazole | IP | 5.0 % w/w | ||
| Dexapanthanol | q.s. | |||
| Ointment base | ||||
| Povidone-Iodine & Ornidazole Ointment. | Composition: | IP | 1.0%w/w | Antifungal& Antiseptic |
| Ornidazole | IP | 5.0%w/w | ||
| Povidone-Iodine (available iodine 0.5% w/w) | ||||
| Ointment base | qs | |||
| Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Betamethasone Dipropionate & Neomycin Cream | Composition: | IP | 0.025% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Betamethasone Dipropionate | IP | 0.5% w/w | ||
| Neomycin sulphate | qs | |||
| Cream Base | ||||
| Econazole Betamethasone Dipropionate & Neomycin cream . | Composition: | IP | 0.025% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Betamethasone Dipropionate | IP | 0.5% w/w | ||
| Neomycin sulphate | 1.0%w/w | |||
| Econazole | qs | |||
| In Cream Base | ||||
| Clindamycin Phosphate & Nicotinamide Gel | Composition: | IP | 1.0% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clindamycin Phosphate | 4.0%w/w | |||
| eq. to Clindamycin | IP | q.s. | ||
| Nicotinamide | ||||
| Aloe Allantoin Gel Base with ethyl lactate | ||||
| Clobetasol Propionate with salicylic Acid Ointment | Composition: | IP | 0.05% w/w | antifungal, corticosteroid, antibacterial & anti-inflammatory |
| Clobetasol Propionate | IP | 3.00% | ||
| Salicyclic Acid | q.s. | |||
| Ointment base | ||||
| Betamethasone & Neomycin Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Betamethasone propionate eq. to. Betamethasone | 0.5 % w/w | |||
| Neomycin sulphate | IP | |||
| Eq. to Neomycin | q.s. | |||
| In a cream base | ||||
| Beclomethasone Dipropionate with salicyclic Acid Cream | Composition: | IP | 0.025%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Beclomethasone Dipropionate | IP | 3.00% | ||
| Salicylic Acid | q.s. | |||
| Cream base | ||||
| Clobetasol Propionate with salicyclic Acid Ointment | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol Propionate | IP | 3.00% | ||
| Salicyclic Acid | q.s. | |||
| Ointment base | ||||
| Mometasone Cream IP | Composition:- | IP | 0.10%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Mometasone Furoate | ||||
| Preservatives: | IP | 0.20%w/w | ||
| Methyl Paraben | IP | 0.20%w/w | ||
| Propyl Paraben | q.s. | |||
| Cream Base | ||||
| Neomycin and Polymyxin B Sulfate and Bacitracin Zinc Ointment USP | Composition : | USP | 5000 units | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Each gm Contains : | ||||
| Polymyxin B Sulfate | IP | |||
| Equ. to Polymyxin | 400units | |||
| Bacitracin Zinc | IP | |||
| Equ. to Bacitracin | 3400units | |||
| Neomycin Sulphate | ||||
| Equ. to Neomycin | IP | 0.1%w/w | ||
| Preservative: | q.s | |||
| Benzyl Alcohol | ||||
| Ointment Base | ||||
| Mometasone &Fusidic Acid Cream | Composition:- | IP | 0.10%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Mometasone furoate | IP | 2.00%w/w | ||
| Fusidic Acid | q.s. | |||
| Cream Base | ||||
| Beclomethasone Dipropionate, Phenylephrine Hydrochloride & Lignocaine Hydrochloride Cream | Composition: | IP | 0.020%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Beclomethasone Dipropionate | IP | 0.10% w/w | ||
| Phenylephrine Hydrochloride | IP | 2.50% w/w | ||
| Lignocaine Hydrochloride | IP | 0.1% w/w | ||
| Chlorocresol | ||||
| (as Preservative) | q.s. | |||
| Cream base | ||||
| Betamethasone Dipropionate Cream IP | Composition | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | |
| Betamethasone propionate | q.s. | |||
| eq. to. Betamethasone | ||||
| In a cream base | ||||
| Mometasone Furoate Ointment | Composition: | IP | 0.1% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Mometasone Furoate | q.s. | |||
| Excipients | ||||
| Fluticasone Propionate Ointment | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Fluticasone Propionate | q.s | |||
| Ointment Base | ||||
| Fluticasone Propionate cream IP | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Fluticasone Propionate | q.s | |||
| Cream Base | ||||
| Mometasone & Salicylic Acid Cream | Composition:- | IP | 0.10%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory , Analgesic |
| Mometasone furoate | IP | 5.00%w/w | ||
| Salicylic Acid | q.s. | |||
| Cream Base | ||||
| Clobetasol Propionate with salicyclic Acid cream | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory , Analgesic |
| Clobetasol Propionate | IP | 6.0% w/w | ||
| Salicyclic Acid | q.s. | |||
| Cream base | ||||
| Halobetasol Cream | Composition : | USP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Halobetasol Propionate | q.s | |||
| Equivalent to Halobetasol | ||||
| Cream Base | ||||
| Fluticasone Cream IP | Composition : | IP | 0.05 %w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Fluticasone Propionate | q.s | |||
| Cream Base | ||||
| Clobetasol Propionate with salicyclic Acid Ointment | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol Propionate | IP | 6.00% | ||
| Salicyclic Acid | q.s. | |||
| Ointment base | ||||
| Clobetasol Propionate& Miconazole Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol Propionate | IP | 2.0 % w/w | ||
| Miconazole Nitrate | q.s. | |||
| Cream Base | ||||
| Clobetasol propionate and Ammonium lactate Gel | Composition: | IP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol propionate | 12.0%w/w | |||
| Ammonium lactate | q.s. | |||
| Gel Base | ||||
| Clobetasol Cream IP | Composition: | IP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol propionate | q.s. | |||
| Cream Base | ||||
| Clobetasol Propionate, Neomycin sulphate, Miconazole &Chlorhexidine Gluconate, Cream | Composition : | IP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol Propionate | IP | 0.50%w/w | ||
| Neomycin sulphate | IP | 2.0%w/w | ||
| Miconazole Nitrate | IP | 0.2%w/w | ||
| Chlorhexidine Gluconate Solution | q.s | |||
| Cream Base | ||||
| Halobetasol& Salicylic acid Cream | Composition : | USP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Halobetasol Propionate Equivalent to Halobetasol | IP | 6.0 % w/w | ||
| Salicylic Acid | q.s | |||
| Cream Base | ||||
| Beclomethasone dipropionate, Econazole & Neomycin cream | Composition : | IP | 0.025 %w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Beclomethasone | ||||
| Dipropionate | IP | 1.0 %w/w | ||
| Econazole Nitrate | IP | |||
| Neomycin Sulphate | 0.5 %w/w | |||
| Eq. to Neomycin | q.s. | |||
| Cream base | ||||
| Halobetasol&Salicylic acid Ointment | Composition : | USP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Halobetasol Propionate | 6.0 % w/w | |||
| Equivalent to Halobetasol | IP | q.s | ||
| Salicylic Acid | ||||
| Ointment Base | ||||
| Clobetasol Propionate and Ammonium lactate Gel | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol Propionate | ||||
| Ammonium Lactate | 12.00% | |||
| equ. to Lactic Acid | q.s. | |||
| Gel base | ||||
| Clobetasol Propionate, Gentamicin, Tolnaftate, Iodochlorhydroxyquinoline & Clotrimazole Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol Propionate | IP | |||
| Gentamicin Sulphate | 0.1 % w/w | |||
| equ. to Gentamicin | IP | 1.0% w/w | ||
| Tolnaftate | IP | 1.0% w/w | ||
| Iodochlorhydroxyquinoline | IP | 1.0% w/w | ||
| Clotrimazole | IP | 0.1%w/w | ||
| Chlorocresol | ||||
| (as preservative) | q.s. | |||
| In a cream base | ||||
| Diphenhydramine HCl, Clotrimazole, Lignocaine HCl, Menthol &Aloe Vera cream | Composition: | IP | 2.0%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Diphenhydramine HCl | IP | 1.0%w/w | ||
| Clotrimazole | IP | 0.5%w/w | ||
| Lignocaine HCl | IP | 1.0%w/w | ||
| Menthol | 0.5%w/w | |||
| Aloe Vera | q.s. | |||
| Cream Base | ||||
| Diclofenac Diethylamine , Oleum Lini,Methyl Salicylate & Menthol gel | Composition: | IP | 1.16% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Diclofenac Diethylamine | ||||
| eq. to Diclofenac sodium | IP | 1.0% w/w | ||
| Oleum Lini (containing predominantly alpha linolenic acid) | BP | 3.0% w/w | ||
| Methyl Salicylate | ||||
| Menthol | IP | 10.0% w/w | ||
| IP | 5.0%w/w | |||
| Gel Base | q.s. | |||
| Chlorhexidine, Metronidazole & Lignocaine Gel | Composition: | IP | 1.0% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Chlorhexidine Gluconate solution | 1.0 %w/w | |||
| equ. to Chlorhexidine | IP | 2.0%w/w | ||
| Metronidazole | IP | q.s. | ||
| Lignocaine Hydrochloride | ||||
| Gel Base | ||||
| Clobetasol Propionate& Gentamicin Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
| Clobetasol Propionate | IP | |||
| Gentamicin Sulphate | 0.1 % w/w | |||
| Equ. to Gentamicin | IP | 0.1 % w/w | ||
| Chlorcresol | q.s. | |||
| Cream Base | ||||
| Nicotinamide Tablets IP | Each Film Coated Tablet Contains:- | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||
| Nicotinamide IP ———— 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Betamethasone Tablets IP | Each Uncoated Tablet Contains: – | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||
| Betamethasone IP ————– 0.5 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Clobetasol Propionate,Salicylic acid,Urea,Lactic acid &Sodium Lactate Ointment | Composition: | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||
| ClobetasolPropionate USP0.05%w/w | ||||
| SalicylicAcid IP3.0%w/w | ||||
| Urea IP10.0%w/w | ||||
| LacticAcid IP3.0%w/w | ||||
| SodiumLactatesolution USP | ||||
| Equ.toLactic Acid 2.0%w/w | ||||
| OintmentBase q.s | ||||
| Antiacne & Antifungal | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Isotretinoin Capsule IP. | Each Hard gelatin capsule Contains: | IP | 10 mg | Antiacne |
| Isotretinoin | qs | |||
| Excipients | ||||
| Approved colour used | ||||
| Isotretinoin Capsule IP | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antiacne |
| Isotretinoin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Clindamycin Phosphate & Nicotinamide Gel | Composition: | IP | 1.0% w/w | Antiacne |
| Clindamycin Phosphate | 4.0%w/w | |||
| eq. to Clindamycin | IP | q.s. | ||
| Nicotinamide | ||||
| Aloe Allantoin Gel Base with ethyl lactate | ||||
| Luliconazole Cream | Composition: | IP | 1 % w/w | Antiacne & Antifungal |
| Luliconazole | ||||
| Preservative: | IP | 1% w/w | ||
| Benzyl Alcohol | q.s. | |||
| Cream Base | ||||
| Ofloxacin, Fluocinolone Acetonide & Clotrimazole Cream IP | Composition : | IP | 0.5 %w/w | Antibaterial, Antifungal |
| Ofloxacin | IP | 0.01%w/w | ||
| Fluocinolone | IP | 1.0%w/w | ||
| Acetonide | 0.12%w/w | |||
| Clotrimazole | q.s | |||
| Cream Base | ||||
| Adapalene and clindamycin Gel | Composition: | BP | 0.1%w/w | Antiacne & Antifungal |
| Adapalene | IP | 1.0 %w/w | ||
| Clindamycin Phosphate | q.s. | |||
| equivalent to Clindamycin | ||||
| Gel Base | ||||
| Hydroquinone, | Composition: | USP | 2.0% w/w | Antiacne & Antifungal |
| Tretinoin & | Hydroquinone | USP | 0.05%w/w | |
| Hydrocortisone Acetate Cream | Tretinoin | IP | 1.0% w/w | |
| Hydrocortisone Acetate | q.s. | |||
| In a Cream Base | ||||
| Adapalene and Benzoyl Peroxide Gel | Composition: | BP | 0.1%w/w | Antiacne & Antifungal |
| Adapalene | USP | 2.5 %w/w | ||
| Benzoyl Peroxide | q.s | |||
| Gel Base | ||||
| Tretinoin Gel USP | Composition : | USP | 0.05 %w/w | Antiacne & Antifungal |
| Tretinoin | q.s | |||
| Gel Base | ||||
| ClobetasolPropionate,GentamicinSulphate,Miconazole Nitrate &ZincOxide Cream | Composition: | Antiacne & antifungal | ||
| ClobetasolPropionate IP 0.05%w/w | ||||
| GentamicinSulphate IP0.2%w/w | ||||
| Eq.toGentamicin | ||||
| MiconazoleNitrate IP2.0%w/w | ||||
| ZincOxide IP0.1% w/w | ||||
| CreamBase q.s | ||||
| Clindamycin Phosphate&TretinointopicalGel | Composition: | Antiacne & antifungal | ||
| ClindamycinPhosphate eq.to IP1.0%w/w | ||||
| Clindamycin | ||||
| Tretinoin USP0.025%w/w | ||||
| Gelbase q.s | ||||
| Hydroquinone, Tretinoin & Mometasone Furoate Cream | Composition: | USP | 2.0% w/w | Anti Acne & Anti Fungal |
| Hydroquinone | USP | 0.025%w/w | ||
| Tretinoin | IP | 0.10%w/w | ||
| Mometasone Furoate | IP | 0.1% w/w | ||
| Chlorocresol (as preservative) | q.s. | |||
| In a Cream Base | ||||
| Amorolfine Hydrochloride cream | Composition: | IP | 0.25%w/w | Anti Acne & Anti Fungal |
| Amorolfine Hydrochloride | IP | 1.0%w/w | ||
| Phenoxyethanol | ||||
| Cream base | ||||
| Clindamycin Phosphate & Isotretinoin topical Gel | Composition: | IP | 1.0% w/w | Anti Acne & Anti Fungal |
| Clindamycin Phosphate | 0.05%w/w. | |||
| eq. to Clindamycin | IP | q.s. | ||
| Isotretinoin | ||||
| Gel base | ||||
| Tretinoin Cream USP | Composition : | USP | 0.05 %w/w | Anti Acne & Anti Fungal |
| Tretinoin | q.s | |||
| Cream Base | ||||
| Sertaconazole Nitrate Cream | Composition: | IP | 2.00% | Anti Acne & Anti Fungal |
| Sertaconazole | q.s. | |||
| Cream Base | ||||
| Tretinoin Cream USP | Composition : | USP | 0.025 %w/w | Anti Acne & Anti Fungal |
| Tretinoin | q.s | |||
| Cream Base | ||||
| Hydroquinone, Tretinoin & Fluocinolone Acetonide Cream | Composition: | USP | 2.0% w/w | Anti Acne & Anti Fungal |
| Hydroquinone | USP | 0.025%w/w | ||
| Tretinoin | IP | 0.01%w/w | ||
| Fluocinolone Acetonide | q.s. | |||
| Cream Base | ||||
| Antihypertensive | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Rosuvastatin &Clopidogrel Capsules | Each hard gelatin capsule contains: | IP | 5.0 mg | Antihypertensive |
| Rosuvastatin Calcium | ||||
| Eq.to Rosuvastatin | ||||
| (As pellets) | 75 mg | |||
| Clopidogrel Bisulphate | IP | |||
| Eq. to Clopidogrel | q.s. | |||
| (As pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Rosuvastatin &Clopidogrel Capsules | Each hard gelatin capsule contains: | IP | 10 mg | Antihypertensive |
| Rosuvastatin Calcium | ||||
| Eq.to Rosuvastatin | 75 mg | |||
| (As pellets) | IP | |||
| Clopidogrel Bisulphate | ||||
| Eq. to Clopidogrel | q.s. | |||
| (As pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Rosuvastatin &Clopidogrel Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Antihypertensive |
| Rosuvastatin Calcium | ||||
| Eq.to Rosuvastatin | ||||
| (As pellets) | 75 mg | |||
| Clopidogrel Bisulphate | IP | |||
| Eq. to Clopidogrel | q.s. | |||
| (As pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Atorvastatin Tablets IP 10 mg | Each Film coated Tablets contains: | IP | 10 mg | Antihypertensive |
| Atorvastatin Calcium | q.s. | |||
| eq. to. Atorvastatin | ||||
| Excipients | ||||
| Colour: Approved ColourUsed | ||||
| Atorvastatin Tablets IP 20 mg | Each Film coated Tablets contains: | 20 mg | Antihypertensive | |
| Atorvastatin Calcium | IP | q.s. | ||
| eq. to. Atorvastatin | ||||
| Excipients | ||||
| Colour: Approved ColourUsed | ||||
| Atorvastatin Tablets IP 40 mg | Each Film coated Tablets contains: | IP | 40 mg | Antihypertensive |
| Atorvastatin Calcium | q.s. | |||
| eq. to. Atorvastatin | ||||
| Excipients | ||||
| Colour: Approved ColourUsed | ||||
| Atorvastatin Tablets IP 80 mg | Each Film coated Tablets contains: | IP | 80 mg | Antihypertensive |
| Atorvastatin Calcium | q.s. | |||
| eq. to. Atorvastatin | ||||
| Excipients | ||||
| Colour: Approved ColourUsed | ||||
| Ramipril and Hydrochlorothiazide Tablets | Each Uncoated Sustained release Tablet Contains:- | IP | 2.5 mg | Antihypertensive |
| Ramipril | IP | 12.5mg | ||
| Hydrochlorothiazide | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Tofacitinib Tablets 5 mg | Each Film coated Tablet Contains:- | 5 mg | Antihypertensive | |
| Tofacitinib Citrate | q.s | |||
| Eq. to Tofacitinib | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Telmisartan & Atorvastatin Tablets | Each Film coated Tablets contains: | IP | 40 mg | Antihypertensive |
| Telmisartan | IP | |||
| Atorvastatin Calcium | 10 mg | |||
| eq. to. Atorvastatin | ||||
| Excipients | q.s | |||
| Colour: Approved Colour Used | ||||
| Losartan Potassium and Hydrochlorothiazide Tablets I.P | Each film coated tablet contains: | Antihypertensive | ||
| Losartan Potassium IP————50 mg | ||||
| Hydrochlorothiazide IP————12.5 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Aspirin Gastro- resistant Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Aspirin IP —————– 75 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aspirin Gastro- resistant Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Aspirin IP —————– 150 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lisinopril and Amlodipine Tablets | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Lisinopril IP | ||||
| Eq. to Anhydrous Lisinopril ———- 5 mg | ||||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ——————–5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Olmesartan Medoxomil Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Olmesartan Medoxomil IP ———-40 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Olmesartan Medoxomil Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Olmesartan Medoxomil IP ———- 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ———- 5.0 mg | ||||
| Telmisartan IP ————–40 mg | ||||
| Hydrochlorothiazide IP —— 12.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine, and Indapamide Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ———- 10.0 mg | ||||
| Indapamide (SR) IP —— 1.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Telmisartan and Amlodipine Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Telmisartan IP ————–40 mg | ||||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ———- 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metoprolol Succinate Extended Release Tablets IP | Each Extended Release Film Coated Tablet Contains:- | Antihypertensive | ||
| Metoprolol Succinate IP 23.75 mg | ||||
| Eq. to Metoprolol Tartrate ———25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metoprolol Succinate Extended Release Tablets IP | Each Extended Release Film Coated Tablet Contains:- | Antihypertensive | ||
| Metoprolol Succinate IP 47.50 mg | ||||
| Eq. to Metoprolol Tartrate ———50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metoprolol Succinate Extended Release Tablets IP | Each Extended Release Film Coated Tablet Contains:- | Antihypertensive | ||
| Metoprolol Succinate IP 11.875 mg | ||||
| Eq. to Metoprolol Tartrate ——-12.50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rosuvastatin Calcium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Rosuvastatin Calcium IP | ||||
| Eq. to Rosuvastatin ———20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rosuvastatin Calcium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Rosuvastatin Calcium IP | ||||
| Eq. to Rosuvastatin ———10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rosuvastatin Calcium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Rosuvastatin Calcium IP | ||||
| Eq. to Rosuvastatin ———5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Atenolol Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Atenolol IP ———– 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Atenolol Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Atenolol IP ———– 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Telmisartan and Hydrochlorothiazide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Telmisartan IP ————–40 mg | ||||
| Hydrochlorothiazide IP —— 12.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Telmisartan Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Telmisartan IP ————– 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Telmisartan Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Telmisartan IP ————– 80 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Telmisartan Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Telmisartan IP ————– 40 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Telmisartan and Amlodipine Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Telmisartan IP ————–80 mg | ||||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ———- 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine, Telmisartan and Hydrochlorothiazide Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ———-2.5 mg | ||||
| Telmisartan IP ————–20 mg | ||||
| Hydrochlorothiazide IP —— 6.25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Valsartan Tablet IP | Each Film coated tablet contains: | Antihypertensive | ||
| Valsartan IP———- 80.0 mg | ||||
| Excipients ———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Valsartan Tablet IP | Each Film coated tablet contains: | Antihypertensive | ||
| Valsartan IP———- 160.0 mg | ||||
| Excipients ———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Valsartan & Hydrochlorothiazide Tablet IP | Each Film coated tablet contains: | Antihypertensive | ||
| Valsartan IP——————–80.0 mg | ||||
| Hydrochlorothiazide IP———12.5 mg | ||||
| Excipients ———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Valsartan & Amlodipine tablet | Each Film coated tablet contains: | Antihypertensive | ||
| Valsartan IP ———————80.0 mg | ||||
| Amlodipine (As besylate) IP ——– 5.0 mg | ||||
| Excipients ———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Valsartan, Amlodipine Hydrochlorothiazide tablet | Each Film coated tablet contains: | Antihypertensive | ||
| Valsartan IP ——————— 160.0 mg | ||||
| Amlodipine (As besylate) IP——– 5.0 mg | ||||
| Hydrochlorothiazide IP———– 12.5 mg | ||||
| Excipients ———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Losartan Potassium & Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Losartan Potassium IP ————— 25 mg | ||||
| Hydrochlorothiazide IP —————-12.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Losartan Potassium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Losartan Potassium IP ————— 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Losartan Potassium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Losartan Potassium IP ————— 25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Carvedilol Tablet IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Carvedilol IP————- 3.125 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Carvedilol Tablet IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Carvedilol IP————- 6.25 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Carvedilol Tablet IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Carvedilol IP————- 12.5 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used | ||||
| Telmisartan & Metoprolol Succinate tablets IP | Each uncoated Bilayer tablet contains: | Antihypertensive | ||
| Metoprolol Succinate 47.5 mg | ||||
| Eq. to Metoprolol Tartrate (SR)———50 mg | ||||
| Telmisartan IP ——————40.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Telmisartan & Metoprolol Succinate tablets IP | Each uncoated Bilayer tablet contains: | Antihypertensive | ||
| Metoprolol Succinate 23.75 mg | ||||
| Eq. to Metoprolol Tartrate (SR)———25 mg | ||||
| Telmisartan IP ——————40.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Telmisartan & Chlorthalidone Tablets | Each Uncoated Tablet contains: | Antihypertensive | ||
| Telmisartan IP ————– 40 mg | ||||
| Chlorthalidone IP————— 12.5 mg | ||||
| Excipients ————— q.s. | ||||
| Colour-Approved colour used. | ||||
| Methyldopa Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Methyldopa IP —————500 mg | ||||
| Excipients—————– q.s | ||||
| Atorvastatin &Fenofibrate Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Atorvastatin Calcium IP | ||||
| Eq. to Atorvastatin ———— 10 mg | ||||
| Fenofibrate IP ————- 160 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate …………….IP | ||||
| Eq. to Amlodipine ………………….10mg | ||||
| Excipients ……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Atenolol Tablets IP | Each Film coated Tablet contains: | IP | 50 mg | Antihypertensive |
| Atenolol | q. s. | |||
| Excipients | ||||
| Atenolol Tablets IP | Each Film coated Tablet contains: | IP | 100 mg | Antihypertensive |
| Atenolol | q. s. | |||
| Excipients | ||||
| Aspirin & Rosuvastatin Capsules. | Each Hard Gelatin capsule contains: | IP | 150mg | Antihypertensive |
| Aspirin | ||||
| (As Enteric coated pellets ) | IP | 10mg | ||
| Rosuvastatin Calcium | ||||
| Eq. to Rosuvastatin | q.s. | |||
| (pellets) | ||||
| Excipients | ||||
| Approved colour used | ||||
| Atorvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
| Atorvastatin Calcium | ||||
| eq. to Atorvastatin (As pellets) | ||||
| Aspirin (As Enteric coated pellets) | IP | 150 mg | ||
| Excipients | q.s | |||
| Approved colour used | ||||
| Rosuvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
| Rosuvastatin Calcium | ||||
| eq. to Rosuvastatin (As pellets) | IP | 75 mg | ||
| Aspirin (As Enteric coated pellets) | q.s | |||
| Excipients | ||||
| Approved colour used | ||||
| Rosuvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antihypertensive |
| Rosuvastatin Calcium | ||||
| eq. to Rosuvastatin (As pellets) | IP | 75 mg | ||
| Aspirin (As Enteric coated pellets) | q.s | |||
| Excipients | ||||
| Approved colour used | ||||
| Aspirin & Clopidogrel Capsule. | Each hard gelatin capsule contain: | IP | 75mg | Antihypertensive |
| Aspirin | ||||
| ( As enteric coated Pellets ) | IP | |||
| Clopidogrel Bisulphate) | 75mg | |||
| eq. to Clopidogrel | ||||
| Excipients | qs | |||
| Approved colour used | ||||
| Aspirin & Clopidogrel capsule | Each hard gelatin capsule contain: | IP | 75mg | Antihypertensive |
| Aspirin | ||||
| ( As enteric coated Pellets ) | IP | |||
| Clopidogrel Bisulphate) | 150mg | |||
| eq. to Clopidogrel | ||||
| (As pellets) | qs | |||
| Excipients | ||||
| Approved colour used | ||||
| Escitalopram Oxalate Tablets IP 10 mg | Each film coated Tablet Contains:- | IP | 10 mg | Antihypertensive |
| Escitalopram Oxalate | q.s. | |||
| Eq. to Escitalopram | ||||
| Excipients | ||||
| Colour- Approved colour used. | ||||
| Escitalopram Oxalate Tablets IP 20 mg | Each film coated Tablet Contains:- | IP | 20 mg | Antihypertensive |
| Escitalopram Oxalate | q.s. | |||
| Eq. to Escitalopram | ||||
| Excipients | ||||
| Colour- Approved colour used. | ||||
| Telmisartan and Hydrochlorothiazide Tablets I.P. | Each Uncoated Bilayered Tablet Contains:- | I.P. | 40 mg | Antihypertensive |
| Telmisartan | I.P. | 12.5 mg | ||
| Hydrochlorothiazide | q.s | |||
| Excipients | ||||
| Colour-Approved colour used | ||||
| Telmisartan and Amlodipine Tablets I.P. | Each Uncoated Tablet Contains:- | I.P. | 40 mg | Antihypertensive |
| Telmisartan | I.P. | |||
| Amlodipine Besylate | 5 mg | |||
| Eq. to Amlodipine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Telmisartan and Hydrochlorothiazide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Telmisartan IP ————– 80 mg | ||||
| Hydrochlorothiazide IP —— 12.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Atenolol Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Atenolol IP ———– 25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Bisoprolol Fumarate tablet | Each Film Coated Tablet Contain: | Antihypertensive | ||
| Bisoprolol Fumarate ———– 5.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour: – Approved colour used | ||||
| Bisoprolol Fumarate tablet | Each Film Coated Tablet Contain: | Antihypertensive | ||
| Bisoprolol Fumarate ———– 10.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour: – Approved colour used | ||||
| Metoprolol Extended Release Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Metoprolol Succinate IP | ||||
| Eq. to Metoprolol Tartrate ——–100 mg | ||||
| Excipients—————– q.s | ||||
| Colour: – Approved colour used | ||||
| Metoprolol ER&Amlopdipine Tablets IP | Each Film Coated Tablet Contains:-: | Antihypertensive | ||
| Metoprolol Succinate IP ———47.5 mg | ||||
| Eq. to Metoprolol Tartrate ———50.0 mg | ||||
| Amlopdipine Besylate IP | ||||
| Eq. to Amlopdipine ——————5.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Metoprolol ER& Amlodipine Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Metoprolol Succinate IP ———23.75 mg | ||||
| Eq. to Metoprolol Tartrate ———25.0 mg | ||||
| Amlopdipine Besylate IP | ||||
| Eq. to Amlopdipine ——————5.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Telmisartan & Atorvastatin Tablets | Each Film coated Tablets contains: | IP | 20 mg | Antihypertensive |
| Telmisartan | IP | |||
| Atorvastatin Calcium | 10 mg | |||
| eq. to. Atorvastatin | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Telmisartan & Atorvastatin Tablets | Each Film coated Tablets contains: | IP | 40 mg | Antihypertensive |
| Telmisartan | IP | |||
| Atorvastatin Calcium | 5 mg | |||
| eq. to. Atorvastatin | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Torsemide & Spironolactone Tablets | Each Uncoated Tablet Contains:- | IP | 20 mg | Antihypertensive |
| Torsemide | IP | 50 mg | ||
| Spironolactone | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 2.5 mg | Antihypertensive |
| Amlodipine Besylate | 5 mg | |||
| Eq. to Amlodipine | IP | 12.5 mg | ||
| Olmesartan Medoxomil | IP | q.s | ||
| Hydrochlorothiazide | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Atenolol Tablets IP 25 mg | Each Uncoated Tablet Contains:- | IP | 25 mg | Antihypertensive |
| Atenolol | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Atenolol Tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Antihypertensive |
| Atenolol | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Atenolol Tablets IP 100 mg | Each Uncoated Tablet Contains:- | IP | 100 mg | Antihypertensive |
| Atenolol | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 10 mg | Antihypertensive |
| Amlodipine Besylate | 40 mg | |||
| Eq. to Amlodipine | IP | 25 mg | ||
| Olmesartan Medoxomil | IP | q.s | ||
| Hydrochlorothiazide | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
| Amlodipine Besylate | 40 mg | |||
| Eq. to Amlodipine | IP | 12.5 mg | ||
| Olmesartan Medoxomil | IP | q.s | ||
| Hydrochlorothiazide | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
| Amlodipine Besylate | 20 mg | |||
| Eq. to Amlodipine | IP | 12.5 mg | ||
| Olmesartan Medoxomil | IP | q.s | ||
| Hydrochlorothiazide | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
| Amlodipine Besylate | 5 mg | |||
| Eq. to Amlodipine | IP | 12.5 mg | ||
| Olmesartan Medoxomil | IP | q.s | ||
| Hydrochlorothiazide | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Azelnidipine Tablets IP 8 mg | Each Uncoated Tablet Contains:- | IP | 8 mg | Antihypertensive |
| Azelnidipine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Azelnidipine Tablets IP 16 mg | Each Uncoated Tablet Contains:- | IP | 16 mg | Antihypertensive |
| Azelnidipine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Bosentan Tablets IP 62.5mg | Each Film Coated Tablet Contains:- | IP | 62.5 mg | Antihypertensive |
| Bosentan Monohydrate | q.s | |||
| Eq. to Bosentan | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Bosentan Tablets IP 125mg | Each Film Coated Tablet Contains:- | IP | 125 mg | Antihypertensive |
| Bosentan Monohydrate | q.s | |||
| Eq. to Bosentan | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Minoxidil Topical solution USP | Composition | IP | 5.0%w/v | Antihypertensive |
| Minoxidil | IP | q.s. | ||
| Iso propyl alcohol | ||||
| Minoxidil Topical lotion USP 2% | Composition: | IP | 2.0%w/v | Antihypertensive |
| Minoxidil | qs | |||
| In Adhesive base | ||||
| Lisinopril Tablets IP 5 mg | Each Uncoated Tablet Contains:- | IP | 5 mg | Antihypertensive |
| Lisinopril | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Lisinopril Tablets IP 2.5 mg | Each Uncoated Tablet Contains:- | IP | 2.5 mg | Antihypertensive |
| Lisinopril | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Losartan Potassium & Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | IP | 25 mg | Antihypertensive |
| Losartan Potassium | IP | 5 mg | ||
| Hydrochlorothiazide | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Fenofibrate and Rosuvastatin Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Fenofibrate IP ————- 160 mg | ||||
| Rosuvastatin Calcium IP | ||||
| Eq. to Rosuvastatin ———10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Olmesartan & Ramipril Tablets. | Each uncoated tablet contains: | Antihypertensive | ||
| Olmesartan IP ————- 20.0 mg | ||||
| Ramipril IP ————–5.0 mg | ||||
| Excipients —————– q.s | ||||
| Colour: – Approved colour used | ||||
| Telmisartan and Amlodipine Tablets I.P. | Each Uncoated Bilayered Tablet Contains:- | I.P. | 40 mg | Antihypertesnive |
| Telmisartan | I.P. | 5 mg | ||
| Amlodipine Besylate | ||||
| Eq. to Amlodipine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Atorvastatin Calcium & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
| Atorvastatin Calcium | 75 mg | |||
| eq. to Atorvastatin (As pellets) | IP | q.s | ||
| Clopidogrel (as Bisulphate) (As pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Atorvastatin Calcium & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antihypertensive |
| Atorvastatin Calcium | ||||
| eq. to Atorvastatin | 75 mg | |||
| (As pellets) | IP | |||
| Clopidogrel (as Bisulphate) | q.s. | |||
| (As pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Propranolol Sustained Release Capsules IP | Each hard gelatin capsule contains: | IP | 40.0 mg | Antihypertensive |
| Propranolol Hydrochloriode | ||||
| ( As sustained Release pellets) | q.s. | |||
| Excipients | ||||
| Approved Colors Used. in Empty Shell & Pellet | ||||
| Propranolol Sustained Release Capsules IP | Each hard gelatin capsule contains: | IP | 60.0 mg | Antihypertensive |
| Propranolol Hydrochloriode | ||||
| ( As sustained Release pellets) | q.s. | |||
| Excipients | ||||
| Approved Colors Used. in Empty Shell & Pellet | ||||
| Propranolol Sustained Release Capsules IP | Each hard gelatin capsule contains: | IP | 80 | Antihypertensive |
| Propranolol Hydrochloriode | ||||
| ( As sustained Release pellets) | q.s. | |||
| Excipients | ||||
| Approved Colors Used. in Empty Shell & Pellet | ||||
| Prasugrel & Aspirin Capsules | Each Hard Gelatin Capsule contains: | USP | 10 mg | Antihypertensive |
| Prasugrel Hydrochlorode | ||||
| Equ. to Prasugrel | 75 mg | |||
| (As pellets) | IP | q.s. | ||
| Aspirin | ||||
| (As enteric coated Pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Prazosin Tablets IP 5 mg | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
| Prazosin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Chlorthalidone Tablets 6.25 mg | Each Uncoated Tablet contains: | IP | 6.25 mg | Antihypertensive |
| Chlorthalidone | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Ramipril and Hydrochlorothiazide Tablets | Each Uncoated Sustained release Tablet Contains:- | IP | 5 mg | Antihypertensive |
| Ramipril | IP | 12.5 mg | ||
| Hydrochlorothiazide | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Enalapril Maleate Tablets IP. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Enalapril Maleate IP.————–2.5mg | ||||
| Excipients———————–q.s. | ||||
| Colour-Approved colour used. | ||||
| Enalapril Maleate Tablets I.P. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Enalapril Maleate I.P ————5- mg | ||||
| Excipients———————–q.s. | ||||
| Colour-Approved colour used. | ||||
| Enalapril Maleate Tablets IP. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Enalapril Maleate IP———-10mg | ||||
| Excipients———————q.s. | ||||
| Colour-Approved colour used. | ||||
| Enalapril Maleate Tablets I.P. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Enalapril Maleate I.P———-20mg | ||||
| Excipients———————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Hydrochlorothiazide IP———25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Hydrochlorothiazide IP———50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lisinopril Tablets I.P. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Lisinopril IP——— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Spironolactone Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Spironolactone IP——— 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Spironolactone Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Spironolactone IP——— 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Spironolactone Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Spironolactone IP——— 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aspirin Tablet IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Aspirin IP——— 75 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Aspirin Tablet IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Aspirin IP——— 150 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ——— 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ——— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fenofibrate and Rosuvastatin Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Fenofibrate IP ————- 145 mg | ||||
| Rosuvastatin Calcium IP | ||||
| Eq. to Rosuvastatin ———5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Methyldopa Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensives | ||
| Methyldopa IP | ||||
| (As Anhydrous) —————125 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Methyldopa Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensives | ||
| Methyldopa IP | ||||
| (As Anhydrous) —————250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Torsemide IP ————– 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Torsemide IP ————– 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Torsemide IP ————– 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Torsemide IP ————– 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Propranolol Tablet IP | Each uncoated tablet contains: | Antihypertensive | ||
| Propranolol HCl IP————–10.0 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Propranolol Tablet IP | Each uncoated tablet contains: | Antihypertensive | ||
| Propranolol HCl IP————–40.0 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used | ||||
| Atorvastatin & Ezetimibe Tablet | Each Film Coated Tablet contain | Antihypertensive | ||
| Atorvastatin IP————40.0 mg | ||||
| Ezetimibe ——————–10.0 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used | ||||
| Atorvastatin & Ezetimibe Tablet | Each Film Coated Tablet contain | Antihypertensive | ||
| Atorvastatin IP————10.0 mg | ||||
| Ezetimibe ——————–10.0 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used | ||||
| Fenofibrate and Rosuvastatin Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Fenofibrate IP ————- 145 mg | ||||
| Rosuvastatin Calcium IP | ||||
| Eq. to Rosuvastatin ———20.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour-approved colour used. | ||||
| Olmesartan & Ramipril Tablets. | Each uncoated tablet contains: | Antihypertensive | ||
| Olmesartan IP ————- 40.0 mg | ||||
| Ramipril IP ————–5.0 mg | ||||
| Excipients —————– q.s | ||||
| Colour: – Approved colour used. | ||||
| Spironolactone and Furosemide Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Spironolactone IP——— 25.0 mg | ||||
| Furosemide IP ————40.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour :- Approved colour used | ||||
| Cilnidipine tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Clinidipine IP ————— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour: Approved colour used | ||||
| Amitriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amitriptyline Hydrochloride IP ——— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour: Approved colour used | ||||
| Amitriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amitriptyline Hydrochloride IP ——— 25 mg | ||||
| Excipients—————– q.s | ||||
| Colour: Approved colour use | ||||
| Amitriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amitriptyline Hydrochloride IP ——— 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour: Approved colour used | ||||
| Escitalopram Oxalate Tablets IP | Each coated Tablet Contains:- | Antihypertensive | ||
| Escitalopram Oxalate I.P. | ||||
| Eq. to Escitalopram —————— 5 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Ramipril & Metoprolol Succinate Tablets | Each Bilayered tablet contains: | Antihypertensive | ||
| Ramipril IP ———————— 2.5 mg | ||||
| Metoprolol Succinate IP ———–23.75 mg | ||||
| Eq. to Metoprolol Tartrate ———-25 mg | ||||
| (Extended Release) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Cilnidipine & Telmisartan Tablets | Each Film Coated Tablet contains: | Antihypertensive | ||
| Cilnidipine IP ————— 10.0 mg | ||||
| Telmisartan IP ————– 40 mg | ||||
| Excipients ——————- q.s. | ||||
| Colour-Approved colour used. | ||||
| Ramipril & Metoprolol Succinate Tablets | Each Bilayered tablet contains: | Antihypertensive | ||
| Ramipril IP ———————— 5.0 mg | ||||
| Metoprolol Succinate IP ———– 47.5 mg | ||||
| Eq. to Metoprolol Tartrate ———-50 mg | ||||
| (Extended Release) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metoprolol Succinate (ER) & Cilnidipine Tablets | Each Film Coated Tablet contains: | Antihypertensive | ||
| Metoprolol Succinate USP | ||||
| Eq. to Metoprolol Tartrate ——— 50 mg | ||||
| Cilnidipine IH ————— 10.0 mg | ||||
| Excipients ————— q.s. | ||||
| Approved Colour Used. | ||||
| Colour-Approved colour used. | ||||
| Metoprolol Succinate (ER) & Cilnidipine Tablets | Each Film Coated Tablet contains: | Antihypertensive | ||
| Metoprolol Succinate USP | ||||
| Eq. to Metoprolol Tartrate ——— 25 mg | ||||
| Cilnidipine IH ————— 10.0 mg | ||||
| Excipients ————— q.s. | ||||
| Colour-Approved colour used. | ||||
| Azilsartan Medoximil Tablets | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Azilsartan Medoximil —————– 40 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Azilsartan Medoximil Tablets | Each Uncoated Tablet Contains:- | Antihypertensive | ||
| Azilsartan Medoximil —————– 80 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Clopidogrel Bisulphate and Aspirin Tablets | Each Film Coated Tablets Contains :- | Antihypertensive | ||
| Clopidogrel Bisulphate | ||||
| Eq. to Clopidogrel —————— 75 mg | ||||
| Aspirin IP —————— 75 mg | ||||
| (As Enteric coated Granules) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Clopidogrel Bisulphate and Aspirin Tablets | Each Film Coated Tablets Contains :- | Antihypertensive | ||
| Clopidogrel Bisulphate | ||||
| Eq. to Clopidogrel —————— 75 mg | ||||
| Aspirin IP —————— 150 mg | ||||
| (As Enteric coated Granules) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ———- 10.0 mg | ||||
| Telmisartan IP ————– 80 mg | ||||
| Hydrochlorothiazide IP —— 25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ———- 2.5 mg | ||||
| Telmisartan IP ————– 20 mg | ||||
| Hydrochlorothiazide IP —— 12.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rosuvastatin & Fenofibrate Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
| Rosuvastatin Calcium IP | ||||
| Eq. to Rosuvastatin ———5.0 mg | ||||
| Fenofibrate IP ————- 67 mg | ||||
| Excipients—————– q.s | ||||
| Colour-approved colour used. | ||||
| Atorvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
| Atorvastatin Calcium | ||||
| eq. to Atorvastatin (As pellets) | 75 mg | |||
| Aspirin (As Enteric coated pellets) | IP | q.s | ||
| Excipients | ||||
| Approved colour used | ||||
| Amlodipine & Atenolol Tablets IP | Each Uncoated Tablet Contains:- | Antihypertesnive | ||
| Amlodipine Besylate IP | ||||
| Eq. to Amlodipine ——— 5 mg | ||||
| Atenolol IP —————- 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Nifedipine Sustained-Release Tablets I.P. | Each Film Coated Sustained-Release Tablets:- | Antihypertesive | ||
| Nifedipine I.P————–10mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Nifedipine Sustained-Release Tablets I.P. | Each Film Coated Sustained-Release Tablets:- | Antihypertesive | ||
| Nifedipine I.P—————20mg | ||||
| Excipients———————q.s. | ||||
| Colour-Approved colour used. | ||||
| Nicorandil Tablets I.P. | Each Uncoated Tablet Contains:- | Antihypertesive | ||
| Nicorandil I.P.——– 5 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Nicorandil Tablets I.P. | Each Uncoated Tablet Contains:- | Antihypertesive | ||
| Nicorandil I.P.————– 10 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Nicorandil Tablets I.P. | Each Uncoated Tablet Contains:- | Antihypertesive | ||
| Nicorandil I.P.……………….. 20 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Midodrine Hydrochloride Tablets USP 2.5 mg | Each Uncoated Tablet Contains:- | USP | 2.5 mg | Antihypotensive |
| Midodrine Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Anti acne & Anti fungal | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Clindamycin Hydrochloride Capsule IP | Each hard gelatin capsule contain: | IP | 300 mg | Anti acne & Anti fungal |
| Clindamycin Hydrochloride | q.s. | |||
| Equivalent to Clindamycin | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule | ||||
| Terbinafine Tablets I.P. | Each Uncoated Tablet Contains:- | Anti Acne & Anti Fungal | ||
| Terbinafine Hydrochloride I.P. | ||||
| Eq.to Terbinafine 250mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Analgesic & anti Inflammatory | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Diclofenac &thiocolchicoside Capsule | Each Hard Gelatin Capsule contain: | IP | 100 mg | Analgesic & anti Inflammatory |
| Diclofenac Sodium (EC) | IP | 8 mg | ||
| Thiocolchicoside | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used in capsule shells. | ||||
| Antihypertensive, Antithrombotic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Rosuvastatin and Aspirin Capsules | Each Hard Gelatin Capsule contain: | IP | 5.0 mg | Antihypertensive, Antithrombotic |
| Rosuvastatin calcium | ||||
| Equivalent to Rosuvastatin | 75 mg | |||
| (As pellets) | IP | |||
| Aspirin | q.s. | |||
| (As enteric coated pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Rosuvastatin and Aspirin Capsules | Each Hard Gelatin Capsule contain: | IP | 10 mg | Antihypertensive, Antithrombotic |
| Rosuvastatin calcium | ||||
| Equivalent to Rosuvastatin | ||||
| (As pellets) | IP | 150 mg | ||
| Aspirin(As enteric coated pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Atorvastatin, Aspirin & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive, Antithrombotic |
| Atorvastatin Calcium | 75 mg | |||
| eq. to Atorvastatin (As pellets) | IP | |||
| Aspirin | ||||
| ( As enteric coated Pellets ) | IP | 75 mg | ||
| Clopidogrel Bisulphate) | q.s. | |||
| equ. to Clopidogrel | ||||
| (As pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Atorvastatin, Aspirin & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antihypertensive, Antithrombotic |
| Atorvastatin Calcium | 75 mg | |||
| eq. to Atorvastatin (As pellets) | IP | |||
| Aspirin | ||||
| ( As enteric coated Pellets ) | IP | 75 mg | ||
| Clopidogrel Bisulphate) | ||||
| equ. to Clopidogrel | q.s. | |||
| (As pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Rosuvastatin, Clopidogrel & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive, Antithrombotic |
| Rosuvastatin Calcium | ||||
| eq. to Rosuvastatin | 75 mg | |||
| (As pellets) | IP | |||
| Aspirin | ||||
| ( As enteric coated Pellets ) | IP | 75 mg | ||
| Clopidogrel Bisulphate) | q.s. | |||
| equ. to Clopidogrel | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Rosuvastatin and Aspi rin Capsules | Each Hard Gelatin Capsule contain: | IP | 10 mg | Antihypertensive, Antithrombotic |
| Rosuvastatin calcium | ||||
| Equivalent to Rosuvastatin | ||||
| (As pellets) | IP | 75 mg | ||
| Aspirin (As enteric coated pellets) | ||||
| Excipients | q.s. | |||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Clopidogrel Bisulphate Tablet IP | Each Film coated tablet contains: | Antihypertensive, antithrombotic | ||
| Clopidogrel Bisulphate IP | ||||
| eq. to. Clopidogrel ——– 75.0 mg | ||||
| Excipients ———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Clopidogrel Bisulphate Tablet IP | Each Film coated tablet contains: | Antihypertensive, antithrombotic | ||
| Clopidogrel Bisulphate IP | ||||
| eq. to. Clopidogrel ——– 150.0 mg | ||||
| Excipients ———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Ramipril Tablet IP | Each uncoated tablet contains: | Antihypertensive, antithrombotic | ||
| Ramipril IP ————-5.0 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used | ||||
| Ramipril Tablet IP | Each uncoated tablet contains: | Antihypertensive, antithrombotic | ||
| Ramipril IP ————-10.0 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used | ||||
| Ramipril Tablet IP 1.25 mg | Each uncoated | Antihypertensive, Antithrombotic | ||
| tablet contains: | ||||
| Ramipril IP ————-1.25 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used | ||||
| Ramipril Tablet IP 2.5 mg | Each uncoated | Antihypertensive, Antithrombotic | ||
| tablet contains: | ||||
| Ramipril IP ————-2.5 mg | ||||
| Excipients —————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Analgesic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Diclofenac Gel IP | Composition: | IP | 1.16%w/w | Analgesic |
| Diclofenac Dimethylamine | 1.0 %w/w | |||
| equivalent to Diclofenac Sodium | q.s. | |||
| Water soluble Gel Base | ||||
| Lignocaine Cream | Composition | IP | 2.0 % w/w | Analgesic |
| Lignocaine | q.s. | |||
| Cream base | ||||
| Lignocaine Cream | Composition | IP | 1.0 % w/w | Analgesic |
| Lignocaine | q.s. | |||
| Cream base | ||||
| Aceclofenac Dispersible Tablets 100 mg | Each Uncoated Dispersible Tablet Contains:- | IP | 100 mg | Analgesic |
| Aceclofenac | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Paracetamol Sustained Release Tablets | Each uncoated Bilayered Tablet Contains: | IP | 300 mg | Analgesic |
| Paracetamol | ||||
| (As Immediate Release) | IP | 700 mg | ||
| Paracetamol | ||||
| (As Sustained Release) | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Nimesulide Tablets BP | Each Uncoated Tablet Contains:- | Analgesic | ||
| Nimesulide BP ——— 100 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol (SR) 1000 mg Tablets | Each Uncoated (SR) Tablet Contains:- | Analgesic | ||
| Paracetamol IP ————————–1000 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Analgesic | ||
| Aceclofenac IP ————— 200 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Methyl salicylate Ointment IP 10%w/w | Composition: | IP | 10.0 % w/w | Analgesic |
| Methyl salicylate | qs | |||
| Ointment base | ||||
| Antibacterial, Analgesic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Nifedipine & Lignocaine Cream | Composition: | IP | 0.3%w/w | Antibacterial, Analgesic |
| Nifedipine | IP | 1.5%w/w | ||
| Lidocaine | q.s. | |||
| Cream base | ||||
| AntiInflammatory, Analgesic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Etoricoxib, Linseed Oil, Methyl Salicylate & Menthol gel | Composition: | IP | 10 mg | AntiInflammatory, Analgesic |
| Each gram contains | 30 mg | |||
| Etoricoxib | BP | 100 mg | ||
| Linseed Oil | IP | 50 mg | ||
| Methyl Salicylate | IP | q.s. | ||
| Menthol | ||||
| Gel Base | ||||
| Antispasmodic & analgesic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Mefenamic Acid &Paracetamol Tablets | Each Uncoated Tablet Contains:- | Antispasmodic & analgesic | ||
| Mefenamic Acid I.P. —————— 500 mg | ||||
| Paracetamol IP ————————– 325 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Muscle relaxant with anti-inflammatory and analgesic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Thiocolchioside and Dexketoprofen Trometamol Tablets | Each Film Coated Tablets Contains:- | Muscle relaxant with anti-inflammatory and analgesic | ||
| Thiocolchioside IP ————— 4 mg | ||||
| Dexketoprofen Trometamol ——-25 mg | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Gastric Resistance & Anti Emetics & analgesic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Rabeprazole (EC) Sodium & Diclofenac sodium Capsule(SR) | Each Hard Gelatin capsule contains | IP | 20mg | Gastric Resistance & Anti Emetics & analgesic |
| Rabeprazole Sodium | ||||
| (As enteric coated pellets) | IP | 100mg | ||
| Diclofenac sodium | ||||
| (as sustained release pellets) | ||||
| Approved coloured used Empty hard Gelatin capsule shells. | ||||
| Tranexamic Acid Tablets IP 250 mg | Each Film coated Tablet Contains:- | IP | 250 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
| Tranexamic Acid | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Eperisone HCl tablets 50 mg | Each Film coated Tablet Contains:- | IP | 50 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
| Eperisone HCl | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Flupirtine Maleate capsules | Each hard gelatin capsule contains:- | 100mg | Gastric Resistance, Antispasmodic & Anti Emetic | |
| Flupirtine Maleate | q.s | |||
| Excipients | ||||
| Colour: Approved colours used un empty capsule shells. | ||||
| Itopride Hydrochloride Sustained release capsules | Each hard gelatin capsule contains:- | 150mg | Gastric Resistance, | |
| Itopride Hydrochloride | ||||
| (As sustained release) | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in capsule shells & pellets. | ||||
| Antiinflammatory | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Indomethacin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 25.0 mg | Antiinflammatory |
| Indomethacin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Piroxicam Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 20.0 mg | Antiinflammatory |
| Piroxicam | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Beclomethasone Dipropionate with salicyclic Acid Ointment | Composition: | IP | 0.025%w/w | Antiinflammatory |
| Beclomethasone Dipropionate | IP | 3.00% | ||
| Salicyclic Acid | q.s. | |||
| Ointment base | ||||
| Hydrocortisone Acetate cream IP | Composition: | IP | 1.0 %w/w | Antiinflammatory |
| Hydrocortisone Acetate | q.s. | |||
| cream base | ||||
| Hydrocortisone Acetate cream IP | Composition: | IP | 2.5 %w/w | Antiinflammatory |
| Hydrocortisone Acetate | q.s. | |||
| cream base | ||||
| White Soft Paraffin & Light Liquid Paraffin Cream | Composition : | IP | 13.2%w/w | Antiinflammatory |
| White Soft Paraffin | IP | 10.2%w/w | ||
| Light Liquid Paraffin | q.s | |||
| Cream Base | ||||
| Clindamycin Phosphate and benzoyl peroxide Gel | Composition:- | IP | 1.00% w/w | Anti-Inflammatory |
| Clindamycin Phosphate | 2.50% w/w | |||
| Equivalent to Clindamycin | IP | q.s. | ||
| Benzoyl Peroxide (as Anhydrous) | ||||
| Gel Base | ||||
| Mometasone Furoate & Terbinafine Hydrochloride Cream | Composition:- | IP | 0.1% w/w | Anti-Inflammatory |
| Mometasone Furoate | IP | 1% w/w | ||
| Terbinafine Hydrochloride | q.s. | |||
| Cream Base | ||||
| Clomiphene Citrate Tablet IP 50 mg | Each uncoated Tablet Contains: – | Antiinflammatory | ||
| Clomiphene Citrate IP ————–50.0 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Diacerein & Aceclofenac Tablets | Each Film coated tablet contains: | Antiinflammatory | ||
| Diacerein IP ————50 mg | ||||
| Aceclofenac IP ———–100 mg | ||||
| Excipients……………q.s. | ||||
| Colour-Approved colour used. | ||||
| Diclofenac sodium (As enteric coated) & Misoprostol Capsules | Each hard gelatin capsule contains: | IP | 50.0 mg | Antinflammatory |
| Diclofenac Sodium | ||||
| (As sustained release pellets) | IP | 200 mcg | ||
| Misoprostol | q.s. | |||
| Excipients | ||||
| Approved Colors Used. in Empty Shell & Pellet | ||||
| Diclofenac sodium (As enteric coated) & Misoprostol Capsules | Each hard gelatin capsule contains: | IP | 75.0 mg | Antinflammatory |
| Diclofenac Sodium | ||||
| (As sustained release pellets) | IP | 200 mcg | ||
| Misoprostol | q.s. | |||
| Excipients | ||||
| Approved Colors Used. in Empty Shell & Pellet | ||||
| Hydrocortisone butyrate cream USP | Composition: | USP | 0.1%w/w | Anti-inflammatory |
| Hydrocortisone butyrate | ||||
| In hydrophilic | q.s. | |||
| cream base | ||||
| Fluocinolone Acetonide Cream IP | Composition : | IP | 0.025 %w/w | Anti-Inflammatory |
| Fluocinolone Acetonide | q.s | |||
| Cream Base | ||||
| Dexamethasone Tablets IP | Each Uncoated Tablet Contains:- | Anti-inflammatory | ||
| Dexamethasone Sodium Phosphate IP | ||||
| Eq. to Dexamethasone ———— 0.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Analgesic & Antiinflammatory | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Diclofenac Potassium and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
| Diclofenac Potassium BP ——- 50 mg | ||||
| Serratiopeptidase IP ———–10 mg | ||||
| (20,000 units of Serratiopeptidase as enteric coated granules) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diclofenac Sodium, Paracetamol &Serratiopeptidase Tablets | Each Uncoated Tablet Contains:- | Analgesic & Antiinflammatory | ||
| Diclofenac Sodium IP ——— 50 mg | ||||
| Paracetamol IP ————–325 mg | ||||
| Serratiopeptidase IP ———–10 mg | ||||
| (20,000 units of Serratiopeptidase as enteric coated granules) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets | Each Uncoated Tablet Contains:- | Analgesic & Antiinflammatory | ||
| Diclofenac Potassium BP ——- 50 mg | ||||
| Paracetamol IP ————–325 mg | ||||
| Chlorzoxazone USP ——— 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diclofenac Potassium Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
| Diclofenac Potassium BP ——- 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
| Diclofenac Potassium BP ——- 50 mg | ||||
| Paracetamol IP ————–325 mg | ||||
| Chlorzoxazone USP ——— 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
| Aceclofenac IP —————- 100 mg | ||||
| Paracetamol IP ————–325 mg | ||||
| Serratiopeptidase IP ———–15 mg | ||||
| (30,000 units of Serratiopeptidase as enteric coated granules) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diacerein Capsules I.P. | Each Hard Gelatin Capsule contains: | IP | 50.0 mg | Analgesic & Anti-Inflammatory |
| Diacerein | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Thiocolchioside and Diclofenac sodium Capsules | Each Hard Gelatin Capsule Contains:- | IP | 4.0 mg | Analgesic & Anti-Inflammatory |
| Thiocolchioside | IP | 50.0 mg | ||
| Diclofenac sodium | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Thiocolchioside and Diclofenac sodium Capsules | Each Hard Gelatin Capsule Contains:- | IP | 16.0 mg | Analgesic & Anti-Inflammatory |
| Thiocolchioside | IP | 100.0 mg | ||
| Diclofenac sodium | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Thiocolchioside Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 4.0 mg | Analgesic & Anti-Inflammatory |
| Thiocolchioside | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Thiocolchioside Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 8.0 mg | Analgesic & Anti-Inflammatory |
| Thiocolchioside | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Oxaceprol Capsules | Each hard gelatin capsule contains: | 200 mg | Analgesic & Anti-Inflammatory | |
| Oxaceprol | q.s. | |||
| Excipients | ||||
| Approved colors used in Hard Gelatin Capsule shell. | ||||
| Aceclofenac along with Linseed oil Menthol, Methyl Salicylate & Capsaicin | Composition: | IP | 1.5 % w/w | Analgesic & Anti-Inflammatory |
| Aceclofenac | BP | 3 % w/w | ||
| Linseed oil | IP | 5.0 % w/w | ||
| Menthol | IP | 10 % w/w | ||
| Methyl Salicylate | USP | 0.01% | ||
| Capsaicin | IP | 1% w/w | ||
| Benzyl Alcohol | q.s. | |||
| Gel Base | ||||
| Diacerein & Glucosamine Sulphate Potassium Chloride Tablets | Each Film coated tablet contains: | Analgesic & Anti-Inflammatory | ||
| Diacerein IP ————50.0 mg | ||||
| Glucosamine Sulphate | ||||
| Potassium Chloride IP ———–1500 mg | ||||
| Excipients……………q.s. | ||||
| Colour-Approved colour used. | ||||
| Trypsin Chymotrypsin Tablet IP | Each Enteric coated Tablet Contains: – | |||
| Trypsin Chymotrypsin IP ———(1,00,000 | ||||
| Armour Units of enzymatic activity) | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used. | ||||
| Thiocolchicoside Capsule IP. | Each Hard gelatin capsule Contains: | IP | 4 mg | Analgesic & anti-inflammatory |
| Thiocolchicoside | ||||
| Approved colour used | ||||
| Thiocolchicoside Capsule IP. | Each Hard gelatin capsule Contains: | IP | 8 mg | Analgesic & anti-inflammatory |
| Thiocolchicoside | ||||
| Approved colour used | ||||
| Anti-Inflammatory Drug | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Apixaban Tablets 2.5 mg | Each Film coated Tablet Contains:- | 2.5 mg | Anti-Inflammatory Drug | |
| Apixaban | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Apixaban Tablets 5 mg | Each Film coated Tablet Contains:- | 5 mg | Anti-Inflammatory Drug | |
| Apixaban | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Anti-Inflammatory & Immuno Suppressant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
| Deflazacort —————- 24 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
| Deflazacort —————- 18 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
| Deflazacort —————- 1 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
| Deflazacort —————- 30 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
| Deflazacort —————- 6 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Carisoprodol Tablets IP | Each Uncoated Tablet Contains:- | Antiinflamatory & Muscle relaxant | ||
| Carisoprodol IP ————— 350 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Eperisone Hydrochloride (Sustained release) Capsule 150mg | Each hard gelatin capsule contains:- | 150mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
| Eperisone Hydrochloride | ||||
| (As sustained release pellets) | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells & pellets. | ||||
| Eperisone Hydrochloride (Sustained release) Capsule 150mg Diclofenac Sodium (Sustained Release) Capsules | Each hard gelatin capsule contains:- | IP | 150mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Eperisone Hydrochloride | ||||
| (As sustained release pellets) | 100mg | |||
| Diclofenac Sodium | ||||
| (As sustained release pellets) | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells & pellets. | ||||
| Choline salicylate & Lignocaine Hydrochloride Gel | Composition: | BP | 8.7% w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
| Choline salicylate | IP | 2.0% w/w | ||
| Lignocaine Hydrochloride | q.s. | |||
| Water Soluble Gel Base in a purified water | ||||
| Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate & Menthol gel | Composition: | IP | 1.16% w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
| Diclofenac Diethylamine | 1.0% w/w | |||
| eq. to Diclofenac sodium | IP | 3.0% w/w | ||
| Linseed Oil | BP | 10.0% w/w | ||
| Methyl Salicylate | IP | 5.0%w/w | ||
| Menthol | IP | 1.0%w/w | ||
| Benzyl Alcohol | IP | q.s. | ||
| (as Preservative) | ||||
| Gel Base | ||||
| Virgin Linseed Oil, Diclofenac Diethylamine, Methyl Salicyclate, Menthol& Capsaicin Gel | Composition: | BP | 3.00%w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
| Virgin Linseed Oil | IP | 1.16%w/w | ||
| Diclofenac Diethylamine | IP | 1.00%w/w | ||
| Equ. to Diclofenac Sodium | IP | 10.00%w/w | ||
| Methyl Salicylate | IP | 5.00%w/w | ||
| Menthol | USP | 0.025%w/w | ||
| Capsaicin | ||||
| Preservative : | IP | 1.00%w/w | ||
| Benzyl Alcohol | q.s. | |||
| Gel Base | ||||
| Choline Salicylate & Lignocaine Hydrochloride Gel | Composition : | BP | 8.7%w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
| Choline Salicylate Solution | ||||
| Equ. to Choline Salicylate | IP | 2.0%w/w | ||
| Lignocaine Hydrochloride | ||||
| Preservative: | IP | 0.01%w/w | ||
| Benzalkonium Chloride | q.s | |||
| In Pleasant Flavoured Base | ||||
| Etodolac Extended Release Tablets 200 mg | Each Film Coated Extended Release Tablet Contains:- | BP | 200 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Etodolac | q.s | |||
| (As extended release) | ||||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Etodolac Extended Release Tablets 300 mg | Each Film Coated Extended Release Tablet Contains:- | BP | 300 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Etodolac(As extended release) | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Etodolac Extended Release Tablets 400 mg | Each Film Coated Extended Release Tablet Contains:- | BP | 400 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Etodolac | ||||
| (As extended release) | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Allopurinol Tablets IP 100 mg | Each Film Coated Tablet Contains:- | IP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Allopurinol | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam Tablets | Each Film Coated Tablets Contains | 4 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
| Lornoxicam | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam Tablets | Each Film Coated Tablets Contains | 8 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
| Lornoxicam | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam and Paracetamol Tablets | Each Enteric Coated Tablets Contains | IP | 4 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Lornoxicam | 325 mg | |||
| Paracetamol | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | IP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Aceclofenac | IP | 325 mg | ||
| Paracetamol | IP | 15 mg | ||
| Serratiopeptidase | ||||
| (30,000 units of Serratiopeptidase as enteric coated granules) | ||||
| Excipients | q.s | |||
| Colour-Approved colour used. | ||||
| Promethazine Tablets IP 25 mg | Each Film Coated Tablets Contains | IP | 25 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Promethazine Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Promethazine Tablets IP 50 mg | Each Film Coated Tablets Contains | IP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Promethazine Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride & Caffeine Tablets | Each Film Coated Tablet Contains:- | BP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Nimesulide | IP | 10 mg | ||
| Phenylephrine Hydrochloride | IP | 5 mg | ||
| Cetirizine Dihydrochloride | IP | 30 mg | ||
| Caffeine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Flavoxate Hydrochloride tablets IP 100 mg | Each Film coated Tablets contains: | IP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Flavoxate Hydrochloride | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Etoricoxib Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Etoricoxib I.P 60mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Etoricoxib Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Etoricoxib I.P 90mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Etoricoxib Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Etoricoxib I.P 120mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Etodolac Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Etodolac I.P —–200mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Etodolac Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Etodolac I.P —–300mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Etodolac Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Etodolac I.P —–400mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Thicolchicoside and Etoricoxib Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Thicolchicoside IP ———— 4 mg | ||||
| Etoricoxib IP —————— 60 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ketorolac Tromethamine Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Ketorolac Tromethamine IP———-10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Piroxicam-Beta-Cyclodextrin Tablets | Each Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Piroxicam-Beta-Cyclodextrin | ||||
| Eq. to Piroxicam IP ————- 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Aceclofenac IP ————— 100 mg | ||||
| Thiocolchioside IP ———— –4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Lornoxicam ——————- 4 mg | ||||
| Thiocolchioside IP ———— –4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Lornoxicam ——————- 4 mg | ||||
| Thiocolchioside IP ———— –8 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Lornoxicam ——————- 8 mg | ||||
| Thiocolchioside IP ———— –8 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Lornoxicam ——————- 16 mg | ||||
| Thiocolchioside IP ———— –16 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tolperisone Hydrochloride and Diclofenac Sodium Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Tolperisone Hydrochloride ———150 mg | ||||
| Diclofenac Sodium —————-50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tolperisone Hydrochloride and Diclofenac Sodium Sustained Release Tablets IP | Each Sustained Release Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Tolperisone Hydrochloride ———450 mg | ||||
| Diclofenac Sodium —————100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Febuxostat Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Febuxostat —————- 80 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Febuxostat Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Febuxostat —————- 120 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Tadalafil IP —————- 2.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Pirfenidone Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Pirfenidone IP ————— 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Pirfenidone Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Pirfenidone IP ————— 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam and Paracetamol Tablets | Each Enteric Coated Tablets Contains | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Lornoxicam —————– 4 mg | ||||
| Paracetamol IP—————-325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lornoxicam and Paracetamol Tablets | Each Enteric Coated Tablets Contains | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Lornoxicam —————– 8 mg | ||||
| Paracetamol IP—————-325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine& Caffeine Tablets | Each Uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Paracetamol IP ————— 500 mg | ||||
| Phenylephrine Hydrochloride IP—— 5 mg | ||||
| Diphenhydramine IP—————— 25 mg | ||||
| Caffeine (Anhydrous) IP ————-30mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diacerein, Glucosamine &Methylsulfonylmethane Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Diacerein IP —————– 50 mg | ||||
| Glucosamine Sulphate Potassium Chloride USP –750 mg | ||||
| Eq. to Glucosamine ———— 446 mg | ||||
| Methylsulfonylmethane USP ——-250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Etoricoxib & Paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
| Etoricoxib IP —————— 60 mg | ||||
| Paracetamol IP————– 325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
| Aceclofenac IP ————— 100 mg | ||||
| Thiocolchioside IP ———— — 8 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac and Drotaverine hydrochloride Tablets | Each Film Coated Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
| Aceclofenac IP ————— 100 mg | ||||
| Drotaverine hydrochloride I.P.——-80 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
| Aceclofenac IP ————— 200 mg | ||||
| (As Sustained Release) | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets | Each Enteric Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Trypsin BP ———————–48 mg | ||||
| Bromelain ————————90 mg | ||||
| Rutoside Trihydrate BP ————-100 mg | ||||
| Diclofenac Sodium IP————–50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol and Diclofenac Potassium Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Paracetamol IP —————– 325 mg | ||||
| Diclofenac Potassium IP ——- 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Serratiopeptidase Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Serratiopeptidase IP ———–10 mg | ||||
| (Eq. to Enzyme Activity 20,000 units of enteric coated granules) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ketoprofen and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Ketoprofen IP ————— 50 mg | ||||
| Thiocolchioside IP ————–4 mg | ||||
| Excipients—————– q.s | ||||
| Colour: Approved colour used | ||||
| Ketoprofen and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Ketoprofen IP ————— 100 mg | ||||
| Thiocolchioside IP ———— –8 mg | ||||
| Excipients—————– q.s | ||||
| Colour: Approved colour used | ||||
| Tolperisone Hydrochloride and paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
| Tolperisone Hydrochloride ———150 mg | ||||
| Paracetamol IP —————- 325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
| Paracetamol IP ————— 325 mg | ||||
| Thiocolchioside IP ————–4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
| Paracetamol IP ————— 325 mg | ||||
| Thicolchicoside IP ————–8 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Etodolac and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
| Etodolac IP ————— 300 mg | ||||
| Thicolchicoside IP ————-4.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Etodolac and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
| Etodolac IP ————— 300 mg | ||||
| Thicolchicoside IP ————-8.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Flavoxate Hydrochloride Tablet | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Flavoxate Hydrochloride IP ———– 200mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diclofenac Potassium and Drotaverine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Diclofenac Potassium BP————- 50 mg | ||||
| Drotaverine hydrochloride I.P.——-80 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Tolperisone Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Tolperisone ————- 150 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Aceclofenac IP —————- 100 mg | ||||
| Paracetamol IP ————–325 mg | ||||
| Serratiopeptidase IP ———–10 mg | ||||
| (20,000 units of Serratiopeptidase as enteric coated granules) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Thicolchicoside and Etoricoxib Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Thicolchicoside IP ———— 8 mg | ||||
| Etoricoxib IP —————— 60 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Trypsin, Bromelain, &Rutoside Trihydrate Tablets | Each Enteric Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Trypsin BP ———————– 96 | ||||
| Bromelain ———————— 180 mg | ||||
| Rutoside Trihydrate ————– 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Trypsin, Bromelain, &Rutoside Trihydrate Tablets | Each Enteric Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Trypsin BP ———————– 48 mg | ||||
| Bromelain BP ———————- 90 mg | ||||
| Rutoside Trihydrate IP ————– 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Trypsin Chymotrypsin & Aceclofenac Tablet IP | Each Enteric coated Tablet Contains: – | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| 50,000 Armour Units of enzymatic activity supplied by a purified concentrate which has specific Trypsin and Chymotrypsin Activity in a ratio of approximately six to one. | ||||
| Aceclofenac IP ————————– 100 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used. | ||||
| Phenylephrine Hydrochloride, Paracetamol, Dextromethorphan Hydrobromide & Cetirizine Hydrochloride Tablets | Each Uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Phenylephrine Hydrochloride ——-5 mg | ||||
| Paracetamol IP ———– 325 mg | ||||
| Dextromethorphan Hydrobromide —- 10 mg | ||||
| Cetirizine Dihydrochloride IP ——–5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Drotaverine hydrochloride & Paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Drotaverine hydrochloride I.P.——80 mg | ||||
| Paracetamol IP ———– 325 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac, Paracetamol and Chlorzoxazone Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Aceclofenac IP ——- 100 mg | ||||
| Paracetamol IP ————–325 mg | ||||
| Chlorzoxazone USP ——— 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenylephrine Hydrochloride, Guaiphenesin, Cetirizine Dihydrochloride & Ambroxol Tablets IP | Each Uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Paracetamol IP ———– 325 mg | ||||
| Phenylephrine Hydrochloride ——-5 mg | ||||
| Guaiphenesin IP ——————–50 mg | ||||
| Cetirizine Dihydrochloride IP —— 5 mg | ||||
| Ambroxol Hydrochloride IP ————-15 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol and Diclofenac Potassium Tablets | Each Uncoated bilayeredtablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Paracetamol …………………………IP 325mg | ||||
| Diclofenac Potassium ………….BP 50mg | ||||
| Excipients……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Diclofenac Potassium & Paracetamol | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Diclofenac Potassium………….BP 50mg | ||||
| Paracetamol…………………………IP 325mg | ||||
| Excipients ……………………………….q.s | ||||
| Colour: Approved colour used. | ||||
| Nimesulide & Paracetamol tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Nimesulide l…………………………BP 100mg | ||||
| Paracetamol…………………………IP 325mg | ||||
| Excipients ……………………………….q.s | ||||
| Colour: Approved colour used. | ||||
| Aceclofenac & Paracetamol tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Aceclofenac…………………………IP 100mg | ||||
| Paracetamol…………………………IP 325mg | ||||
| Excipients ……………………………….q.s | ||||
| Colour: Approved colour used. | ||||
| Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride & Caffeine Tablets | Each uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Nimesulide BP………………….………… 100 mg | ||||
| Phenylephrine Hydrochloride IP…10 mg | ||||
| Cetirizine Dihydrochloride IP………. 5 mg | ||||
| Caffeine IP…………………..………………30 mg | ||||
| Excipients ……………………………………..q. s. | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenylephrine Hydrochloride, Caffeine & Chlorpheniramine Maleate Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Paracetamol IP………………………………………..325 mg | ||||
| Phenylephrine Hydrochloride IP …………….12.5 mg | ||||
| Caffeine IP ……………………………………………… 30 mg | ||||
| Chlorpheniramine Maleate IP ………………..2 mg | ||||
| Excipients………………………………………………..q.s. | ||||
| Colour: Approved colours used. | ||||
| Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Paracetamol IP………………………………………..500 mg | ||||
| Chlorpheniramine Maleate IP ………………… 2 mg | ||||
| Phenylephrine Hydrochloride IP ……………. 10 mg | ||||
| Excipients ………………………………………………..q.s. | ||||
| Colour-Approved colours used | ||||
| Diclofenac Potassium, Paracetamol, Cetirizine hydrochloride & Magnesium Trisilicate Tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
| Diclofenac Potassium BP……………………….. 50 mg | ||||
| Paracetamol IP ………………………………………325 mg | ||||
| Cetirizine hydrochloride IP …………………… 5 mg | ||||
| Magnesium Trisilicate IP ………………………. 100 mg | ||||
| Excipients ……………………………………………….q.s. | ||||
| Colour-Approved colours used | ||||
| Diclofenac Potassium Paracetamol & Chlorzoxazone Tablets | Each Film Coated Tablet contains: | BP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Diclofenac Potassium | IP | 325 mg | ||
| Paracetamol | USP | 250 mg | ||
| Chlorzoxazone | q. s. | |||
| Excipients | ||||
| Thiocolchicoside and Dexketoprofen Trometamol Tablets | Each Film coated Tablet contains: | IP | 4 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Thiocolchicoside | 25 mg | |||
| Dexketoprofen Trometamol | q. s. | |||
| Excipients | ||||
| Approved Colour used | ||||
| Eperisone Hydrochloride 75 Sustained release | Each Hard gelatin capsule Contains: | 75mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
| Eperisone Hydrochloride | q. s. | |||
| Excipients | ||||
| Approved colour used | ||||
| Nimesulide, Paracetamol, Phenylephrine Hydrochloride & Caffeine Tablets | Each Uncoated Tablet Contains:- | BP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Nimesulide | IP | 325 mg | ||
| Paracetamol | IP | 10 mg | ||
| Phenylephrine Hydrochloride | ||||
| Caffeine (Anhydrous) | IP | 25 mg | ||
| Excipients | q. s. | |||
| Colour: Approved colours used. | ||||
| Diclofenac Potassium, Paracetamol& Serratiopeptidase Tablets | Each film coated tablet contains:- | BP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Diclofenac Potassium | IP | 325 mg | ||
| Paracetamol | IP | 10 mg | ||
| Serratiopeptidase | ||||
| (20,000 units of Serratiopeptidase) | ||||
| Excipients | q.s. | |||
| Approved colour used | ||||
| Diclofenac potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains:- | BP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Diclofenac Potassium | IP | 325 mg | ||
| Paracetamol | IP | 15 mg | ||
| Serratiopeptidase | ||||
| (As Enteric coated granules) | ||||
| (Eq. to 30,000 Enzymatic Units of serratiopeptidase) | ||||
| Excipients | ||||
| Colour- Approved colour Used. | ||||
| Paracetamol, Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablets | Each uncoated tablet contains:- | IP | 500 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Paracetamol | IP | 5 mg | ||
| Phenylephrine Hydrochloride | IP | 5 mg | ||
| Cetirizine Hydrochloride | q.s | |||
| Excipients | ||||
| Colour : Approved colour used. | ||||
| Nimesulide & Paracetamol tablets | Each uncoated Bilayered tablet contains: | B.P. | 100mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Nimesulide | I.P. | 325mg | ||
| Paracetamol | q.s | |||
| Excipients. | ||||
| Colour: Approved colour used. | ||||
| Etodolac & Thiocolchicoside Tablets | Each film coated Tablets Contains: | I.P. | 400 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Etodolac | I.P. | 4 mg | ||
| Thiocolchicoside | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenylephrine HCI, Chlorpheniramine Maleate & Caffeine Tablets | Each Uncoated Tablet Contains :- | I.P. | 500 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Paracetamol | I.P. | 5 mg | ||
| Phenylephrine hydrochloride | I.P. | 2 mg | ||
| Chlorpheniramine Maleate | I.P. | 16 mg | ||
| Caffeine (Anhydrous) | q.s. | |||
| Excipie nts | ||||
| Colour-Approved colour used. | ||||
| Trypsin, Bromelain, Rutoside Trihydrate & Aceclofenac Tablets | Each Enteric Coated Tablet Contains:- | B.P. | 48 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Trypsin | 90 mg | |||
| Bromelain | B.P. | 100 mg | ||
| Rutoside Trihydrate | ||||
| Aceclofenac | I.P. | 100 mg | ||
| Excipients | q. s. | |||
| Colour-Approved colour used. | ||||
| Aceclofenac, Paracetamol and Thiocolchicoside Tablets | Each film coated tablets contains: | I.P. | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Aceclofenac | I.P. | 325 mg | ||
| Paracetamol | I.P. | 4 mg | ||
| Thiocolchicoside | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Nimesulide, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | B.P. | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Nimesulide | I.P. | 325 mg | ||
| Paracetamol | I.P. | 15 mg | ||
| Serratiopeptidase | ||||
| (30,000 units of Serratiopeptidase as enteric coated granules) | ||||
| Excipients | ||||
| Colour-Approved colour used. | q.s. | |||
| Diclofenac Sodium & Paracetamol Tablets I.P. | Each film coated tablet contains:- | I.P. | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
| Diclofenac Sodium | I.P. | 325 mg | ||
| Paracetamol | q.s. | |||
| Excipients | ||||
| Colour- Approved colour used. | ||||
| Antiallergic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Cinnarizine & Dimenhydrinate Tablets | Each Uncoated Sustained release Tablet Contains:- | IP | 20 mg | Antiallergic |
| Cinnarizine | USP | 40 mg | ||
| Dimenhydrinate | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Loratadine Dispersible Tablet | Each Uncoated Dispersible tablet contains: | USP | 10 mg | Antiallergic |
| Loratadine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Betahistine Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
| Betahistine Hydrochloride I.P.——8 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Betahistine Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
| Betahistine Hydrochloride I.P.……16 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Cetirizine Tablets | Each Film Coated Tablet Contains:- | Antiallergic | ||
| Cetirizine Hydrochloride IP ———-20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fexofenadine Hydrochloride and Montelukast Tablets | Each Film Coated Tablet Contains:- | Antiallergic | ||
| Fexofenadine Hydrochloride IP — 120 mg | ||||
| Montelukast Sodium IP | ||||
| Eq. to Montelukast —————10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levocetirizine Dihydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic | ||
| Levocetirizine Dihydrochloride—— 5 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Montelukast Sodium And Levocetirizine Dihydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic | ||
| Montelukast Sodium I.P. | ||||
| eq. to Montelukast 4mg | ||||
| Levocetirizine Dihydrochloride I.P —2.5mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Montelukast Sodium And Levocetirizine Dihydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic | ||
| Montelukast Sodium I.P. | ||||
| eq. to Montelukast 10mg | ||||
| Levocetirizine Dihydrochloride I.P — 5mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Betahistine Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
| Betahistine Hydrochloride I.P.——24 mg | ||||
| Excipients q.s. | ||||
| Colour: Approved colour used | ||||
| Montelukast Sodium, Fexofenadine and Acebrophyline (SR) tablets | Each Film Coated Tablet Contains:- | Antiallergic | ||
| Montelukast Sodium IP | ||||
| Eq. to Montelukast —————10 mg | ||||
| Fexofenadine Hydrochloride IP — 120 mg | ||||
| Acebrophyline (SR)————– 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Cinnarizine & Dimenhydrinate Tablets | Each Uncoated Tablet Contains:- | Antiallergic | ||
| Cinnarizine USP ————————– 20 mg | ||||
| Dimenhydrinate ————————40 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Montelukast Orally Disintegrating Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
| Montelukast Sodium I.P. | ||||
| Eq.to Montelukast——— 4 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Loratadine Tablet USP | Each film coated tablet contains: | Antiallergic | ||
| Loratadine USP ———– 10 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Domperidone & Cinnarizine Tablet | Each uncoated Tablet | IP | 20 mg | Antiallergic |
| Cinnarizine | IP | 10 mg | ||
| Domperidone | q. s. | |||
| Excipients | ||||
| Approved coloured used | ||||
| Loratadine Tablets I.P. | Each uncoated tablet contains:- | I.P. | 10 mg | Antiallergic |
| Loratadine | q.s. | |||
| Excipients | ||||
| Colour- Approved colour used. | ||||
| antiallergic, antiasthamatic & mucolvtic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Levocetirizine &Ambroxol Capsule | Each Hard Gelatin Capsule Contains: | IP | 5 mg | antiallergic, antiasthamatic & mucolvtic |
| Levocetirizine Hydrochloride | ||||
| Ambroxol Hydrochloride | IP | 75 mg | ||
| (As Sustain Release) | q.s | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Hydroxyzine Hydrochloride tablet IP 25 mg | Each Film coated Tablets contains: | IP | 25 mg | Antiallergic, Antiasthamatic & Mucolvtic |
| Hydroxyzine Hydrochloride | q.s. | |||
| Excipients | ||||
| Colour: Approved ColourUsed | ||||
| Levocetirizine Hydrochloride, Phenylephrine Hydrochloride & Paracetamol Tablets | Each Film coated Tablet Contains:- | IP | 5 mg | Antiallergic, Antiasthamatic & Mucolvtic |
| Levocetirizine Hydrochloride | IP | 5 mg | ||
| Phenylephrine Hydrochloride | IP | 500 mg | ||
| Paracetamol | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Cetirizine Tablets | Each Film Coated Tablet Contains:- | Antiallergic, Antiasthamatic & Mucolvtic | ||
| Cetirizine Hydrochloride IP ———-10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Hydroxyzine Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic, Antiasthamatic & Mucolvtic | ||
| Hydroxyzine Hydrochloride IP | ||||
| Eq. to Hydroxyzine ——— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Hydroxyzine Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic, Antiasthamatic & Mucolvtic | ||
| Hydroxyzine Hydrochloride IP | ||||
| Eq. to Hydroxyzine ——— 25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antidiabetic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Repaglinide Tablets IP 0.5 mg | Each Uncoated Tablet Contains:- | IP | 0.5 mg | Antidiabetic |
| Repaglinide | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Repaglinide & Metformin Hydrochloride Tablets IP | Each Film coated Tablet Contains:- | IP | 1 mg | Antidiabetic |
| Repaglinide | IP | 500 mg | ||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Repaglinide & Metformin Hydrochloride Tablets IP | Each Film coated Tablet Contains:- | IP | 2 mg | Antidiabetic |
| Repaglinide | IP | 500 mg | ||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin Tablets 10 mg | Each Film Coated Tablet Contains:- | 10 mg | Antidiabetic | |
| Empagliflozin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin Tablets 25 mg | Each Film Coated Tablet Contains:- | 25 mg | Antidiabetic | |
| Empagliflozin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Gliclazide Tablets I.P. | Each Uncoated Modified Release Tablet Contains:- | Antidiabetic | ||
| Gliclazide I.P—————80mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Gliclazide and Metformin Hydrochloride Extended Release Tablets I.P. | Each Film Coated Extended Release Tablet Contains:- | Antidiabetic | ||
| Gliclazide (MR) I.P—————30mg | ||||
| Metformin Hydrochloride (ER) IP -500 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Gliclazide and Metformin Hydrochloride Extended Release Tablets I.P. | Each Film Coated Extended Release Tablet Contains:- | Antidiabetic | ||
| Gliclazide (MR)I.P—————60mg | ||||
| Metformin Hydrochloride (ER) IP -500 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Metformin Hydrochloride and Alpha Lipoic Acid Tablets | Each Film Coated Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride I.P——–500mg | ||||
| Alpha Lipoic Acid ————— 200 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Metformin Tablets IP | Each Film Coated Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP ——500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metformin Tablets IP | Each Film Coated Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP ——850 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metformin Hydrochloride Sustained Release Tablets IP | Each Film Coated Sustained Release Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP ——1000 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used | ||||
| Metformin Hydrochloride Sustained Release Tablets IP | Each Film Coated Sustained Release Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP ——500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP | ||||
| (Prolonged Release) ———500 mg | ||||
| Glimepiride IP ——————1 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP | ||||
| (Prolonged Release) ———500 mg | ||||
| Glimepiride IP ——————2 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Metformin HCl (Extended Release) Fenofibrate Tablets IP | Each uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
| Metformin HCl (Extended Release) IP-500 mg | ||||
| Fenofibrate IP ————- 80 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metformin HCl (Extended Release) Fenofibrate Tablets IP | Each uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
| Metformin HCl (Extended Release) IP-500 mg | ||||
| Fenofibrate IP ————- 160 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP | ||||
| (Prolonged Release) ———500 mg | ||||
| Glimepiride IP —————— 0.5 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Metformin HCl (SR/ER/PR) Voglibose& Glimepiride Tablet | Each uncoated Bilayered tablet contains: | Antidiabetic | ||
| Metformin HCl ————-500 mg | ||||
| (SR/ER/PR) | ||||
| Voglibose IP ————– 0.2 mg | ||||
| Glimepiride IP —————1 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Metformin HCl (SR/ER/PR) Voglibose& Glimepiride Tablet | Each uncoated Bilayered tablet contains: | Antidiabetic | ||
| Metformin HCl ————-500 mg | ||||
| (SR/ER/PR) | ||||
| Voglibose IP ————– 0.2 mg | ||||
| Glimepiride IP ————— 2 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Glimepiride, Pioglitazone & Metformin Tablets | Each Uncoated Bilayered Tablet contains: | Antidiabetic | ||
| Glimepiride IP ————– 1 mg | ||||
| Pioglitazone IP ————— 15mg | ||||
| Metformin Hydrochloride (ER) IP —-500 mg | ||||
| Excipients ————— q.s. | ||||
| Colour-Approved colour used. | ||||
| Glimepiride, Pioglitazone & Metformin Tablets | Each Uncoated Bilayered Tablet contains: | Antidiabetic | ||
| Glimepiride IP ————– 2 mg | ||||
| Pioglitazone IP ————— 15mg | ||||
| Metformin Hydrochloride (ER) IP—–500 mg | ||||
| Excipients ————— q.s. | ||||
| Colour-Approved colour used. | ||||
| Metformin HCl (Sustained Release) Voglibose& Glimepiride Tablet | Each uncoated Bilayered tablet contains: | IP | 500 mg | Antidiabetic |
| Metformin HCl | ||||
| (As Sustained Release) | IP | 0.2 mg | ||
| Voglibose | IP | 1 mg | ||
| Glimepiride | q. s. | |||
| Excipients | ||||
| Colour-Approved colours used | ||||
| Gliclazide & Metformin Hydrochloride Tablets | Each uncoated tablets contains: | I.P. | 80 mg | Antidiabetic |
| Gliclazide | ||||
| Metformin Hydrochloride | I.P. | 500 mg | ||
| Excipients | q.s. | |||
| Colour-Approved colour used. | ||||
| Dapagliflozin Tablet | Each film coated tablet contains: | Antidiabetic | ||
| Dapagliflozin propandiol monohydrate IH | ||||
| eq. to Dapagliflozin—————10 mg | ||||
| Excipients ————— q.s | ||||
| Colour-Approved colour used. | ||||
| Dapagliflozin Tablet | Each film coated tablet contains: | Antidiabetic | ||
| Dapagliflozin propandiol monohydrate IH | ||||
| q. to Dapagliflozin—————5.0 mg | ||||
| Excipients ————— q.s | ||||
| Colour-Approved colour used. | ||||
| Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP | ||||
| (Prolonged Release) ———1000 mg | ||||
| Glimepiride IP ——————1 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
| Metformin Hydrochloride IP | ||||
| (Prolonged Release) ———1000 mg | ||||
| Glimepiride IP ——————2 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
| Glimepiride IP —————-1 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-approved colour used. | ||||
| Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
| Glimepiride IP —————-2 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-approved colour used. | ||||
| Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
| Glimepiride IP —————-3 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-approved colour used. | ||||
| Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
| Glimepiride IP —————-4 mg | ||||
| Excipients——————-q.s. | ||||
| Colour-approved colour used. | ||||
| Pioglitazone HCl & Glimepiride tablets | Each Uncoated SR tablet contains: | Antidiabetic | ||
| Pioglitazone HCl IP ————–15 mg | ||||
| Glimepiride IP —————-1 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour: Approved Colour Used | ||||
| Vildagliptin Tablet | Each uncoated tablet contains: | Antidiabetic | ||
| Vildagliptin IH ————– 50.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Vildagliptin and Metformin HCL Tablets | Each film coated tablet contains: | Antidiabetic | ||
| Vildagliptin IH ————– 50.0 mg | ||||
| Metformin HCL IP ———- 500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Vildagliptin & Metformin SR Tablets. | Each uncoated Bilayer tablet contains: | Antidiabetic | ||
| Vildagliptin IH ————– -50.0 mg | ||||
| Metformin HCL IP ———- 1000.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Sitagliptin tablet | Each film coated tablet Contains: | Antidiabetic | ||
| Sitagliptin (As phosphate) IH — -50.0 mg | ||||
| Excipients……………q.s. | ||||
| Approved colour used. | ||||
| Sitagliptin & Metformin tablets | Each film coated tablet Contains: | Antidiabetic | ||
| Sitagliptin (As phosphate)IH— -50.0 mg | ||||
| Metformin HCl IP — 500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour: Approved Colour Used | ||||
| Sitagliptin & Metformin tablets | Each film coated tablet Contains: | Antidiabetic | ||
| Sitagliptin (As phosphate)—– 50 mg | ||||
| Metformin HCl IP———- 1000.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour: Approved Colour Used | ||||
| Teneligliptin tablets IP | Each uncoated Tablet Contains: | Antidiabetic | ||
| Teneligliptin Hydrobromide Hydrate IP | ||||
| eq. to. Teneligliptin— 20.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Tenegliptin Hydrobromide Hydrate & Metformin HCl Tablets | Each uncoated Tablet Contains: | Antidiabetic | ||
| Tenegliptin Hydrobromide Hydrate IP | ||||
| eq. to. Tenegliptin IP — 20.0 mg | ||||
| Metformin HCl ————-500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Tenegliptin Hydrobromide Hydrate & Metformin HCl Tablets | Each uncoated Tablet Contains: | Antidiabetic | ||
| Tenegliptin Hydrobromide Hydrate IP | ||||
| eq. to. Tenegliptin IP—– 20.0 mg | ||||
| Metformin HCl ————-1000.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Voglibose Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
| Voglibose IP ————- 0.3 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Voglibose Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
| Voglibose IP ————- 0.2 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Voglibose& Metformin HCl Tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
| Voglibose IP ————– 0.2 mg | ||||
| Metformin HCl (SR) ———500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Voglibose& Metformin HCl Tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
| Voglibose IP————– 0.3 mg | ||||
| Metformin HCl (SR) IP ———500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Glibenclamide& Metformin HCl (SR) tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
| Glibenclamide ———2.5 mg | ||||
| Metformin HCl (SR) IP ———500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Glibenclamide& Metformin HCl (SR) tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
| Glibenclamide ———5.0 mg | ||||
| Metformin HCl (SR) IP ———500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Saxagliptin HCl tablet | Each Film coated tablet contains: | Antidiabetic | ||
| Saxagliptin HCl eq. | ||||
| to. Saxagliptin ——————-2.5 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Saxagliptin HCl tablet | Each Film coated tablet contains: | Antidiabetic | ||
| Saxagliptin HCl eq. | ||||
| to. Saxagliptin ——————-5.0 mg | ||||
| Colour-Approved colour used | ||||
| Saxagliptin HCl & Metformin tablet | Each Film coated tablet contains: | Antidiabetic | ||
| Saxagliptin HCl eq. | ||||
| to. Saxagliptin———-2.5 mg | ||||
| Metformin HCl IP———1000.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Saxagliptin HCl & Metformin tablet | Each Film coated tablet contains: | Antidiabetic | ||
| Saxagliptin HCl eq. | ||||
| to. Saxagliptin———- 5.0 mg | ||||
| Metformin HCl IP———500.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used | ||||
| Metformin Hydrochloride Prolonged Release Tablets IP 850 mg | Each Uncoated Prolonged Release Tablet Contains:- | IP | 850 mg | Antidiabetic |
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Sitagliptin tablet IP | Each Uncoated tablet Contains: | Antidiabetic | ||
| Sitagliptin phosphate IP | ||||
| Eq. to Sitagliptin——- 25.0 mg | ||||
| Excipients……………q.s. | ||||
| Approved colour used. | ||||
| Sitagliptin tablet IP | Each Uncoated tablet Contains: | Antidiabetic | ||
| Sitagliptin phosphate IP | ||||
| Eq. to Sitagliptin——- 50.0 mg | ||||
| Excipients……………q.s. | ||||
| Approved colour used. | ||||
| Sitagliptin tablet IP | Each Uncoated tablet Contains: | Antidiabetic | ||
| Sitagliptin phosphate IP | ||||
| Eq. to Sitagliptin——- 100.0 mg | ||||
| Excipients……………q.s. | ||||
| Approved colour used. | ||||
| Repaglinide Tablets IP 2 mg | Each Uncoated Tablet Contains:- | IP | 2 mg | Antidiabetic |
| Repaglinide | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Voglibose Dispersible Tablet IP 0.2 mg | Each uncoated Dispersible tablet contains: | IP | 0.2 mg | Antidiabetic |
| Voglibose | q.s | |||
| Excipients . | ||||
| Colour-Approved colour used | ||||
| Voglibose Dispersible Tablet IP 0.3 mg | Each uncoated Dispersible tablet contains: | IP | 0.3 mg | Antidiabetic |
| Voglibose | q.s | |||
| Excipients . | ||||
| Colour-Approved colour used | ||||
| Empagliflozin and Linagliptin tablets | Each Film Coated Tablet Contains:- | 25 mg | Antidiabetics | |
| Empagliflozin | 5 mg | |||
| Linagliptin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidiabetic |
| Empagliflozin | 500 mg | |||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidiabetic |
| Empagliflozin | 850 mg | |||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidiabetic |
| Empagliflozin | 1000 mg | |||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 12.5 mg | Antidiabetic |
| Empagliflozin | 500 mg | |||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 12.5 mg | Antidiabetic |
| Empagliflozin | 850 mg | |||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin and Linagliptin tablets | Each Film Coated Tablet Contains:- | 10 mg | Antidiabetics | |
| Empagliflozin | 5 mg | |||
| Linagliptin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 12.5 mg | Antidiabetic |
| Empagliflozin | 1000 mg | |||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Metformin HCl (Sustained Release) Glimepiride &Voglibose Tablet | Each Film Coated tablet contains: | IP | 500 mg | Antidiabetic |
| Metformin HCl | IP | 3 mg | ||
| (As Sustained Release) | IP | 0.3 mg | ||
| Glimepiride | q.s | |||
| Voglibose | ||||
| Excipients | ||||
| Colour-Approved colour used | ||||
| Dapagliflozin &Metformin Hydrochloride Tablet | Each film coated tablet contains: | IP | 10 mg | Antidiabetic |
| Dapagliflozin | 500 mg | |||
| Metformin Hydrochloride | q.s | |||
| (Extended Release) | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Dapagliflozin &Metformin Hydrochloride Tablet | Each film coated tablet contains: | IP | 10 mg | Antidiabetic |
| Dapagliflozin | 1000 mg | |||
| Metformin Hydrochloride | q.s | |||
| (Extended Release) | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Gliclazide and Metformin Hydrochloride Tablets | Each Film Coated Extended Release Tablet Contains:- | IP | 80 mg | Antidiabetic |
| Gliclazide | IP | 500 mg | ||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Gliclazide and Metformin Hydrochloride Tablets | Each Uncoated Tablet Contains:- | IP | 80 mg | Antidiabetic |
| Gliclazide | IP | 500 mg | ||
| Metformin Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Repaglinide Tablets IP 1 mg | Each Uncoated Tablet Contains:- | IP | 1 mg | Antidiabetic |
| Repaglinide | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Antiemetics | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pantoprazole Sodium (Enteric Coated) & Itopride Hydrochloride (Sustained Release) Capsule | Each Hard Gelatin Capsule contain: | IP | 40 mg | Antiemetics |
| Pantoprazole Sodium Sesquihydrate | ||||
| Equivalent to Pantoprazole | ||||
| (As enteric coated pellets) | 150 mg | |||
| Itopride Hydrochloride | ||||
| (As sustained release pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Palonosetron melt in mouth Tablets 0.5 mg | Each Uncoated Tablets contains: | 0.5 mg | antiemetics | |
| Palonosetron Hydrochloride | q.s | |||
| Eq. to Palonosetron | ||||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Ondansetron Orally Disintegrating Tablets IP | Each Uncoated Orally Disintegrating Tablet Contains:- | Antiemetic | ||
| Ondansetron Hydrochloride IP | ||||
| Eq. to Ondansetron ——— 4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ondansetron Orally Disintegrating Tablets IP | Each Uncoated Orally Disintegrating Tablet Contains:- | Antiemetic | ||
| Ondansetron Hydrochloride IP | ||||
| Eq. to Ondansetron ——— 8 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Metclopramide Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiemetic | ||
| Metclopramide Hydrochloride IP | ||||
| Eq. to Metclopramide Anhydrous —- 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Cinnarizine & Domperidone Tablets | Each Uncoated Tablet Contains:- | Antiemetic | ||
| Cinnarizine IP ————————– 20 mg | ||||
| Domperidone IP ———————— 15 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Gastric resistant Antiemetics | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pantoprazole sodium & Domperidone capsule | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
| Pantoprazole sodium sesquihydrate | ||||
| eq. to Pantoprazole | 10 mg | |||
| (as enteric coated pellets) | IP | q.s. | ||
| Domperidone | ||||
| (As Sustained release) | ||||
| Excipients | ||||
| Approved colour used in | ||||
| Empty capsule shells. | ||||
| Omeprazole & Domperidone capsule IP | Each hard gelatin capsule contains | IP | 20 mg | Gastric resistant Antiemetics |
| Omeprazole | ||||
| (As Enteric coated pallets) | IP | 30 mg | ||
| Domperidone | ||||
| (As Sustain Release pallets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty capsule shell | ||||
| Pantoprazole Sodium (EC) & Domperidone (SR)capsule IP | Each hard gelatin capsule contains | IP | 40 mg | Gastric resistant Antiemetics |
| Pantoprazole Sodium | ||||
| (As Enteric coated pallets) | IP | 30 mg | ||
| Domperidone | ||||
| (10 mg as immediate release & 20 mg As Sustain Release pallets) | q. s. | |||
| Excipients | ||||
| Approved colour used in empty capsule shell | ||||
| Rabeprazole Sodium (EC)&Levosulpride (SR) Capsule | Each hard gelatin capsules contains: | IP | 20 mg | Gastric resistant Antiemetics |
| Rabeprazole Sodium | ||||
| (As enteric coated pellets) | IP | 75 mg | ||
| Levosulpride | ||||
| (As sustained release pellets) | q.s. | |||
| Excipients | ||||
| Approved Colours Used in Capsule Shell & Pellets | ||||
| Rabeprazole Sodium (EC) & Domperidone (SR)capsules | Each hard gelatin capsule contains | IP | 20 mg | Gastric resistant Antiemetics |
| Rabeprazole Sodium | ||||
| (As Enteric coated pallets) | IP | 30 mg | ||
| Domperidone | ||||
| (As Sustained Release pallets) | q. s. | |||
| Excipients | ||||
| Approved colour used in empty capsule shell | ||||
| Omeprazole Capsule IP | Each Hard gelatin capsule contains | IP | 20 mg | Gastric resistant Antiemetics |
| Omeprazole | ||||
| (As Enteric coated pallets) | q.s. | |||
| Excipients | ||||
| Approved colour used. in empty capsule shell | ||||
| Esomeprazole & Itopride Capsules | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
| Esomeprazole magnesium | ||||
| (As enteric Coated pellets) | 150 mg | |||
| Itopride | q.s. | |||
| (As SR pellets) | ||||
| Excipients | ||||
| Approved colour used in | ||||
| empty capsule shells. | ||||
| Esomeprazole (Enteric-coated) & Levosulpiride(Sustained-release) Capsules | Each hard gelatin Capsule contains : | IP | 40mg | Gastric resistant Antiemetics |
| Esomeprazole Magnesium Trihydrate | ||||
| Equ. to Esomeprazole | 75mg | |||
| (as enteric coated pellets) | IP | |||
| Levosulpiride | q.s | |||
| (as sustained release pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Omeprazole & Domperidone Capsules | Each hard gelatin capsule Contains: | IP | 20 mg | Gastric resistant Antiemetics |
| Omeprazole | IP | 10 mg | ||
| (Enteric Coated pellets) | q.s. | |||
| Domperidone | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Aceclofenac& Rabeprazole Capsule | Each hard gelatin Capsule contain: | IP | 200 mg | Gastric resistant Antiemetics |
| Aceclofenac (SR) | IP | 10 mg | ||
| Rabeprazole sodium | ||||
| (As enteric coated pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Aceclofenac& Rabeprazole Capsule | Each hard gelatin Capsule contain: | IP | 200 mg | Gastric resistant Antiemetics |
| Aceclofenac (SR) | IP | 20 mg | ||
| Rabeprazole sodium | q.s. | |||
| (As enteric coated pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Pantoprazole Sodium (EC) &Itopride (ER) Capsules | Each hard gelatin capsule contains: | IH | 40 mg | Gastric resistant Antiemetics |
| Pantoprazole Sodium (as EC pellets) | IP | 150 mg | ||
| Itopride (ER pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Pantoprazole Sodium (EC) &Cinitapride (ER) Capsules | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
| Pantoprazole Sodium (as EC pellets) | IH | 3 mg | ||
| Cinitapride (ER pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Omeprazole (EC) &Cinitapride (ER) Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastric resistant Antiemetics |
| Omeprazole (EC pellets) | IH | 3 mg | ||
| Cinitapride (ER pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Pantoprazole sodium &Levosulpride capsule | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
| Pantoprazole sodium | ||||
| eq. to Pantoprazole | 75 mg | |||
| (as enteric coated pellets) | q.s. | |||
| Levosulpride | ||||
| (As Sustained release) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Rabeprazole sodium & Itopride Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastric resistant Antiemetics |
| Rabeprazole sodium | ||||
| (As enteric Coated pellets) | 150 mg | |||
| Itopride | ||||
| (As SR pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Dexlansoprazole delayed release capsules | Each hard gelatin capsule contains: | IP | 30.0 mg | Gastric Resistance & Anti Emetics |
| Dexlansoprazole | q.s. | |||
| (As delayed release) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Dexlansoprazole delayed release capsules | Each hard gelatin capsule contains: | IP | 60.0 mg | Gastric Resistance & Anti Emetics |
| Dexlansoprazole | q.s. | |||
| (As delayed release) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Cinitapride Extended Release Tablets | Each Uncoated Extended Release Tablets contains: | 3 mg | Gastric Resistance & Anti Emetics | |
| Cinitapride Hydrogen Tartarate | q.s | |||
| Eq. to Cinitapride | ||||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Domperidone Tablets I.P. | Each Film Coated Tablet Contains:- | Gastric Resistance & Anti Emetics | ||
| Domperidone Maleate I.P. | ||||
| Eq. to Domperidone ———-10 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Pantoprazole Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
| Pantoprazole Sodium IP | ||||
| Eq. to Pantoprazole ————–20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rabeprazole Sodium Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
| Rabeprazole Sodium IP ——— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Esomeprazole Gastro resistant Tablet IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
| Esomeprazole magnesium Trihydrate IP | ||||
| Eq. to Esomeprazole ———— 20 mg | ||||
| Excipients———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Esomeprazole Gastro resistant Tablet IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
| Esomeprazole magnesium Trihydrate IP | ||||
| Eq. to Esomeprazole ———— 30 mg | ||||
| Excipients———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Pantoprazole sodium& Ondansetron Tablets | Each Enteric Coated Tablet Contains:- | Gastric Resistance & Anti Emetics | ||
| Pantoprazole sodium | ||||
| Eq. to Pantoprazole…………………………IP 40mg | ||||
| Ondansetron Hydrochloride | ||||
| Eq. to Ondansetron…………………………IP 4mg | ||||
| Excipients……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Pantoprazole Sodium (EC) & Domperidone (SR)capsule IP | Each hard gelatin capsule contains:- | Gastric Resistance & Anti Emetics | ||
| Pantoprazole Sodium IP—– 40 mg | ||||
| (As Enteric coated pallets) | ||||
| Domperidone IP ————-30 mg | ||||
| (As Sustained Release pallets) | ||||
| Excipients | ||||
| Approved colour used in empty capsule shell | ||||
| Lansoprazole capsule IP 30 mg | Each Hard Gelatin capsule contains: | IP | 30mg | Gastric Resistance & Anti Emetics |
| Lansoprazole | q. s. | |||
| Excipients | ||||
| Approved colour used | ||||
| Pantoprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules | Each Hard Gelatin Capsule contains: | IP | 40 mg | Gastric Resistance & Anti Emetics |
| Pantoprazole Sodium | ||||
| eq. to Pantoprazole | ||||
| (As Enteric Coated pellets) | 30 mg | |||
| Domperidone | IP | |||
| (As Sustained Release pellets) | ||||
| Excipients | ||||
| Approved colour used | ||||
| Lansoprazole Gastro Resistant capsules IP | Each hard gelatin capsule contains: | IP | 30 mg | Gastric Resistance & Anti Emetics |
| Lansoprazole | qs | |||
| Excipients | ||||
| Approved colour used | ||||
| Lansoprazole Orally Disintegrating Tablets | Each uncoated orally disintegrating tablets contains: | I.P. | 30 mg | Gastric Resistance & Anti Emetics |
| Lansoprazole | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Omeprazole Gastro resistant Capsules IP | Each hard gelatin capsule contains:- | IP | 40mg | Gastic Resistance, & Anti Emetic |
| Omeprazole | ||||
| (As enteric coated pellets) | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells & pellets. | ||||
| Rabeprazole sodium &Itopride( SR) Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastic Resistance, & Anti Emetic |
| Rabeprazole sodium | ||||
| (As enteric Coated pellets) | 150 mg | |||
| Itopride (As SR pellets) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Esomeprazole & domperidone Capsules | Each Hard Gelatin Capsule Contains:- | IP | 40 mg | Gastic Resistance, & Anti Emetic |
| Esomeprazole Magnesium Trihydrate | 30.0 mg | |||
| Eq. to Esomeprazole | IP | |||
| ( as enteric coated pellets ) | q.s. | |||
| Domperidone | ||||
| (as sustained release pellets ) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Esomeprazole & domperidone Capsules | Each Hard Gelatin Capsule Contains:- | IP | 20 mg | Gastic Resistance, & Anti Emetic |
| Esomeprazole Magnesium Trihydrate | 30.0 mg | |||
| Eq. to Esomeprazole | IP | |||
| ( as enteric coated pellets ) | q.s. | |||
| Domperidone | ||||
| (as sustained release pellets ) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Esomeprazole & Itopride Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastic Resistance, & Anti Emetic |
| Esomeprazole Magnesium Trihydrate | 150 mg | |||
| Eq. to Esomeprazole | IP | q.s. | ||
| ( as enteric coated) | ||||
| Itopride (As SR pellets) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Esomeprazole Gastro- Resistant Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 20.0 mg | Gastric Resistance, & Anti Emetic |
| Esomeprazole Magnesium Trihydrate | q.s. | |||
| Eq. to Esomeprazole | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell0 | ||||
| Esomeprazole Gastro- Resistant Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 40.0 mg | Gastic Resistance, & Anti Emetic |
| Esomeprazole Magnesium Trihydrate | q.s. | |||
| Eq. to Esomeprazole | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Lansoprazole OrallyDisintegratingTablets | EachUncoatedorallyDisintegratingTabletContains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Lansoprazole IP———-15mg | ||||
| Excipients q.s. | ||||
| Colour-Approvedcolour used. | ||||
| Tranexamic acid and Mefenamic Acid Tablets | Each Uncoated Tablet Contains: – | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Tranexamic acid IP ———–500 mg | ||||
| Mefenamic Acid IP ——– 250 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Sodium Bicarbonate IP | Each film Coated Tablet Contains: | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Sodium Bicarbonate IP —————- 1000 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Lansoprazole Gastro- Resistant Capsules | Each Hard Gelatin Capsule Contains: | IP | 15.0 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
| Lansoprazole | q.s. | |||
| (As Enteric Coated Granules) | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Mefenamic Acid Capsules I.P. | Each Hard Gelatin Capsule Contains: | IP | 250 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
| Mefenamic Acid | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Mefenamic Acid Capsules I.P. | Each Hard Gelatin Capsule Contains: | IP | 500 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
| Mefenamic Acid | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Esomeprazole Gastro resistant Tablet IP | Each Enteric Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Esomeprazole magnesium Trihydrate IP | ||||
| Eq. to Esomeprazole ————40 mg | ||||
| Excipients———-q.s. | ||||
| Colour-Approved colour used. | ||||
| Rabeprazole Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Rabeprazole Sodium IP ——— 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rabeprazole and Domperidone Tablets | Each Enteric Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Rabeprazole Sodium IP ——— 20 mg | ||||
| Domperidone IP —————— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Dicyclomine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Dicyclomine Hydrochloride ——— 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ondansetron Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Ondansetron Hydrochloride IP | ||||
| Eq. to Ondansetron ——— 4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ondansetron Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Ondansetron Hydrochloride IP | ||||
| Eq. to Ondansetron ——— 8 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tranexamic Acid Tablets IP | Each Uncoated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Tranexamic Acid IP ———— 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Cimetidine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Cimetidine IP————- 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Famotidine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Famotidine IP ——- 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Famotidine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Famotidine IP ——- 40 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Solifenacin Succinate Tablets | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Solefenacin Succinate ——- 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Solefenacin Succinate Tablets | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
| Solefenacin Succinate ——- 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Analgesic & antiemetics | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Domperidone & Paracetamol Tablets | Each Enteric Coated Tablet Contains:- | Analgesic & antiemetics | ||
| Domperidone IP —————— 10 mg | ||||
| Paracetamol IP —————— 325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antiviral | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Aciclovir Cream IP | Compositions | IP | 5% w/w | Antiviral |
| Aciclovir | q.s. | |||
| In a cream base | ||||
| Aciclovir Tablet IP 200 mg | Each uncoated tablet Contains | IP | 200 mg | Antiviral |
| Aciclovir | q.s. | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Aciclovir Tablets IP 200 mg | Each Film Coated Tablet Contains:- | IP | 200mg | Antiviral |
| Aciclovir | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Aciclovir Tablets IP 800 mg | Each Film Coated Tablet Contains:- | IP | 800mg | Antiviral |
| Aciclovir | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Griseofulvin Tablets IP | Each Uncoated Tablet Contains:- | IP | 250 mg | Antiviral |
| Griseofulvin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Griseofulvin Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
| Griseofulvin IP——— 125 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Griseofulvin Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
| Griseofulvin IP——— 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lopinavir and Ritonavir Tabl ets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
| Lopinavir IP —————200 mg | ||||
| Ritonavir IP ————–50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Lopinavir and Ritonavir Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
| Lopinavir IP —————100 mg | ||||
| Ritonavir IP ————– 25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aciclovir DispersibleTablets IP | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
| Aciclovir IP 200mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aciclovir DispersibleTablets IP | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
| Aciclovir IP 400mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aciclovir DispersibleTablets IP | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
| Aciclovir IP 800mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Rifaximin Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
| Rifaximin BP ———– 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rifaximin Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
| Rifaximin BP ———– 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rifaximin Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
| Rifaximin BP ———– 550 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Rifaximin Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
| Rifaximin BP ———– 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Valacyclovir Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
| Valacyclovir Hydrochloride USP—1000 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Valacyclovir Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
| Valacyclovir Hydrochloride USP—500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Entecavir Tablet IP | Each Uncoated Tablet Contains:- | Antiviral | ||
| Entecavir IP—————- 0.5 mg | ||||
| (As monohydrate) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Entecavir Tablet IP | Each Uncoated Tablet Contains:- | Antiviral | ||
| Entecavir IP—————- 0.1 mg | ||||
| (As monohydrate) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Nitrofurantoin SR Tablets | Each Film Coated Sustained Release Tablet Contains:- | Antiviral | ||
| Nitrofurantoin BP ————– 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Doxycycline Hyclate Tablet IP | Each film coated tablet contains: | Antiviral | ||
| Doxycycline Hyclate | ||||
| Eq. to Doxycycline——— 100 mg. | ||||
| Excipients —————– q.s | ||||
| Colour-approved colour used. | ||||
| Tenofovir Disoproxil Fumarate tablet IP 300 mg | Each Film Coated Tablet contain: | Antiviral | ||
| Tenofovir Disoproxil Fumarate IP—–300 mg | ||||
| Excipients —————–q.s | ||||
| Colour: approved colour used | ||||
| Nitrofurantoin Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
| Nitrofurantoin IP ————– 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aciclovir Tablets IP | Each Uncoated Tablet Contains:- | Antiviral | ||
| Aciclovir IP 200mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aciclovir Tablets IP | Each Uncoated Tablet Contains:- | Antiviral | ||
| Aciclovir IP 400mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Aciclovir Tablets IP | Each Uncoated Tablet Contains:- | Antiviral | ||
| Aciclovir IP ——— 800mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Nitrofurantoin Tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Antiviral |
| Nitrofurantoin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Nitrofurantoin Tablets IP 100 mg | Each Uncoated Tablet Contains:- | IP | 100 mg | Antiviral |
| Nitrofurantoin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Analgesics And Antipyretics | ||||
| Ibuprofen Tablets IP 600 mg | Each Film Coated Tablet Contains:- | IP | 600 mg | Analgesics And Antipyretics |
| Ibuprofen | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Ibuprofen and Paracetamol Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
| Ibuprofen IP ———— 400 mg | ||||
| Paracetamol ————-325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ibuprofen Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
| Ibuprofen IP —————-400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ibuprofen Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
| Ibuprofen IP —————- 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
| Aceclofenac IP ————— 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Aceclofenac And Paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antipyretic | ||
| Aceclofenac IP —————- 100 mg | ||||
| Paracetamol IP ————— 325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Nimesulide and Paracetamol (Not for below 12 Years) | Each Film Coated Tablet Contains:- | Analgesic & Antipyretic | ||
| Nimesulide BP ————-100 mg | ||||
| Paracetamol IP ————–325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Anticoagulant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Dabigatran Etexilate capsule 150 mg | Each hard gelatin capsule contains: | IH | 150 mg | Anticoagulant |
| Dabigatran etexilatemesilate | q.s. | |||
| eq. to Dabigatran | ||||
| Excipients | ||||
| Approved colours used in Empty capsules shells. | ||||
| Heparin Sodium , Benzyl nicotinate and Sorbic Acid ointment | Composition: | IP | 50 IU | Anticoagulant |
| Heparin Sodium | IP | 2.0 mg | ||
| Benzyl Nicotinate | 1.97 mg | |||
| Sorbic Acid | q.s. | |||
| Ointment base | ||||
| Nicoumalone Tablets IP 2 mg | Each uncoated tablet Contains: | IP | 2 mg | Anticoagulant |
| Nicoumalone | q.s. | |||
| Excipients | ||||
| Colour: Approved ColourUsed | ||||
| Nicoumalone Tablets IP 4 mg | Each uncoated tablet Contains: | IP | 4 mg | Anticoagulant |
| Nicoumalone | q.s. | |||
| Excipients | ||||
| Colour: Approved ColourUsed | ||||
| Rivaroxaban Tablets 2.5 mg | Each Film coated Tablet Contains:- | 2.5 mg | Anticoagulant | |
| Rivaroxaban | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Warfarin Tablets IP | Each Uncoated Tablet Contains:- | Anticoagulant | ||
| Warfarin Sodium Clathrate IP | ||||
| Eq. to Warfarin —————5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Nicoumalone Tablets IP | Each uncoated Tablet Contains:- | Anticoagulant | ||
| Nicoumalone IP ———— 2 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Nicoumalone Tablets IP | Each uncoated Tablet Contains:- | Anticoagulant | ||
| Nicoumalone IP ———— 4 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Warfarin sodium tablet IP 5.0 mg | Each uncoated tablet contains: | Anti-Coagulants | ||
| Wafarin sodium clathrate IP | ||||
| Equivalent to Warfarin sodium—–5.0 mg | ||||
| Excipients ————–q.s. | ||||
| Colour: Approved colour used | ||||
| Anticanvalsant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pregabalin &Methylcobalamin Capsule IP | Each hard gelatin capsule contains: | IP | 75 mg | Anticanvalsant |
| Pregabalin | 750 mcg | |||
| Methylcobalamin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Pregabalin (Sustained Release) & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
| Pregabalin IP | ||||
| (As Sustained Release) ———-–75 mg | ||||
| Methylcobalamin IP ————– 1500 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Pregabalin, Nortriptyline & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
| Pregabalin IP | ||||
| (As Sustained Release) ———-–75 mg | ||||
| Nortriptyline IP ———————- 10 mg | ||||
| Methylcobalamin IP ————– 1500 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Carbamazepine Tablets IP | Each Uncoated Tablet Contains:- | Anticonvulsants. | ||
| Carbamazepine IP—– 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Phenobarbitone tablets IP | Each Uncoated Tablet Contains:- | Anticanvalsant | ||
| Phenobarbitone IP—– 30 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Phenobarbitone tablets IP | Each Uncoated Tablet Contains:- | Anticanvalsant | ||
| Phenobarbitone IP—– 60 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Nortriptyline IP Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
| Nortriptyline Hydrochloride | ||||
| Eq. to Nortriptyline IP ————-25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Sodium Valproate & Valproic Acid | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
| Sodium Valproate IP————- 333 mg | ||||
| Valproic Acid IP ——————- 145 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Oxcarbazepine Tablet | Each uncoated Tablet Contains:- | Anticanvalsant | ||
| Oxcarbazepine ———— 300 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Oxcarbazepine Tablet | Each uncoated Tablet Contains:- | Anticanvalsant | ||
| Oxcarbazepine ———— 600 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Piracetam with Citicoline Sodium Tablets | Each film coated tablet contains: | Anticanvalsant | ||
| Citicoline Sodium IP | ||||
| equivalent to Citicoline ———– 500 mg | ||||
| Piracetam———– 800 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Pregabalin & Nortriptyline Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
| Pregabalin IP —————–75 mg | ||||
| Nortriptyline IP ———————- 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Gabapentin Tablets IP 100 mg | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
| Gabapentin…………………………IP 100mg | ||||
| Excipients……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Gabapentin & Nortriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
| Gabapentin…………………………IP 100mg | ||||
| Nortriptyline Hydrochloride | ||||
| Eq. to Nortriptyline…………………………IP 10mg | ||||
| Excipients……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Sodium Picosulfate tablets 10 mg | Each uncoated Tablet Contains:- | BP | 10 mg | Anticanvalsant |
| Sodium Picosulfate | q. s. | |||
| Excipients | ||||
| Colour-Approved colours used. | ||||
| Sodium Valproate Controlled release tablets 200 mg | Each film coated controlled release tablet contains:- | IP | 133.5 mg | Anticanvalsant |
| Sodium Valproate | IP | 58 mg | ||
| Valproic Acid | ||||
| (Both together corresponds to Sodium Valproate IP 200 mg) | ||||
| Excipients | q. s. | |||
| Colour-Approved colours used. | ||||
| Sodium Valproate Controlled release tablets 300 mg | Each film coated controlled release tablet contains:- | IP | 200 mg | Anticanvalsant |
| Sodium Valproate | IP | 87 mg | ||
| Valproic Acid | ||||
| (Both together corresponds to sodium valproate IP 300 mg) | ||||
| Excipients | q. s. | |||
| Colour-Approved colours used. | ||||
| Sodium Valproate Controlled release tablets 500 mg | Each film coated controlled release tablet contains:- | IP | 133 mg | Anticanvalsant |
| Sodium Valproate | IP | 145 mg | ||
| Valproic Acid | ||||
| (Both together corresponds to sodium valproate IP 500 mg) | ||||
| Excipients | q. s. | |||
| Colour-Approved colours used. | ||||
| Pregabalin capsule IP | Each hard gelatin capsule contains: | IP | 75mg | Anticanvalsant |
| Pregabalin | qs | |||
| Excipients | ||||
| Approved colour used | ||||
| Pregabalin Capsules I.P. | Each hard gelatin capsule contains:- | I.P. | 300 mg | Anticanvalsant |
| Pregabalin | q.s. | |||
| Excipients | ||||
| Colour – Approved colour used. | ||||
| Gabapentin & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
| Gabapentin IP —————– 300 mg | ||||
| Methylcobalamin IP ————500 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Divalproex Sodium Extended Release Tablets IP | Each Film Coated Extended Release Table Contains:- | Anticonvulsant | ||
| Divalproex Sodium IP | ||||
| Eq. to Valproic Acid ———- 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Divalproex Sodium Extended Release Tablets IP | Each Film Coated Extended Release Tablet Contains:- | Anticonvulsant | ||
| Divalproex Sodium IP | ||||
| Eq. to Valproic Acid ———- 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Phenytoin Sodium Tablet IP | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
| Phenytoin Sodium IP ——100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Sodium Valproate Tablets IP | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
| Sodium Valproate IP ———– 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Sodium Valproate Tablets IP | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
| Sodium Valproate IP ———– 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Pregabalin Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Anticonvulsant | ||
| Pregabalin IP ———– 75 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | anticonvulsants | ||
| Gabapentin IP ————— 300 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | anticonvulsants | ||
| Gabapentin IP ————— 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | anticonvulsants | ||
| Gabapentin IP ————— 800 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Gabapentin & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticonvulsants | ||
| Gabapentin IP —————– 100 mg | ||||
| Methylcobalamin IP ————500 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Perampanel Tablets 2 mg | Each Film coated Tablet Contains:- | 2 mg | Anticonvulsants | |
| Perampanel | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Perampanel Tablets 4 mg | Each Film coated Tablet Contains:- | 4 mg | Anticonvulsants | |
| Perampanel | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Perampanel Tablets 6 mg | Each Film coated Tablet Contains:- | 6 mg | Anticonvulsants | |
| Perampanel | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Perampanel Tablets 10 mg | Each Film coated Tablet Contains:- | 10 mg | Anticonvulsants | |
| Perampanel | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Perampanel Tablets 12 mg | Each Film coated Tablet Contains:- | 12 mg | Anticonvulsants | |
| Perampanel | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Brivaracetam Tablets 50 mg | Each Film Coated Tablet Contains:- | 50 mg | Anticonvulsants | |
| Brivaracetam | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Brivaracetam Tablets 75 mg | Each Film Coated Tablet Contains:- | 75 mg | Anticonvulsants | |
| Brivaracetam | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Brivaracetam Tablets 100 mg | Each Film Coated Tablet Contains:- | 100 mg | Anticonvulsants | |
| Brivaracetam | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Zonisamide Capsule IP 25mg | Each hard gelatin capsule contains:- | IP | 25mg | Anticonvulsants |
| Zonisamide | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells. | ||||
| Zonisamide Capsule IP 50mg | Each hard gelatin capsule contains:- | IP | 50mg | Anticonvulsants |
| Zonisamide | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells. | ||||
| Zonisamide Capsule IP 100mg | Each hard gelatin capsule contains:- | IP | 100mg | Anticonvulsants |
| Zonisamide | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells. | ||||
| Antimigrain | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Propranolol & Flunarizine Capsules | Each Hard gelatin capsule contain: | IP | 40 mg | Antimigrain |
| Propranolol HCl IP | IH | 5 mg | ||
| Eq. to Propranolol (as SR pellets) | q.s. | |||
| Flunarizine | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Propranolol & Flunarizine Capsules | Each Hard gelatin capsule contain: | IP | 40 mg | Antimigrain |
| Propranolol HCl IP | IH | 10 mg | ||
| Eq. to Propranolol (as SR pellets) | q.s. | |||
| Flunarizine | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Naproxen Tablets IP | Each Film Coated Tablet Contains:- | Antimigrain | ||
| Naproxen IP ———– 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Naproxen Tablets IP | Each Film Coated Tablet Contains:- | Antimigrain | ||
| Naproxen IP ———– 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Flunarizine Tablets | Each uncoated tablet contains: | Antimigrain | ||
| Flunarizine Dihydrochloride | ||||
| Eq. to Flunarizine——————— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Naproxen SR Tablets IP | Each Uncoated sustained Release Tablet Contains:- | Antimigrain | ||
| Naproxen IP ———– 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Naproxen SR Tablets IP | Each Uncoated sustained Release Tablet Contains:- | Antimigrain | ||
| Naproxen IP ———– 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Cinnarizine Tablet IP | Each Uncoated Tablet Contains:- | Antimigrain | ||
| Cinnarizine IP ———– 25 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Naproxen Sodium & Domperidone Tablets | Each Film coated Tablet | Antimigrain | ||
| Contains:- | ||||
| Naproxen Sodium……………………… USP 500mg | ||||
| Domperidone Maleate………………….IP | ||||
| Eq. to Domperidone……………………….10mg | ||||
| Excipients………………………………………..q.s | ||||
| Colour-Approved colour used. | ||||
| Naproxen Sodium & Domperidone Tablets | Each film coated tablet contains: | BP | 500 mg | Antimigrain |
| Naproxen Sodium | IP | 10 mg | ||
| Domperidone | q.s. | |||
| Excipients | ||||
| Approved colour used | ||||
| Eletriptan Tablets 20 mg | Each Film Coated Tablet Contains:- | IP | 20 mg | Antimigraine |
| Eletriptan Hydrobromide | q.s | |||
| Eq. to Eletriptan | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Eletriptan Tablets 40 mg | Each Film Coated Tablet Contains:- | IP | 40 mg | Antimigraine |
| Eletriptan Hydrobromide | q.s | |||
| Eq. to Eletriptan | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Naproxen Sodium & Domperidone tablets | Each Film coated Tablet Contains:- | Antimigrain | ||
| Naproxen Sodium ………………USP 250mg | ||||
| Domperidone Maleate……………..IP | ||||
| Eq. to Domperidone………………10mg | ||||
| Excipients……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Naproxen Prolonged – Release Tablets | Each Film Coated Prolonged – Release Tablets Contains:- | Antimirgrain | ||
| Naproxen IP ————— 375 mg | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Propranolol (SR) & Flunarizine Tablets | Each uncoated Bilayered tablet contains: | anti-migraine | ||
| Propranolol HCl | ||||
| (in Sustained Release) IP ————–40 mg | ||||
| Flunarizine Dihydrochloride BP | ||||
| Eq. to Flunarizine——————— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antispasmodic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Hyoscine Butylbromide Tablets 10 mg | Each Uncoated Tablet Contains:- | IP | 10 mg | Antispasmodic |
| Hyoscine Butylbromide | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Drotaverine hydrochloride & Mefenamic Acid Tablets | Each Film Coated Tablet Contains:- | Antispasmodic | ||
| Drotaverine hydrochloride I.P.——80 mg | ||||
| Mefenamic Acid I.P. ………………250 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Dicyclomine HCl and Mefenamic Acid Tablets IP | Each Film Coated Tablet Contains:- | Antispasmodic | ||
| Dicyclomine HCl IP ——— 10 mg | ||||
| Mefenamic Acid ————250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Mefenamic Acid & Dicyclomine Hydrochloride Tablets IP | Each uncoated tablet Contains:- | Antispasmodic | ||
| Mefenamic Acid…………………………IP 250mg | ||||
| Dicyclomine Hydrochloride…………………………IP 10mg | ||||
| Excipients……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Mefenamic Acid & Drotaverine Hydrochloride Tablets | Each uncoated tablet contains: | I.P. | 250 mg | Antispasmodic |
| Mefenamic Acid | I.P. | 80 mg | ||
| Drotaverine Hydrochloride | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Tamsulosin Hydrochloride (Modified Release) &Tolteridone Tartrate (Extended release) Capsules | Each hard gelatin capsule contains:- | IP | 0.4mg | Antispasmodic |
| Tamsulosin Hydrochloride | ||||
| (As Modified release pellets) | IP | 2mg | ||
| Tolteridone Tartrate(As Extended release pellets) | ||||
| Excipients | q.s. | |||
| Colour: Approved colours used in empty capsule shells & Pellets. | ||||
| Tamsulosin Hydrochloride (Modified Release) &Tolteridone Tartrate (Extended release) Capsules | Each hard gelatin capsule contains:- | IP | 0.4mg | Antispasmodic |
| Tamsulosin Hydrochloride | ||||
| (As Modified release pellets) | IP | 4mg | ||
| Tolteridone Tartrate | ||||
| (As Extended release pellets) | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells & Pellets. | ||||
| Tamsulosin Hydrochloride (Prolonged Release) & Dutasteride Capsules IP | Each hard gelatin capsule contains:- | IP | 0.4mg | Antispasmodic |
| Tamsulosin Hydrochloride | ||||
| (As Prolonged release pellets) | IP | 0.5mg | ||
| Dutasteride | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells & Pellets. | ||||
| Mirabegron Extended Release Tablets 25 mg | Each Film Coated Extended Release Tablet Contains:- | 25 mg | Antispasmodics | |
| Mirabegron | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Pinaverium Bromide Tablets 50 mg | Each Film Coated Tablet Contains:- | 50 mg | Antispasmodic agents | |
| Pinaverium Bromide | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Antiameanic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ferrous Ascorbate & Folic Acid Ta blets | Each Film Coated Tablet Contains:- | Antiameanic | ||
| Ferrous Ascorbate | ||||
| Eq. to Elemental Iron ———– 100 mg | ||||
| Folic Acid IP ——————– 1.5 mg | ||||
| Excipients—————– q.s. | ||||
| Colour-Approved colour used. | ||||
| Ferrous Ascorbate, Folic Acid & Zinc Tablets | Each Film Coated Tablet Contains:- | Antiameanic | ||
| Ferrous Ascorbate | ||||
| Eq. to Elemental Iron ———– 100 mg | ||||
| Folic Acid IP ——————– 1.5 mg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc———- 22.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Anthelmintic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Diethylcarbamazine Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
| Diethylcarbamazine Citrate IP—– 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Diethylcarbamazine Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
| Diethylcarbamazine Citrate IP—- 100 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Albendazole chewable Tablets IP | Each Film Coated Tablet Contains:- | Anthelmintic | ||
| Albendazole IP ———— 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Albendazole Tablets IP | Each uncoated chewable tablet Contains:- | Anthelmintic | ||
| Albendazole …………………………IP 400mg | ||||
| Excipients……………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Albendazole Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
| Albendazole IP ———— 400 mg | ||||
| Excipients—————– q.s | ||||
| Albendazole and Ivermectin Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
| Albendazole IP ———— 400 mg | ||||
| Ivermectin ————— 6 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ivermectin tablet | Each uncoated dispersible tablet contains: | Anthelmintics | ||
| Ivermectin IP———–12.0 mg | ||||
| Excipients ————–q.s. | ||||
| Colour: Approved colour used | ||||
| Antiamaemic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Folic acid, Mecobalamin, Pyridoxine HCl, Docosahexaenoic acid Capsule | Each Hard Gelatin Capsule Contains: | IP | 5 mg | Antiamaemic |
| Folic acid | IP | 1500 mcg | ||
| Mecobalamin | IP | 1.5 mg | ||
| Pyridoxine HCl | IH | 200 mg | ||
| Docosahexaenoic acid | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Ferrous Ascorbate & Folic Acid Tablets I.P. | Each Film Coated Tablet Contains:- | I.P. | 100 mg | Antiamaemic |
| Ferrous Ascorbate | ||||
| Eq. to Elemental Iron | I.P. | 1.5 mg | ||
| Folic Acid | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Ferrous Bisglycinate, Zinc Bisglycinate, Folic Acid & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | IP | 60 mg | Antiamaemic |
| Ferrous Bisglycinate | IP | |||
| Eq. to elemental Iron | 15 mg | |||
| Zinc Bisglycinate | 1 mg | |||
| Eq. to elemental Zinc | 500 mcg | |||
| Folic Acid | q.s | |||
| Methylcobalamin | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Ferrous Ascorbate, Folic Acid & Zinc Tablets | Each film coated tablet contains: | IP | 100 mg | Antiamaenic |
| Ferrous Ascorbate | IP | 1.5 mg | ||
| Folic Acid | IP | 61.8 mg | ||
| Zinc Sulphate Monohydrate | 22.5 mg | |||
| Eq. to Elemental Zinc | q.s. | |||
| Excipients | ||||
| Approved colour used | ||||
| Carbonyl Iron, folic acid & Zinc Capsules | Each hard gelatin capsule contain: | IP | 50 mg | Antiamaenic |
| Carbonyl Iron | 0.5 mg | |||
| Equivalent to Elemental Iron | IP | |||
| Folic acid | IP | 61.8 mg | ||
| Zinc sulphate monohydrate | 22.5 mg | |||
| Equivalent to elemental zinc | ||||
| Excipients | ||||
| Approved colour used | q.s. | |||
| Ferrous Ascorbate & Folic Acid Tablets | Each Film Coated Tablet Contains:- | Antianaemia | ||
| Ferric Ascorbate | ||||
| Eq. to Elemental Iron ————– 100 mg | ||||
| Folic Acid IP ———————- 1.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ferrous Ascorbate, Folic Acid & Zinc Tablets | Each Film Coated Tablet Contains:- | Antianaemia | ||
| Ferric Ascorbate | ||||
| Eq. to Elemental Iron ————– 100 mg | ||||
| Folic Acid IP ———————- 1.5 mg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc———— 22.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antihistaminic, Cough Suppressant & Sympathomimetic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Paracetamol Tablets IP | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
| Paracetamol —————- 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol Tablets IP | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
| Paracetamol —————- 650 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levocetirizine Hcl& Montelukast tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
| Levocetirizine Hcl…………………………IP 5mg | ||||
| Montelukast Sodium IP | ||||
| Eq. to Montelukast ………………………… 10mg | ||||
| Excipients ……………………………….q.s | ||||
| Colour: Approved colour used. | ||||
| Levocetirizine Dihydrochloride tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
| Levocetirizine Dihydrochloride…………………………IP 5mg | ||||
| Excipients ……………………………….q.s | ||||
| Colour: Approved colour used. | ||||
| Levocetirizine Dihydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
| Levocetirizine Dihydrochloride…………………………IP 10mg | ||||
| Excipients…………………………………………………………………q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenylephrine Hcl, Caffeine & Diphenhydramine Hcl Tablets | Each uncoated tablet contains: | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Paracetamol…………………………IP 325mg | ||||
| Phenylephrine Hcl l………………………… IP 5mg | ||||
| Caffeine (Anhydrous) l…………………………IP 30mg | ||||
| Diphenhydramine Hcl l…………………………IP 25mg | ||||
| Excipients ……………………………….q.s | ||||
| Colour: Approved colour used. | ||||
| Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablets IP | Each Film coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Levocetirizine Dihydrochloride IP —— 5 mg | ||||
| Ambroxol Hydrochloride IP ————- 60 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Levocetirizine, Phenylephrine, Ambroxol and Paracetamol Tablets IP | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Levocetirizine Dihydrochloride IP —— 5 mg | ||||
| Phenylephrine Hydrochloride ——-5 mg | ||||
| Ambroxol Hydrochloride IP ————- 30 mg | ||||
| Paracetamol IP ———– 325 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Acebrophylline& Acetylcysteine Tablets | Each Film Coated Bilayered Tablet Contains:- | BP | 100 mg | Antihistaminic, Cough Suppressant & Svmpathomimetic |
| Acebrophylline | 600 mg | |||
| Acetylcysteine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Terbutaline Tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Terbutaline Sulphate IP ———— 2.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Cetirizine Dihydrochloride & Phenylephrine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Paracetamol IP ———– 325 mg | ||||
| Cetirizine Dihydrochloride IP ——–5 mg | ||||
| Phenylephrine Hydrochloride ——-5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenylephrine &Cetirizine Tablets | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Paracetamol IP ———– 325 mg | ||||
| Phenylephrine IP ——- 10 mg | ||||
| Cetirizine IP ——– 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenlephrine Hydrochloride & Chlopheniramine Maleate Tablets | Each Uncoated Tablets Contains : | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Paracetamol IP—————–500 mg | ||||
| Phenlephrine Hydrochloride—– 10 mg | ||||
| Chlopheniramine Maleate ——-2 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Paracetamol, Phenylephrine Hydrochloride & Chlopheniramine Maleate Tablets | Each Uncoated Tablets Contains : | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
| Paracetamol IP—————–325 mg | ||||
| Phenylephrine Hydrochloride—– 5 mg | ||||
| Chlopheniramine Maleate ——-2 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levofloxacin & Ambroxol (Sustained Release) Tablets | Each Film Coated Tablet Contains:- | IP | 500 mg | Antihistaminic, Cough Suppressant & Svmpathomimetic |
| Levofloxacin Hemihydrate | 75 mg | |||
| Eq. to Levofloxacin | IP | q.s | ||
| Ambroxol Hydrochloride | ||||
| (Sustained Release) | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Acebrophyline (Sustained Release) & Montelukast Sodium, tablets | Each Film Coated Bilayered Tablet Contains:- | 200 mg | Antihistaminic, Cough Suppressant & Svmpathomimetic | |
| Acebrophyline (Sustained Release) | IP | |||
| Montelukast Sodium | 10 mg | |||
| Eq. to Montelukast | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| antimalarials | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Melfloquine Tablets IP | Each Film Coated Tablet Contains:- | antimalarials | ||
| Melfloquine Hydrochloride IP ——- 250mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Pyrimethamine and Sulphadoxine Tablets IP | Each Film Coated Tablet Contains:- | antimalarials | ||
| Pyrimethamine IP ——- 25mg | ||||
| Sulphadoxine IP ——–500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Artmether and Lumefantrine Tablets IP | Each Film Coated Tablet Contains:- | Antimalarials | ||
| Artmether IP —————20 mg | ||||
| Lumefantrine IP ————– 120 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Hydroxychloroquine Tablets IP | Each Film Coated Tablet Contains:- | Antimalarial | ||
| Hydroxychloroquine IP——— 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Artmether and Lumefantrine Tablets IP | Each Film Coated Tablet Contains:- | Antimalarial | ||
| Artmether IP ————— 80 mg | ||||
| Lumefantrine IP ————– 480 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Artmether and Lumefantrine Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains:- | antimalarials | ||
| Artmether IP ————— 40 mg | ||||
| Lumefantrine IP ————– 480 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Hydroquinone,Tretinoin & Allantoin Gel | Composition: | Antimalarial | ||
| Hydroquinone USP2.0%w/w | ||||
| Tretinoin USP0.025%w/w | ||||
| Allantoin USP1.0% w/w | ||||
| GelBase q.s | ||||
| Quinine Bisulphate Tablets IP | Each Film Coated Tablet Contains:- | Antimalaria | ||
| Quinine Bisulphate IP ————— 300 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antidepressant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Doxepin capsules IP | Each hard gelatin capsule contains:- | IP | 10mg | Antidepressant |
| Doxepin HCl | q.s. | |||
| Eq. to Doxepin | ||||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells. | ||||
| Doxepin capsules IP | Each hard gelatin capsule contains:- | IP | 25mg | Antidepressant |
| Doxepin HCl | q.s. | |||
| Eq. to Doxepin | ||||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells. | ||||
| Amitriptyline Hydrochloride & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidepressant |
| Amitriptyline Hydrochloride | IP | 1500 mcg | ||
| Methylcobalamin | q.s | |||
| Excipients | ||||
| Colour: Approved colour used | ||||
| Amitriptyline Hydrochloride & Methylcobalamin Tablets | Each Film Coated Bilayered Tablet Contains:- | IP | 10 mg | Antidepressant |
| Amitriptyline Hydrochloride | IP | 1500 mcg | ||
| Methylcobalamin | ||||
| (As Sustained Release) | q.s | |||
| Excipients | ||||
| Colour: Approved colour used | ||||
| Sertraline Tablets IP 25 mg | Each Film Coated Tablet Contains:- | IP | 25 mg | Antidepressant |
| Sertraline Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Gabapentin & Nortriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antidepressant | ||
| Gabapentin IP ———— 400 mg | ||||
| Nortriptyline Hydrochloride | ||||
| Eq. to Nortriptyline IP ————-10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fluoxetine Tablets IP | Each Film Coated Tablet Contains:- | Antidepressant | ||
| Fluoxetine Hydrochloride IP | ||||
| Eq. to Fluoxetine ————— 20 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Citicoline Sodium Tablet IP | Each film coated tablet contains: | Antidepressant | ||
| Citicoline Sodium IP | ||||
| equivalent to Citicoline———– 500 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Piracetam with Citicoline Tablets | Each film coated tablet contains: | Antidepressant | ||
| Citicoline Sodium IP | ||||
| equivalent to Citicoline ———– 500 mg | ||||
| Piracetam———– 400 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Venlafaxine Tablets | Each uncoated Tablet Contains:- | Antidepressant | ||
| Venlafaxine Hydrochloride BP ——– 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Citicoline Sodium (PR) Tablet IP | Each film coated prolonged release tablet contains: | Antidepressant | ||
| Citicoline Sodium IP | ||||
| equivalent to Citicoline———– 1000 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Sertraline Tablets IP 50 mg | Each Film Coated Tablet Contains:- | Antidepressant | ||
| Sertraline Hydrochloride IP | ||||
| Eq. to Sertraline……………………………….. 50 mg | ||||
| Excipients ……………………………………………q.s. | ||||
| Colour-Approved colours used. | ||||
| Sertraline Tablets IP 100 mg | Each Film Coated Tablet Contains:- | Antidepressant | ||
| Sertraline Hydrochloride IP | ||||
| Eq. to Sertraline………………………………. 100 mg | ||||
| Excipients ………………………………………….q.s. | ||||
| Colour-Approved colours used. | ||||
| Propranolol(SR) & Flunarizine capsule | Each Hard gelatin capsule Contains: | IP | 40 mg | Antidepressant |
| Propranolol Hydrochloride | 10 mg | |||
| Eq to Propranolol(SR pellets) | ||||
| Flunarizine | ||||
| Approved colour used | ||||
| Antidiarrheal | ||||
| Loperamide Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 2.0 mg | Antidiarrheal |
| Loperamide Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Loperamide Tablets IP | Each Film Coated Tablet Contains:- | Antidiarrheal | ||
| Loperamide Hydrochloride IP ——2 mg | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Rececadotril capsules IP100. | Each Hard Gelatin capsule contains | IP | 100mg | Antidiarrheal |
| Rececadotril | q. s. | |||
| Excipients | ||||
| Approved colour used | ||||
| Antacid, Anti Ulcer And Antispasmodic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Calcium Carbonate and Simethicone Chewable Tablets | Each Film Coated Tablet Contains:- | Antacid, Anti Ulcer And Antispasmodic | ||
| Calcium Carbonate IP ————- 600 mg | ||||
| Simethicone IP ———————80 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Dicyclomine Tablets IP | Each Film coated Tablet contains: | IP | 20 mg | Antacid, Anti Ulcer And Antispasmodic |
| Dicyclomine Hydrochloride | q. s. | |||
| Excipients | ||||
| White Soft Paraffin & Liquid Paraffin Cream | Composition: | IP | 15.0%w/w | Antacid, Anti Ulcer And Antispasmodic |
| White Soft Paraffin | IP | 6.0%w/w | ||
| Liquid Paraffin | q.s | |||
| Cream Base | ||||
| Antiseptic, Antiulcer | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Povidone Iodine, & Sucralfate Ointment | Composition: | IP | 5.0 % w/w | Antiseptic, Antiulcer |
| Povidone Iodine (available iodine 1.0% w/w) | IP | 7.0 % w/w | ||
| Sucralfate | q.s. | |||
| Ointment base | ||||
| Povidone-Iodine, Ointment USP | Composition: | IP | 5.0% w/w | Antiseptic |
| Povidone-Iodine (available iodine 0.5% w/w) | ||||
| Water Soluble Ointment base | q.s. | |||
| Silver Nitrate, Chlorhexidine Gluconate, Aloevera& Allantoin Cream | Composition : | IP | 0.2%w/w | Antiseptic |
| Silver Nitrate | IP | 0.2%w/w | ||
| Chlorhexidine Gluconate Solution | 0.1%w/w | |||
| Allantoin | IP | 15.0%w/w | ||
| Aloe Vera extract | ||||
| Preservatives: | IP | 0.1%w/w | ||
| Chlorocresol | q.s | |||
| Cream Base | ||||
| Povidone-Iodine, Ointment USP | Composition: | IP | 5.0% w/w | Antiseptic |
| Povidone-Iodine (available iodine 0.5% w/w) | ||||
| Water Soluble Ointment base | q.s. | |||
| Povidone-Iodine, Ointment USP | Composition: | IP | 10.0% w/w | Antiseptic |
| Povidone-Iodine (available iodine 1.0% w/w) | q.s. | |||
| Ointment base | ||||
| Povidone-Iodine solution IP | Composition: | IP | 10.0% w/v | Antiseptic |
| Povidone-Iodine (available iodine 1.0% w/w) | q.s. | |||
| Ointment base | ||||
| Zinc oxide cream IP | Composition: | IP | 32.00% | Antiseptic |
| Zinc oxide | q.s. | |||
| Cream Base | ||||
| Misoprostol Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
| Misoprostol IP ———–200 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ranitidine Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
| Ranitidine Hydrochloride IP | ||||
| Eq. to Ranitidine —————150 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Pantoprazole and Domperidone Tablets | Each Enteric Coated Tablet Contains:- | Antiulcer | ||
| Pantoprazole Sodium (Sesquihydrate) IP | ||||
| Eq. to Pantoprazole ————– 40 mg | ||||
| Domperidone IP —————— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
| Calcium Carbonate IP | ||||
| Eq. to Elemental Calcium———–400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
| Calcium Carbonate IP | ||||
| Eq. to Elemental Calcium———–500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
| Calcium Carbonate IP | ||||
| Eq. to Elemental Calcium———–625 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
| Calcium Carbonate IP | ||||
| Eq. to Elemental Calcium———-1000 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ranitidine Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
| Ranitidine Hydrochloride IP | ||||
| Eq. to Ranitidine —————300 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Chlorhexidine Gluconate sodium Fluoride & Zinc chloride mouth wash. | Composition: | IP | 0.2%w/v | Antiulcer |
| Each 100 ml contains: | ||||
| Chlorhexidine Gluconate | IP | 0.05%w/v | ||
| ( As Chlorhexidine Gluconate solution IP) | IP | 0.09%w/v | ||
| Sodium Fluoride | IP | qs | ||
| Zinc chloride | ||||
| Colour Approved colour used | ||||
| Antihistamines | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Desloratadine Tablet | Each film coated tablet contains: | Antihistamines | ||
| Desloratadine BP ———– 5 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Desloratadine & Montelukast Tablet | Each film coated tablet contains: | Antihistamines | ||
| Desloratadine BP ———– 5 mg | ||||
| Montelukast Sodium IP | ||||
| eq. to Montelukast ————- 10 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet | Each Film Coated Tablet Contains:- | Antihistamines | ||
| Doxylamine Succinate USP —- 10 mg | ||||
| Pyridoxine Hydrochloride IP —— 10 mg | ||||
| Folic Acid IP —————————- 2.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Fexofenadine Hydrochloride Tablets IP 30 mg | Each Film coated Tablet contains: | IP | 30 mg | antihistamines |
| Fexofenadine Hydrochloride | q. s. | |||
| Excipients | ||||
| Approved Colour used | ||||
| Fexofenadine Hydrochloride Tablets IP 60 mg | Each Film coated Tablet contains: | IP | 60 mg | antihistamines |
| Fexofenadine Hydrochloride | q. s. | |||
| Excipients | ||||
| Approved Colour used | ||||
| Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablets | Each Enteric Coated Tablet Contains:- | B.P. | 10 mg | Antihistamines |
| Doxylamine Succinate | I.P. | 10 mg | ||
| Pyridoxine Hydrochloride | I.P. | 2.5 mg | ||
| Folic Acid | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Fexofenadine Hydrochloride Tablet I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
| Fexofenadine Hydrochloride I.P——-120mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Fexofenadine Hydrochloride Tablet I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
| Fexofenadine Hydrochloride I.P——180mg | ||||
| Excipients—————————q.s. | ||||
| Colour-Approved colour used. | ||||
| Chlorpheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
| Chlorpheniramine Maleate I.P. ———4mg | ||||
| Excipients—————————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Chlorpheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
| Chlorpheniramine Maleate I.P———8mg | ||||
| Excipients————————–q.s. | ||||
| Colour-Approved colour used. | ||||
| antimuscarinics | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Trihexyphenidyl Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antimuscarinics | ||
| Trihexyphenidyl Hydrochloride IP—- 1 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Solifenacin Succinate Tablets | Each Film coated Tablet Contain: | IP | 10 mg | antimuscarinics. |
| Solifenacin Succinate | q. s. | |||
| Excipients | ||||
| Antifibrotic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Silymarin Tablets | Each Film Coated Tablet Contains:- | Antifibrotic | ||
| Silymarin ————– 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| SilymarinTablets | Each Film Coated Tablet contains: | IP | 140 mg | Antifibrotic |
| Silymarin | q. s. | |||
| Excipients | ||||
| Antipsychotic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Quetiapine Fumarate Tablets IP 25 mg | Each Film Coated Tablets Contains | IP | 25 mg | Antipsychotics |
| Quetiapine Fumarate | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Quetiapine Fumarate Tablets IP 50 mg | Each Film Coated Tablets Contains | IP | 50 mg | Antipsychotics |
| Quetiapine Fumarate | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Flupentixol Tablets BP 1 mg | Each Film Coated Tablet Contains:- | BP | 1 mg | antipsychotic |
| Flupentixol Dihydrochloride | q.s | |||
| Eq. to Flupentixol | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Flupentixol Tablets BP 3 mg | Each Film Coated Tablet Contains:- | BP | 3 mg | antipsychotic |
| Flupentixol Dihydrochloride | q.s | |||
| Eq. to Flupentixol | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Chlorpromiazine Hydrochloride, Trifluoperazine And Trihexyphenidyl Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antipsychotic | ||
| ChlorpromiazineHydrochloride I.P–50mg | ||||
| Trifluoperazine Hydrochloride I.P. | ||||
| Eq. to Trifluoperazine 5mg | ||||
| Trihexyphenidyl Hydrochloride I.P…—2mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Olanzapine Tablets IP | Each uncoated Tablet Contains:- | Antipsychotics | ||
| Olanzapine IP ———————-2.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Olanzapine Tablets IP | Each uncoated Tablet Contains:- | Antipsychotics | ||
| Olanzapine IP ———————-5.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Olanzapine Tablets IP | Each uncoated Tablet Contains:- | Antipsychotics | ||
| Olanzapine IP ———————-10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levosulpiride Tablets | Each Film Coated Tablet Contains:- | Antipsychotic | ||
| Levosulpiride ——————– 75 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Levosulpiride Tablets | Each Film Coated Tablet Contains:- | Antipsychotic | ||
| Levosulpiride ——————– 150 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Levosulpiride Tablets | Each Film Coated Tablet Contains:- | antipsychotic | ||
| Levosulpiride ——————– 200 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Haloperidol Tablets | Each Film Coated Tablet Contains:- | Antipsychotics | ||
| Haloperidol IP ———– 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Prochlorperazine Maleate Mouth Dissolving Tablet | Each uncoated mouth | Antipsychotic | ||
| dissolving tablet Contains: | ||||
| Prochlorperazine Maleate…………..IP 5mg | ||||
| Excipients…………………………………….q.s | ||||
| Colour-Approved colour used. | ||||
| Antianginal | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Nitroglycerine Sustained Release Tablets (Glyceryl Trinitrate Controlled Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Antianginal | ||
| Nitroglycerine IP——– 2.6 mg | ||||
| (As Diluted Nitroglycerine IP) | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Nifedipine Prolonged Release Tablets IP ( Nifedipine Sustained release Tablets IP) | Each Film Coated Prolonged Release Tablet Contains:- | Antianginal | ||
| Nifedipine IP—————— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Nifedipine Prolonged Release Tablets IP ( Nifedipine Sustained release Tablets IP) | Each Film Coated Prolonged Release Tablet Contains:- | Antianginal | ||
| Nifedipine IP—————— 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
| Verapamil Hydrochloride IP ——– 40 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
| Verapamil Hydrochloride IP ——– 80 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
| Verapamil Hydrochloride IP —— 120 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
| Verapamil Hydrochloride IP —— 160 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ivabradine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antianginal | ||
| Ivabradine Hydrochloride ———- 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ivabradine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antianginal | ||
| Ivabradine Hydrochloride ———7.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Isosorbide Mononitrate Tablets IP. | Each Film Coated Tablet Contains:- | Anti-Anginal | ||
| Diluted Isosorbide Dinitrate I.P.—-20mg | ||||
| Excipients—————————q.s. | ||||
| Colour-Approved colour used. | ||||
| Anti-spasmodic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Benzhexol Tablets IP (Trihexyphenidyl Hydrochloride Tablets IP) | Each Film Coated Tablet Contains:- | Anti-spasmodic | ||
| Benzhexol Hydrochloride IP——– 2 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Benzhexol Tablets IP (Trihexyphenidyl Hydrochloride Tablets IP) | Each Film Coated Tablet Contains:- | Anti-spasmodic | ||
| Benzhexol Hydrochloride IP——–5 mg | ||||
| Excipients—————–q.s | ||||
| Colour-Approved colour used. | ||||
| Hyoscine Butylbromide Tablets IP | Each Sugar Coated Tablet Contains:- | Antisapsmodic | ||
| Hyoscine Butylbromide IP ——10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Anti-Rheumatic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Azathioprine tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Anti-Rheumatic |
| Azathioprine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Azathioprine tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Anti-Rheumatic |
| Azathioprine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Hydroxychloroquine Tablets IP | Each Film Coated Tablet Contains:- | Anti-Rheumatic | ||
| Hydroxychloroquine IP——— 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Anti Gallstones | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ursodeoxycholic Acid Tablets I.P | Each film coated tablet contains: | Anti Gallstones | ||
| Ursodeoxycholic Acid I.P———–450 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Ursodeoxycholic Acid Tablets I.P | Each film coated tablet contains: | Anti Gallstones | ||
| Ursodeoxycholic Acid I.P———–300 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Ursodeoxycholic Acid Tablets I.P | Each film coated tablet contains: | Anti Gallstones | ||
| Ursodeoxycholic Acid I.P———- 150 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Ursodeoxycholic Acid Sustained Release Tablets I.P | Each Sustained Release Tablet contains: | Anti Gallstones | ||
| Ursodeoxycholic Acid I.P———–300 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Ursodeoxycholic Acid Sustained Release Tablets I.P | Each Sustained Release Tablet contains: | Anti Gallstones | ||
| Ursodeoxycholic Acid I.P———–600 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Anticold | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Anticold | ||
| Pheniramine Maleate I.P 25mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Pheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Anticold | ||
| Pheniramine Maleate I.P 50mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Antiparkinsonism agents | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pramipexol Dihydrochloride Tablets 0.125 mg | Each Uncoated Tablets contains: | USP | 0.125 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Tablets 0.25 mg | Each Uncoated Tablets contains: | USP | 0.25 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Tablets 0.5 mg | Each Uncoated Tablets contains: | USP | 0.5 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Tablets 1 mg | Each Uncoated Tablets contains: | USP | 1 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Tablets 1.5 mg | Each Uncoated Tablets contains: | USP | 1.5 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Extended Release Tablets 0.375 mg | Each Uncoated extended release Tablets contains: | USP | 0.375 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Extended Release Tablets 0.75 mg | Each Uncoated extended release Tablets contains: | USP | 0.75 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Extended Release Tablets 1.5 mg | Each Uncoated extended release Tablets contains: | USP | 1.5 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Extended Release Tablets 3 mg | Each Uncoated extended release Tablets contains: | USP | 3 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pramipexol Dihydrochloride Extended Release Tablets 4.5 mg | Each Uncoated extended release Tablets contains: | USP | 4.5 mg | Antiparkinsonism agents |
| Pramipexol Dihydrochloride Monohydrate | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Febuxotat Tablet 40 mg | Each Film coated Tablets contains: | IH | 40 mg | Antihyperuricemic agents |
| Febuxotat | q.s. | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Amantadine hydrochloride Capsules IP | Each hard gelatin capsule Contains: | IP | 100 mg | Antiparkinson agent |
| Amantadine Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Piribedil (SR) Tablets | Each Sustained Release Tablets Contains | 50 mg | Antiparkinsonian agent | |
| Piribedil | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Antiarrhythmics | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Amiodarone HCl Tablets IP 100 mg | Each Uncoated Tablet Contains:- | IP | 100 mg | Antiarrhythmic |
| Amiodarone HCl | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Amiodarone HCl Tablets IP 200 mg | Each Uncoated Tablet Contains:- | IP | 200 mg | Antiarrhythmic |
| Amiodarone HCl | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Mexiletine Hydrochloride Capsules IP | Each hard gelatin capsule contains: | IP | 50 mg | Antiarrhythmics |
| Mexiletine Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colors used in Hard Gelatin Capsule shell. | ||||
| Mexiletine Hydrochloride Capsules IP | Each hard gelatin capsule contains: | IP | 150 mg | Antiarrhythmics |
| Mexiletine Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colors used in Hard Gelatin Capsule shell. | ||||
| Digoxin tablet IP 250 µg | Each uncoated tablet contains | IP | 250 µg | Antiarrhythmics |
| Digoxin | q.s. | |||
| Excipients | ||||
| Colour: Approved Colour used | ||||
| Antidepresant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Fluoxetine Tablets IP 10 mg | Each Film Coated Tablet Contains:- | IP | 10 mg | Antidepresant |
| Fluoxetine Hydrochloride | ||||
| Eq. to Fluoxetine | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Citicoline Tablet IP 250 mg | Each film coated tablet contains: | IP | 250 mg | Antidepresant |
| Citicoline Sodium | ||||
| equivalent to Citicoline | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Mirtazapine Tablets IP 15 mg | Each Film Tablet Contains:- | IP | 15 mg | Antideprresant |
| Mirtazapine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Mirtazapine Tablets IP 30 mg | Each Film Tablet Contains:- | IP | 30 mg | Antidepresant |
| Mirtazapine | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Cyclobenzaprine Extended Release capsules | Each hard gelatin capsule contains: | IP | 15 mg | Antidepressants |
| Cyclobenzaprine | ||||
| (As sustained release pellets) | q.s. | |||
| Excipients | ||||
| Approved Colors Used. in Empty Shell & Pellet | ||||
| Cyclobenzaprine Extended Release capsules | Each hard gelatin capsule contains: | IP | 30 mg | Antidepressants |
| Cyclobenzaprine | ||||
| (As sustained release pellets) | q.s. | |||
| Excipients | ||||
| Approved Colors Used. in Empty Shell & Pellet | ||||
| Trazodone Hydrochloride Tablets USP 50 mg | Each Uncoated Tablets contains: | USP | 50 mg | Antideprresant |
| Trazodone Hydrochloride | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Trazodone Hydrochloride Tablets USP 100 mg | Each Uncoated Tablets contains: | USP | 100 mg | Antideprresant |
| Trazodone Hydrochloride | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Trazodone Hydrochloride Tablets USP 25 mg | Each Uncoated Tablets contains: | USP | 25 mg | Antideprresant |
| Trazodone Hydrochloride | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Antianeamic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Folic Acid Tablets IP 10 mg | Each Uncoated Tablet Contains:- | IP | 10 mg | Antianeamic |
| Folic Acid | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Folic Acid Tablets IP 5 mg | Each Uncoated Tablet Contains:- | IP | 5 mg | Antianeamic |
| Folic Acid | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Ferrous Ascorbate, Folic Acid and Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Antianeamic | ||
| Ferrous Ascorbate | ||||
| Eq. to Elemental Iron————–100 mg | ||||
| Folic Acid IP————————-1.5 mg | ||||
| Zinc Sulphate USP | ||||
| Eq. to Elemental Zinc ————–22.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Sulphate Tablets | Each Film Coated Tablet Contains:- | Antianeamic | ||
| Ferrous Ascorbate | ||||
| Eq. to elemental Iron ————– 100 mg | ||||
| Folic Acid IP ——————— 1.5 mg | ||||
| Cyanocobalamin IP —————-15 mcg | ||||
| Zinc Sulphate monohydrate IP | ||||
| Eq. to Elemental Zinc ————–22.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ferrous Ascorbate, Folic Acid and Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Antianeamic | ||
| Ferrous Ascorbate IP | ||||
| eq. to elemental Iron—————- 100 mg | ||||
| Folic Acid IP ——————- 1.5mg | ||||
| Methylcobalamin IP ————– 1500 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ferrous Bisglycinate, Folic Acid, Zinc Bisglycinate&Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | IP | 60 mg | Anti-anemic |
| Ferrous Bisglycinate | 1 mg | |||
| Folic Acid | 15 mg | |||
| Zinc Bisglycinate | IP | 500 mcg | ||
| Methylcobalamin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Antioxidant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ascorbic Acid Tablets IP | Each UncoatedChewableTablet Contains:- | Antioxidant | ||
| Ascorbic Acid IP ———– 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Ascorbic Acid Tablets IP 100 mg | Each Chewable Tablet Contains : | IP | 100 mg | Antioxidants |
| Ascorbic Acid | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Vitamin C Tablets IP | Each Uncoated Tablet Contains:- | Antioxidants | ||
| Vitamin C IP ————— 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Vitamin C Tablets IP | Each Uncoated Tablet Contains:- | Antioxidants | ||
| Vitamin C IP ————— 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antipsoriatic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Acitretin Capsules IP. | Each Hard Gelatin Capsule Contains: | IP | 25mg | Antipsoriatic |
| Acitretin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Acitretin Capsules I.P. | Each Hard Gelatin Capsule Contains: | IP | 10mg | Antipsoriatic |
| Acitretin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Antiepileptic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Gabapentin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 100.0 mg | Antiepileptic |
| Gabapentin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Gabapentin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 300.0 mg | Antiepileptic |
| Gabapentin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Gabapentin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 400.0 mg | Antiepileptic |
| Gabapentin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | Antiepileptic | ||
| Gabapentin IP ———— 600 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levetiracetam Tablet IP 750 mg | Each film Coated Tablet Contains: | anticonvulsants/antiepileptics | ||
| Levetiracetam IP ——————-750 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Levetiracetam Tablet IP 1000 mg | Each film Coated Tablet Contains: | anticonvulsants/antiepileptics | ||
| Levetiracetam IP ——————-1000 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Levetiracetam Sustained Release Tablets | Each Sustained Release Tablet Contains:- | Anticonvulsants/Antiepileptics | ||
| Levetiracetam USP ————1000 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levetiracetam Tablet IP 500 mg | Each film Coated Tablet Contains: | Anticonvulsants/Antiepileptics | ||
| Levetiracetam IP ——————-500 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Antihistamins | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Diphenhydramine Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 25.0 mg | Antihistamins |
| Diphenhydramine Hydrochloride | q.s. | |||
| Excipients q.s | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Diphenhydramine Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 50.0 mg | Antihistamins |
| Diphenhydramine Hydrochloride | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Antineoplastics | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Isotretinoin Capsule USP | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antineoplastics |
| Isotretinoin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Anti Scabies | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Permethrin Cream | Composition : | 5.0%w/w | Anti Scabies | |
| Permethrin | q.s | |||
| Cream Base | ||||
| Alzheimer’s disease | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Donepzil Hydrochloride &Memantadine Hydrochloride Tablets | Each Film coated Tablets contains: | IP | 5 mg | Alzheimer’s disease |
| Donepzil Hydrochloride | IP | 5 mg | ||
| Memantadine Hydrochloride | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Donepzil Hydrochloride &Memantadine Hydrochloride Tablets | Each Film coated Tablets contains: | IP | 5 mg | Alzheimer’s disease |
| Donepzil Hydrochloride | IP | 10 mg | ||
| Memantadine Hydrochloride | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Antiparkinson | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Levodopa And Carbidopa Tablets I.P. | Each Film Coated Tablet Contains:- | Antiparkinson | ||
| Levodopa I.P ——————– 250mg | ||||
| Carbidopa IP 25mg | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Levodopa And Carbidopa Tablets I.P. | Each Film Coated Tablet Contains:- | AntiParkinson | ||
| Levodopa I.P ——————– 100mg | ||||
| Carbidopa IP 25mg | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Levodopa And Carbidopa Tablets I.P. | Each Film Coated Tablet Contains:- | AntiParkinson | ||
| Levodopa I.P ——————– 100mg | ||||
| Carbidopa IP 10mg | ||||
| Excipients——————q.s. | ||||
| Colour-Approved colour used. | ||||
| Antiaginal | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Isosorbide Dinitrate Tablets IP. | Each Film Coated Tablet Contains:- | Antiaginal | ||
| Diluted Isosorbide Dinitrate I.P. | ||||
| Eq. to Isosorbide Dinitrate———-20mg | ||||
| Excipients—————————q.s. | ||||
| Colour-Approved colour used. | ||||
| Antidiuretic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Furosemide Tablets IP | Each Uncoated Tablet Contains:- | Antidiuretic | ||
| Furosemide IP ————— 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Furosemide Tablets IP | Each Uncoated Tablet Contains:- | Antidiuretic | ||
| Furosemide IP ————— 40 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antidotes | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Calcium Gluconate Tablets IP | Each Uncoated Tablet Contains:- | Antidotes | ||
| Calcium Gluconate IP ————500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Gluconate Tablets IP | Each Uncoated Tablet Contains:- | Antidotes | ||
| Calcium Gluconate IP ————325 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Gluconate Tablets IP | Each Uncoated Tablet Contains:- | Antidotes | ||
| Calcium Gluconate IP ————650 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antacids | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pantoprazole Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Antacids | ||
| Pantoprazole Sodium IP | ||||
| Eq. to Pantoprazole ————– 40 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Alcohol Antagonist | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Disulfiram Tablets IP 200 mg | Each Uncoated Tablet Contains: – | Alcohol Antagonist | ||
| Disulfiram IP———————-200 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Anti-Fibrinolytic Agents | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ethamsylate& Tranexamic acid Tablets | Each Uncoated Tablet Contains: – | Anti-Fibrinolytic Agents | ||
| Ethamsylate BP ————– 250.0 mg | ||||
| Tranexamic acid IP ———–250.0 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Antihemorrhagic | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ethamsylate Tablets | Each Uncoated Tablet Contains: – | Antihemorrhagic | ||
| Ethamsylate BP ————– 250 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved colour used | ||||
| Ethamsylate Tablets | Each Uncoated Tablet Contains: – | Antihemorrhagic | ||
| Ethamsylate BP ————– 500 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Antigout agents | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Probenecid Tablets IP | Each Film Coated Tablet Contains:- | Antigout agents | ||
| Probenecid IP ————— 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antiglaucoma | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Acetazolamide Tablets IP | Each Uncoated Tablet Contains:- | Antiglaucoma | ||
| Acetazolamide IP—– 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antidysrhythmics | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Digoxin Tablet IP | Each uncoated Tablet Contains:- | |||
| Digoxin IP ———— 250 µg | ||||
| Excipients —————— q.s. | ||||
| Colour-Approved colour used. | ||||
| antiplatelet | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Cilostazole Tablet IP | Each uncoated tablet contains: | antiplatelet | ||
| Cilostazole IP —————— 50.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Cilostazole Tablet IP | Each uncoated tablet contains: | antiplatelet | ||
| Cilostazole IP —————— 200.0 mg | ||||
| Excipients ——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Benign Prostatic Hyperplasia | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Silodosin Capsules | Each hard gelatin capsules contain: | IH | 4 mg | Benign Prostatic Hyperplasia |
| Silodosin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Silodosin Capsules | Each hard gelatin capsules contain: | IH | 8 mg | Benign Prostatic Hyperplasia |
| Silodosin | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Dutasteride Capsules IP | Each hard gelatin capsule contains: | IP | 0.5 mg | Benign Prostatic Hyperplasia |
| Dutasteride | q.s. | |||
| Excipients | ||||
| Approved colors used in Hard Gelatin Capsule shell. | ||||
| Silodosin & Dutasteride Capsules | Each hard gelatin capsules contain: | IH | 8 mg | Benign Prostatic Hyperplasia |
| Silodosin ( as pellets ) | IP | 0.5 mg | ||
| Dutasteride( as pellets ) | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Tamsulosin HCl Prolonged release | Each hard gelatin capsule contains:- | IP | 200mcg | Benign Prostatic Hyperplasia |
| Capsules IP | Tamsulosin HCl | |||
| (As prolonged release pellets) | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells & pellets. | ||||
| Tamsulosin HCl Prolonged release | Each hard gelatin capsule contains:- | IP | 400mcg | Benign Prostatic Hyperplasia |
| Capsules IP | Tamsulosin HCl | |||
| (As prolonged release pellets) | q.s. | |||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells & pellets. | ||||
| Tamsulosin HCl (Sustained Release) and Deflazacort tablets | Each Film Coated Bilayered Tablet Contains:- | IP | 0.4 mg | Benign Prostatic Hyperplasia |
| Tamsulosin HCl | ||||
| (As Sustained Release) | 30 mg | |||
| Deflazacort | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Tamsulosin HCl and Dutasteride tablets | Each Film Coated Tablet Contains:- | Benign Prostatic Hyperplasia | ||
| Tamsulosin HCl IP————- 0.4 mg | ||||
| Dutasteride IP ——————- 0.5 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Bronchodilator | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Acebrophylline Capsules | Each Hard Gelatin Capsules Contains: | 100.0 mg | Bronchodilator | |
| Acebrophylline | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Theophylline Prolonged – release Tablets IP | Each Film Coated Tablet Contains:- | Bronchodilator | ||
| Theophylline IP ——- 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Acebrophylline Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Broncodilator | ||
| Acebrophylline ——————- 200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Salbutamol Tablets IP | Each Film Coated Tablet Contains:- | Bromcholdialtor | ||
| Salbutamol Sulphate IP | ||||
| Eq. to Salbutamol ————— 4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Etofylline & Theophylline Tablets | Each Uncoated Sustained Release Tablet Contains:- | Bromcholdialtor | ||
| Etofylline —————– 231 mg | ||||
| Theophylline —————— 69 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium & Vitamins | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Methylcobalamin, Calcium carbonate, Calcitriol, folic acid and Pyridoxin Hydrochloride Capsules | Each Hard Gelatin Capsule contains: | IP | 1500 mcg | Calcium & Vitamins |
| Methylcobalamin | ||||
| Calcium carbonate equivalent to elemental Calcium | IP | 200 mg | ||
| Calcitriol | IP | 0.25 mcg | ||
| Folic Acid | IP | 1.5 mg | ||
| Pyridoxine Hydrochloride | IP | 3.0 mg | ||
| Excipients | q.s. | |||
| Approved colored used in Hard Gelatin Capsule shell | ||||
| Methylcobalamin, Alpha lipoic Acid, Inositol, Folic acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules | Each hard gelatin Capsules contains: | IP | 1500mcg | Calcium & Vitamins drug |
| Methylcobalamin | USP | 100mg | ||
| Alpha Lipoic Acid | BP | 100mg | ||
| Inositol | IP | 1.5mg | ||
| Folic Acid | USP | 200mcg | ||
| Chromium Polynicotinate | USP | 55mcg | ||
| Selenium Dioxide | 150mg | |||
| Benfotiamine | q.s | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Calcium, Magnesium, Vitamin D3 and Zinc Sulphate | Each Uncoated Tablet Contains:- | Calcium & Vitamins | ||
| Calcium citrate USP | ||||
| Eq. to Elemental calcium———— 200mg | ||||
| Vitamin D3 Granules | ||||
| Eq. to Vitamin D3 IP—————– 200 IU | ||||
| Magnesium Hydroxide IP | ||||
| Eq. to Elemental Magnesium ———50mg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc—————–4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Vitamin K2-7, Calcitriol, Calcium, Zinc and Magnesium Tablets | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
| Vitamin K2-7 ———————– 50 mcg | ||||
| Calcium Carbonate IP | ||||
| Eq. to Elemental calcium———— 500mg | ||||
| Calcitriol IP ———————- 0.25 mcg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc—————7.5 mg | ||||
| Magnesium Sulphate IP | ||||
| Eq. to elemental Magnesium ——- 50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Citrate, Magnesium, Zinc with Vitamin D3 Tablets | Each Film Coated Tablet Contains:- | Calcium & vitamins | ||
| Calcium citrate USP ————1000mg | ||||
| Magnesium Hydroxide IP——– 100mg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc—————–4 mg | ||||
| Vitamin D3 IP—————– 200 IU | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium and Vitamin D3 Tablets IP | Each Film Coated Tablet Contains:- | Calcium & vitamins | ||
| Calcium Carbonate IP | ||||
| Eq. to Elemental Calcium———-500mg | ||||
| Vitamin D3 IP—————– 250 IU | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Zinc & Vitamin C Chewable Tablet | Each uncoated chewable tablet contains: – | Calcium & vitamins | ||
| Zinc Gluconate 87.1 mg | ||||
| eq. to. Elemental zinc 12.5 mg) | ||||
| Ascorbic acid 100 mg + Sodium Ascorbate 170 mg | ||||
| eq. to ascorbic acid 150 mg | ||||
| Excipients —————–q.s. | ||||
| Colour:- Approved colour used | ||||
| Calcium, Calcitriol, Vitamin K2-7 Tablets | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
| Calcium Carbonate IP | ||||
| Eq. to Elemental calcium———— 500mg | ||||
| Calcitriol IP ———————- 0.25 mcg | ||||
| Vitamin K2-7 ———————– 1000 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Carbonate and Vitamin D3 Tablets IP | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
| Calcium Carbonate IP | ||||
| Eq. to Elemental Calcium———- 250mg | ||||
| Vitamin D3 IP—————– 125 IU | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium and Vitamin D3 Tablets IP | Each Film Coated Tablet Contains:- | Calcium & vitamins | ||
| Calcium Carbonate 1.25 gm IP | ||||
| Eq. to elemental calcium (Derived From an Organic source oyster shell) ———- 500mg | ||||
| Vitamin D3 IP—————– 500 IU | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Citrate Maleate, Magnesium, Zinc, Vit. D3, Methylcobalamin, L- Methyl Folate & Pyridoxal Phosphate | Each Film Coated Tablet contains: | Calcium & Vitamin | ||
| Calcium Citrate Maleate USP 12.50 mg | ||||
| Eq. to elemental Calcium ———- 250 mg | ||||
| Magnesium Hydroxide IP———- 100 mg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to Elemental Zinc —————- 10 mg | ||||
| Vitamin D3 ———————————- 2000 IU | ||||
| Methylcobalamin IP —————–1500 mcg | ||||
| L- Methyl Folate IP —————— 1 mg | ||||
| Pyridoxal Phosphate IP —————– 20 mg | ||||
| Excipients ——————- q.s. | ||||
| Colour-Approved colour used. | ||||
| Calcium Citrate, Vitamin D3 &Zinc Tablets | Each Uncoated Tablet Contains:- | Calcium & Vitamin | ||
| Calcitriol Citrate USP————-1000 mg | ||||
| Vitamin D3 IP ——————200 IU | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc————– 4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium, Magnesium Vitamin D3 &Zinc Tablets | Each Uncoated Tablet Contains:- | Calcium & Vitamins | ||
| Calcium Citrate USP————-1000 mg | ||||
| Vitamin D3 IP ——————200 IU | ||||
| Magnesium Hydroxide IP | ||||
| Eq. to Elemental Magnesium ——-100 mg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc————– 4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium citrate, Vitamin D3, Magnesium Hydroxide and Zinc Sulphate | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
| Calcium citrate USP | ||||
| Eq. to Elemental calcium———— 1000mg | ||||
| Vitamin D3 Granules | ||||
| Eq. to Vitamin D3 IP—————– 400 IU | ||||
| Magnesium Hydroxide IP | ||||
| Eq. to Elemental Magnesium ———100mg | ||||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to elemental Zinc—————–4 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Calcium Pantothenate Tablets IP 100 mg | Each Film Coated Tablet Contains:- | IP | 100 mg | Calcium & Vitamin |
| D- Calcium Pantothenate | q.s | |||
| Excipients | ||||
| Colour-Approved colour used | ||||
| Calcium Carbonate, Vitamin D3, Methylcobalamin, L- Methyl Folate Calcium & Pyridoxal 5 Phosphate | Each Film Coated Tablet contains: | IP | 1250 mg | Calcium & Vitamin |
| Calcium Carbonate | ||||
| Eq. to Elemental Calcium | IP | 2000 IU | ||
| Vitamin D3 | IP | 1500 mcg | ||
| Methylcobalamin | 1 mg | |||
| L- Methyl Folate | 20 mg | |||
| Pyridoxal 5 Phosphate | ||||
| Excipients . | q.s | |||
| Colour-Approved colour used. | ||||
| Calcium Dobesilate capsules | Each Hard Gelatin Capsule contains: | IP | 500 mg | Calcium & Vitamins |
| Calcium dobesilate Monohydrate | q.s. | |||
| Excipients | ||||
| Approved colored used in Hard Gelatin Capsule shell | ||||
| Cholecalciferol Tablets IP | Each Film Coated Tablet Contains:- | Calcium & Vitamin | ||
| Cholecalciferol IP ———–60000 IU | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Cholinesterase inhibitor | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Rivastigmine Capsules USP | Each hard gelatin capsule contains:- | USP | 1.5mg | Cholinesterase inhibitor. |
| Rivastigmine Tartrate | q.s. | |||
| Eq. to Rivastigmine | ||||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells. | ||||
| Rivastigmine Capsules USP | Each hard gelatin capsule contains:- | USP | 3mg | Cholinesterase inhibitor. |
| Rivastigmine Tartrate | q.s. | |||
| Eq. to Rivastigmine | ||||
| Excipients | ||||
| Colour: Approved colours used in empty capsule shells. | ||||
| Corticosteroid & Bronchodilator | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Doxofylline MR Tablets 650 mg | Each Uncoated Modified Release Tablet Contains:- | IP | 650 mg | Corticosteroid & Bronchodilator |
| Doxofylline | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Deflazacort Tablets 12 mg | Each Uncoated Tablet Contains:- | 12 mg | Corticosteroid & Bronchodilator | |
| Deflazacort | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Montelukast And Olopatadine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Montelukast Sodium I.P. | ||||
| eq. to Montelukast 10mg | ||||
| Olopatadine Hydrochloride I.P—-5mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Montelukast Tablets I.P. | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Montelukast Sodium I.P. | ||||
| Eq.to Montelukast——— 5mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Montelukast Tablets I.P. | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Montelukast Sodium I.P. | ||||
| Eq.to Montelukast———- 10mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Ambroxol Hydrochloride And Olopatadine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Ambroxol Hydrochloride I.P——-30mg | ||||
| Olopatadine Hydrochloride USP—-5mg | ||||
| Excipients————————q.s. | ||||
| Colour-Approved colour used. | ||||
| Prednisolone Tablets I.P | Each film coated tablet contains: | Corticosteroid & Bronchodilator | ||
| Prednisolone Acid I.P———– 5 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Prednisolone Tablets I.P | Each film coated tablet contains: | Corticosteroid & Bronchodilator | ||
| Prednisolone Acid I.P———– 10 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Prednisolone Tablets I.P | Each film coated tablet contains: | Corticosteroid & Bronchodilator | ||
| Prednisolone Acid I.P———– 20 mg | ||||
| Excipients————————–q.s | ||||
| Colour-Approved colour used. | ||||
| Doxofylline Tablets IP | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Doxofylline IP ——— 400 mg | ||||
| Excipients—————– q.s | ||||
| Methylprednisolone Tablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Methylprednisolone 4mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Methylprednisolone Tablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Methylprednisolone 2mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Methylprednisolone Tablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Methylprednisolone 16mg | ||||
| Excipients q.s. | ||||
| MethylprednisoloneTablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
| Methylprednisolone 8.0mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Calcium supplement | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Cholecalciferol Chewable tablets 60,000 I.U. | Each uncoated chewable tablet contains: | IP | 60,000 IU | Calcium supplement |
| Cholecalciferol (As Stabilized) | q. s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Alfacalcidol, Calcium Carbonate and Betacarotene Tablets | Each Film Coated Tablet Contains:- | Calcium supplement | ||
| Alfacalcidol I.P.————– 0.25 mcg | ||||
| Calcium Carbonate IP 625 mg | ||||
| (From an Organic Source Oyster Shell) | ||||
| Eq. to Elemental Calcium —- 250 mg | ||||
| Betacarotene (30%)————– 2500 IU | ||||
| Excipients—————————q.s. | ||||
| Colour-Approved colour used. | ||||
| Diagestive enzyme | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pancreatin and Activated Dimethicone Tablets | Each Enteric Coated Tablets Contains | Diagestive enzyme | ||
| Pancreatin IP ———— 170 mg | ||||
| Activated Dimethicone IP —–80 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Erectile Dysfunction | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Erectile Dysfunction | ||
| Tadalafil IP —————- 5.0 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Erectile Dysfunction | ||
| Tadalafil IP —————- 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Erectile Dysfunction | ||
| Tadalafil IP —————- 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
| Labeltalol Hydrochloride IP ——-50 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
| Labeltalol Hydrochloride IP ——-100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
| Labeltalol Hydrochloride IP ——-200 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
| Labeltalol Hydrochloride IP ——- 400 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Sildenafil Citrate Tablets IP | Each Film Coated Tablet Contains:- | Erectile dysfunction | ||
| Sildenafil Citrate IP | ||||
| Eq. to Sildenafil ————— 50 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Sildenafil Citrate Tablets IP | Each Film Coated Tablet Contains:- | Erectile dysfunction | ||
| Sildenafil Citrate IP | ||||
| Eq. to Sildenafil ————— 100 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Gastrointestinal Agent | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Acotiamide Hydrochloride Hydrate Tablets 100 mg | Each Film coated Tablets contains: | 100 mg | Gastrointestinal Agent | |
| Acotiamide Hydrochloride Hydrate Excipients | q.s | |||
| Colour: Approved Colour Used | ||||
| Hydrating agent | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Urea, Lactic acid, Propylene Glycol & Liquid Paraffin Cream | Composition : | IP | 10%w/w | Hydrating agent |
| Urea | IP | 10%w/w | ||
| Lactic Acid | IP | 10%w/w | ||
| Propylene Glycol | IP | 10%w/w | ||
| Liquid Paraffin | ||||
| Preservatives: | IP | 0.16%w/w | ||
| Methyl Paraben | IP | 0.04%w/w | ||
| Propyl Paraben | q.s | |||
| Cream Base | ||||
| Histamine Hl-Receptor Antagonist | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Cyproheptadine Hydrochloride 4 mg IP | Each uncoated tablet contains : – | Histamine Hl-Receptor Antagonist | ||
| Cyproheptadine Hydrochloride IP ——4.0 mg | ||||
| Excipients……………q.s. | ||||
| Colour : Approved Colour Used | ||||
| Hypothyroidism | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
| Thyroxine Sodium IP ————- 12.5 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
| Thyroxine Sodium IP ————- 100 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
| Thyroxine Sodium IP ————- 25 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
| Thyroxine Sodium IP ————- 50 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
| Thyroxine Sodium IP ————- 75 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Levothyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
| Levothyroxine Sodium IP | ||||
| Eq. to Levothyroxine ————- 25 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Immunosuppresant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Tacrolimus Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 0.5 mg | Immunosuppresant |
| Tacrolimus | q.s. | |||
| Eq. to Anhydrous Tacrolimus | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Tacrolimus Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 1.0 mg | Immunosuppresant |
| Tacrolimus | q.s. | |||
| Eq. to Anhydrous Tacrolimus | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Cyclosporine Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 25.0 mg | Immunosuppresant |
| Cyclosporine | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Cyclosporine Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 50.0 mg | Immunosuppresant |
| Cyclosporine | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Cyclosporine Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 250.0 mg | Immunosuppresant |
| Cyclosporine | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
| Mycophenolate Mofetil IP——— 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
| Mycophenolate Mofetil IP——— 360 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
| Mycophenolate Mofetil IP——— 500 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
| Mycophenolate Mofetil IP——— 750 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Tacrolimus ointment 0.1% w/w | Composition: | U.S.P. | 0.1%w/w | Immunosuppressive |
| Tacrolimus | q.s | |||
| Ointment Base | ||||
| Tacrolimus Ointment | Composition:- | IP | 0.03%w/w | Immunosuppressive Agents |
| Tacrolimus | q.s. | |||
| Excipients | ||||
| Iron, Calcium & Vitamin | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Zinc Acetate Tablets | Each Film coated Tablet Contains:- | USP | 50 mg | Iron, Calcium & Vitamin |
| Zinc Acetate (As Dihydrate) | q.s | |||
| Eq. to. Zinc | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Zinc Sulphate Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains:- | IRON, CALCIUM & VITAMIN D | ||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to Elemental Zinc ———— 20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Zinc Sulphate Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains:- | IRON, CALCIUM & VITAMIN D | ||
| Zinc Sulphate Monohydrate IP | ||||
| Eq. to Elemental Zinc ———— 10 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Laxative | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Prucalopride Tablet 1 mg | Each Film coated Tablet Contains:- | 1 mg | Laxative | |
| Prucalopride Succinate | q.s | |||
| Eq. to Prucalopride | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Prucalopride Tablet 2 mg | Each Film coated Tablet Contains:- | 2 mg | Laxative | |
| Prucalopride Succinate | q.s | |||
| Eq. to Prucalopride | ||||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Activated Dimethicone, Magnesium Hydroxide, Dried Aluminium Hydroxide Gel and Magnesium Aluminum Silicate Hydrate Tablets | Each Uncoated chewable tablet Contains:- | laxatives | ||
| Activated Dimethicone IP ——50 mg | ||||
| Magnesium Hydroxide IP ——— 250 mg | ||||
| Dried Aluminium Hydroxide Gel IP —250 mg | ||||
| Magnesium Aluminum Silicate Hydrate —————————————- 250 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Multivitamins | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Carbonyl Iron, folic acid, Vitamin B12 and Zinc Sulphate Capsules | Each hard gelatin capsule contain: | IP | 100 mg | Multivitamins |
| Carbonyl Iron | 1.5 mg | |||
| Equivalent to Elemental Iron | IP | 15 mcg | ||
| Folic acid | IP | 61.8 mg | ||
| Vitamin B12 | IP | 22.5 mg | ||
| Zinc sulphate monohydrate | q.s. | |||
| Equivalent to elemental zinc | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Multivatamin, Multiminerals with lycopene Capsules | Each Hard Gelatin capsule contains: | USP | 5 mg | Multivatamin |
| Lycopene 6 % | USP | 6 mg | ||
| Lutien 8 % | USP | 10 mg | ||
| Beta carotene (10 % Dispersion) | IP | 5 mcg | ||
| Vitamin B6 | IP | 200 IU | ||
| Vitamin B12 | IP | |||
| Vitamin D3 | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Alpha Lipoic acid, Methylcobalamin, Vitamin B6, Folic acid, Benfotiamine ,Biotin, Chromium Picolinate Capsules | Each Hard Gelatin capsule contains: | USP | 100 mg | Mutivitamins |
| Alpha Lipoic Acid | IP | 1500mcg | ||
| Methylcobalamin | IP | 3 mg | ||
| Vitamin B6 | IP | 1.5 mg | ||
| Folic acid | IH | 50 mg | ||
| Benfotiamine | USP | 5 mg | ||
| Biotin | USP | 200 mcg | ||
| Chromium Picolinate USP | q.s. | |||
| Eq. to Chromium | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Methylcobalamin, Alpha lipoic acid, Benzothiazine, Vit B6, calcium Pantothenate, Nicotinamide & Folic acid capsule | Each Hard gelatin capsule contain: | IP | 750 mcg | Multivitamin |
| Methylcobalamin | USP | 100 mg | ||
| Alpha lipoic acid | IH | 7.5 mg | ||
| Benfothiamine | IP | 1.5 mg | ||
| Vit B6 | IP | 25 mg | ||
| Calcium Pantothenate | IP | 50 mg | ||
| Nicotinamide | IP | 0.75 mg | ||
| Folic acid | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Mecobalamin, Vitamin B1, B6, Alpha lipoic Acid & Folic Acid Capsule | Each hard gelatin capsule contains: | IP | 1500 mcg | Multivitamin |
| Mecobalamin | IP | 10 mg | ||
| Vitamin B1(Thiamine Mononitrate) | IP | 3 mg | ||
| Vitamin B6(Pyridoxine HCL) | USP | 100 mg | ||
| Alpha Lipoic Acid | IP | 1.5 mg | ||
| Folic Acid | q. s | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Alpha lipoic Acid &Methylcobalamin capsules | Each Hard gelatin Capsule contains: | IP | 1500 mcg | Multivitamins |
| Methylcobalamin | IP | 300 mg | ||
| Alphalipoic Acid | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Methylcobalamin, Folic Acid, Alpha Lipoic Acid Vitamin B1 & vitamin B6 | Each Hard Gelatin Capsule Contains: | IP | 500 mcg | Mutivitamins |
| Methylcobalamin | IP | 1.5 mg | ||
| Folic Acid | USP | 100 mg | ||
| Alpha Lipoic Acid | IP | 10.0 mcg | ||
| Vitamin B1 Mononitrate | IP | 3.0 mg | ||
| Vitamin B6 HCl | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Alpha Lipoic acid, Pyridoxine HCl, Methylcobalamin, Folic acid, Benfothiamine, Biotin & Chromium Capsules | Each hard gelatin capsule contains:- | USP | 100mg | Mutlivitamin |
| Alpha Lipoic Acid | IP | 3mg | ||
| Pyridoxine Hydrochloride | IP | 1500mcg | ||
| Methylcobalamin | IH | 50mg | ||
| Benfothiamine | USP | 5mg | ||
| Biotin | IP | 1.5mg | ||
| Folic Acid | USP | |||
| Chromium Picolinate | 200mcg | |||
| Eq. to Chromium | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Methylcobalamin, Pregabalin, Vitamin B6, Folic Acid &Benfothiamine Capsules | Each hard gelatin capsule contains: | IP | 750 mcg | Multivitamin |
| Methylcobalamin | IP | 75 mg | ||
| Pregabalin | IP | 1.5 mg | ||
| Vitamin B6 | IP | 0.75 mg | ||
| Folic Acid | IH | 7.5 mg | ||
| Benfothiamine | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells. | ||||
| Sodium Feredetate, Folic Acid & Vitamin B12 Tablets | Each Film Coated Tablet Contains:- | BP | 231 mg | Mutivitamin |
| Sodium Feredetate | 33 mg | |||
| Eq. to Elemental Iron | 1.5 mg | |||
| Folic Acid | 15 mcg | |||
| Vitamin B12 | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Vitamin C, Sodium Ascorbate & Zinc Citrate Tablets | Each Uncoated Tablet Contains:- | IP | 100 mg | Mutivitamin |
| Ascorbic Acid | IP | |||
| Sodium Ascorbate (450 mg) | 400 mg | |||
| Eq. to Ascorbic Acid | IP | |||
| Zinc Citrate | 5 mg | |||
| Eq. to Elemental Zinc | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Methylcobalamin, L- Methylfolate, Pyridoxal Phosphate, Vitamin D3 & DHA Tablets | Each Film coated Tablet Contains:- | IP | 1500 mcg | Multivitamin |
| Methylcobalamin | 1 mg | |||
| L- Methylfolate | 0.5 mg | |||
| Pyridoxal Phosphate | 1000 IU | |||
| Vitamin D3 | 100 mg | |||
| Doscosahexaneoic Acid (DHA ) | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| L- Methylfolate, Pyridoxal 5 Phosphate & Methylcobalamin Tablets | Each Film coated Tablet Contains:- | IP | 5 mg | Multivitamin |
| L- Methylfolate | 3 mg | |||
| Pyridoxal 5 Phosphate | 1500 mcg | |||
| Methylcobalamin | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Methylcobalamin, L- Methyl Folate Calcium, & Pyridoxal-5 Phosphate Tablets | Each Film Coated Tablet contains: | Mutivitamin | ||
| Methylcobalamin IP —————–1500 mcg | ||||
| L- Methyl Folate Calcium ———- 1 mg | ||||
| Pyridoxal-5 Phosphate —————– 0.5 mg | ||||
| Excipients ——————- q.s. | ||||
| Colour-Approved colour used. | ||||
| Calcium Citrate Malate, Calcitriol, Vitamin K2-7 Tablets | Each Film Coated Tablet Contains:- | Mutivitamin | ||
| Calcium Citrate Malate IP | ||||
| Eq. to Elemental calcium———— 250mg | ||||
| Calcitriol ————————— 0.25 mcg | ||||
| Vitamin K2-7 ———————– 50 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Antioxidant Multivitamins &Multiminerals Tablets | Each Film Coated Tablet Contains:- | Multivitamin | ||
| Vitamin A Acetate IP ————— 5000 IU | ||||
| Vitamin E Acetate IP —————- 25 IU | ||||
| Ascorbic Acid IP ——————- 100 mg | ||||
| Thiamine Monohydrate IP ——– 10 mg | ||||
| Riboflavin IP ————————–10 mg | ||||
| Pyridoxine Hydrochloride IP —— 3 mg | ||||
| Cyanocobalamin IP—————— 5 mcg | ||||
| Niacinamide IP ———————— 50 mg | ||||
| Folic Acid IP —————————–1 mg | ||||
| Calcium Pantothenate IP ————12.5 mg | ||||
| Zinc Oxide IP | ||||
| Eq. to Elemental Zinc ————– 15 mg | ||||
| Cupric Oxide USP | ||||
| Eq. to Elemental Cupric ————– 2.5 mg | ||||
| Sodium Selenate BP | ||||
| Eq. to Elemental Sodium ————– 60 mcg | ||||
| Magnesium Chloride USP | ||||
| Eq. to Magnesium ——————-1.5 mg | ||||
| Chromium Chloride USP | ||||
| Eq. to Elemental Chromium ——— 65 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used | ||||
| Adenosylcobalamin, Iron, Folic Acid and Zinc Tablets | Each Film Coated Tablet Contains:- | Mutivitamin | ||
| Adenosylcobalamin ———- 15 mcg | ||||
| Ferrous Ascorbate | ||||
| Eq. to Elemental Iron————–100 mg | ||||
| Folic Acid IP————————-1.5 mg | ||||
| Zinc Sulphate USP | ||||
| Eq. to Elemental Zinc —————-22.5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Sodium Feredetate, Folic Acid and Vitamin B12 Tablets | Each Film Coated Tablet Contains:- | Multivitamins | ||
| Sodium Feredetate BP ————- 231mg | ||||
| (Eq. to 33 mg. Elemental Iron) | ||||
| Folic Acid IP ———————– 1.5 mg | ||||
| Vitamin B12 IP ——————- 15 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Methylcobalamin, Alpha Lipoic Acid, Vitamin D3, Pyridoxine Hydrochloride, Folic Acid Tablets | Each Film Coated Tablet Contains:- | Mutivitamins | ||
| Methylcobalamin IP ————– 1500 mcg | ||||
| Alpha Lipoic Acid USP ————- 100 mg | ||||
| Vitamin D3 IP—————– —1000 IU | ||||
| Pyridoxine Hydrochloride IP —— 3 mg | ||||
| Folic Acid IP ——————- 1.5mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Methylcobalamin, Alpha Lipoic Acid, Gabapentin & Pyridoxine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Mutivitamins | ||
| Methylcobalamin IP ————– 750 mcg | ||||
| Alpha Lipoic Acid USP ————- 100 mg | ||||
| Gabapentin IP——————— 300 mg | ||||
| Pyridoxine Hydrochloride IP —— 3 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Methylcobalamin, Alpha Lipoic Acid, Vitamin B6, Folic Acid, Zinc, Chromium, Selenium, Biotin & Inositol Tablets | Each Film Coated Tablet Contains:- | Multivitamin | ||
| Methylcobalamin IP ————– 1500 mcg | ||||
| Alpha Lipoic Acid USP ————- 100 mg | ||||
| Vitamin B6 ——————– 3 mg | ||||
| Folic Acid IP ——————- 1.5mg | ||||
| Zinc ——————————– 15 mg | ||||
| Chromium ———————– 60 mcg | ||||
| Selenium ————————- 65 mcg | ||||
| Biotin —————————– 100 mcg | ||||
| Inositol ————————- 2 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Biotin Tablets | Each Film Coated Tablet Contains:- | Multivitamin | ||
| Biotin USP ————————— 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Muscle Relaxant | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Baclofen Extended Release Capsules | Each hard gelatin capsule contains: | IP | 30 mg | Muscle Relaxant |
| Baclofen | ||||
| ( As extended Release pellets ) | q.s. | |||
| Excipients | ||||
| Approved colours used in empty capsule shells & pellets. | ||||
| Alfuzosin HCl (ER) and Dutasteride Tablets | Each Film Coated Tablet Contains :- | Muscle Relaxant | ||
| Alfuzosin Hydrochloride I.P—— 10mg | ||||
| Dutasteride I.P. — 0.5mg | ||||
| Excipients——————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Drotaverine Tablets IP | Each film coated tablet contains: | Muscle Relaxant | ||
| Drotaverine Hydrochloride IP——40mg | ||||
| Excipients—————————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Drotaverine Tablets IP | Each film coated tablet contains: | Muscle Relaxant | ||
| Drotaverine Hydrochloride IP——-80mg | ||||
| Excipients————————–q.s. | ||||
| Colour-Approved colour used. | ||||
| Carisoprodol Tablets USP 500 mg | Each Uncoated Tablets contains: | USP | 500 mg | Skeletal Muscle Relaxants |
| Carisoprodol | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used. | ||||
| Baclofen Tablets IP 10 mg | Each Uncoated Tablets contains: | IP | 10 mg | Skeletal Muscle Relaxants |
| Baclofen | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Baclofen Tablets IP 25 mg | Each Uncoated Tablets contains: | IP | 25 mg | Skeletal Muscle Relaxants |
| Baclofen | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Pancreatic Enzymes | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pancreatin 300 mg Capsule | Each Hard Gelatin capsule contains: | IP | 300 mg | Pancreatic Enzymes |
| Pancreatin (Enteric coated pellets) | q.s. | |||
| Eq. to. Pancreatin | ||||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| L-Ornithine L-Aspartate and Pancreatin Tablets | Each Enteric Coated Tablets Contains | Pancreatic Enzymes | ||
| L-Ornithine L-Aspartate——– 150 mg | ||||
| Pancreatin IP——————- 100 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Pancreatin Tablets | Each Enteric Coated Tablets Contains | Pancreatin Enzyme Deficiency | ||
| Pancreatin IP ———— 212.5 mg | ||||
| Eq. to Lipase activity ———-6000 FIP units | ||||
| Amylase Activity ————4500 FIP units | ||||
| Protease Activity —— 300 FIP units | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Protease Inhibitors | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ritonavir Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 10.0 mg | Protease Inhibitors |
| Ritonavir | q.s. | |||
| Excipients | ||||
| Approved colour used in empty hard gelatin capsule shell | ||||
| Skin lightening agent | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Hydroquinone | Composition: | USP | 4.0% w/w | Skin lightening agent |
| Cream USP | Hydroquinone | q.s. | ||
| In a Cream Base | ||||
| Sedative | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Melatonin Tablets 3 mg | Each Uncoated Tablets contains: | 3 mg | Sedative | |
| Melatonin | q.s | |||
| Excipients | ||||
| Colour: Approved Colour Used | ||||
| Treatment osteoporosis | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ibandronic Acid Tablets 150 mg | Each Film coated Tablets contains: | Treatment osteoporosis | ||
| Ibandronic Acid monosodium Monohydrate | ||||
| Eq. to Ibandronic Acid 150 mg | ||||
| Excipients q.s | ||||
| Colour: Approved Colour Used | ||||
| Alendronic Acid Tablets USP | Each Film Coated Tablet Contains:- | Treatment osteoporosis | ||
| Alendronate Sodium USP | ||||
| Eq.to Alendronic Acid 10 mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Treat iron overload | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Deferasirox Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Treat iron overload | ||
| Deferasirox 500mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Deferasirox Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Treat iron overload | ||
| Deferasirox 250mg | ||||
| Excipients q.s. | ||||
| Colour-Approved colour used. | ||||
| Transfusional hemosiderosis | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Deferasirox Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Transfusional hemosiderosis | ||
| Deferasirox———–500mg | ||||
| Excipients————————-q.s. | ||||
| Colour-Approved colour used. | ||||
| Treatment vitamin B6 deficiency | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Pyridoxine Tablets IP | Each Film Coated Tablet Contains:- | Treatment vitamin B6 deficiency | ||
| Pyridoxine Hydrochloride IP——– 5 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| uterine relaxants | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Ritodrine Hydrochloride Tablets IP 10 mg | Each Film Coated Tablet Contains:- | IP | 10 mg | uterine relaxants |
| Ritodrine Hydrochloride | q.s | |||
| Excipients. | ||||
| Colour-Approved colour used. | ||||
| Uricosuric Agent | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Allopurinol Tablets IP | Each Film Coated Tablet Contains:- | Uricosuric Agent | ||
| Allopurinol IP ———— 300 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Vitamins | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Vitamins | ||
| Methylcobalamin IP —————-500 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Vitamins | ||
| Methylcobalamin IP —————-1000 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Vitamins | ||
| Methylcobalamin IP —————-1500 mcg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Biotin Tablets USP | Each Film Coated Tablet Contains: | U.S.P. | 5 mg | Vitamin Supplement |
| Biotin | q.s. | |||
| Excipients | ||||
| Colour-Approved colour used | ||||
| Vasodilator | ||||
| Generic Name | Composition | Ph. Ref. | Str. | Category |
| Isoxsuprine HCl Sustained Release Tablets 40 mg | Each Uncoated Sustained release Tablet Contains:- | IP | 40 mg | Vasodilator |
| Isoxsuprine Hydrochloride | q.s | |||
| Excipients | ||||
| Colour-Approved colour used. | ||||
| Isoxsuprine Tablets IP | Each Film Coated Tablet Contains:- | vasodilators | ||
| Isoxsuprine IP———20 mg | ||||
| Excipients—————– q.s | ||||
| Colour-Approved colour used. | ||||
| Hydroquinoine, Octyl Methoxycinnamate & Oxybenzone Cream | Composition : | USP | 2.0 %w/w | |
| Hydroquinoine | USP | 5.0 %w/w | ||
| Octyl Methoxycinnamate | USP | 3.0 %w/w | ||
| Oxybenzone | q.s. | |||
| Cream base | ||||
| Doxofylline Tablets IP | Each Uncoated Tablet | |||
| Contains:- | ||||
| Doxofylline………………………….IP 400mg | ||||
| Excipients | ||||
| Colour-Approved colour used…………..q.s | ||||
| Mefenamic Acid and Paracetamol Tablets | Each Uncoated Tablet Contains:- | I.P. | 250 mg | |
| Mefenamic Acid | I.P. | 325 mg | ||
| Paracetamol | q.s | |||
| Excipients . | ||||
| Colour-Approved colour used. | ||||
[/vc_column_text][/vc_column][/vc_row]
